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Epigenetic parent-of-origin effects contribute significantly to phenotypic variation in 
animals. Imprinted genes, which show differential allelic expression in a parent of-origin 
dependent manner, are critical regulators of prenatal development. Altered epigenetic 
modifications of imprinted genes in response to maternal environmental stimuli are believed 
to impact on prenatal development with long-term consequences for postnatal phenotype, a 
process which is known as fetal programming. Most studies in the area of fetal programming 
have focused on the epigenetic link between intrauterine environment and fetal phenotype, 
and genetic programming of variation in pre- and postnatal growth traits remains largely 
unexplored. 
We hypothesised that heterosis, i.e., the superiority of F1 hybrids compared to their 
parents, in growth traits is programmed prenatally through changes in expression patterns of 
imprinted genes. The purpose of this thesis was (i) to perform a comparative in silico analysis 
of promoter-specific transcripts and splice variants of the imprinted IGF2 and IGF2R genes as 
well as their imprinted regulatory non-coding RNAs, H19 and AIRN, (ii) to analyse 
expression patterns of all identified transcripts in bovine pre- and postnatal tissues, and (iii) to 
investigate fetal genetic effects on gene expression and their association with heterotic 
phenotype. 
To this end, a bovine model was employed using two genetically and phenotypically 
distinct subspecies of domesticated cattle, Bos taurus and Bos indicus, and their reciprocal 
crosses. Real time quantitative PCR was used to quantify expression of IGF2 promoter-
specific transcripts, IGF2R, H19 and AIRN, in liver, brain, heart, cotyledon, skeletal muscle, 
kidney, lung and testis at three developmental stages, Day-48 embryo, Day-153 fetus and 12-
month juvenile. Heterotic effects on transcript abundances and expression patterns of 
imprinted genes and their correlations with fetal body weight and weights of fetal tissues were 
estimated with general linear models. 
xiv 
All studied imprinted genes were subject to developmental control of gene expression 
with the transcript abundance being downregulated in postnatal tissues. We identified IGF2 
promoter-specific transcripts and the bovine orthologue of human P0 promoter, and found a 
developmental shift in tissue specificity of P0 from fetal skeletal muscle to postnatal liver. 
Fetal body weight and absolute weights of fetal tissues, except brain, were subject to 
significant parent-of-origin effects, and were higher in fetal groups with B. taurus maternal 
genetics compared to B. indicus maternal genetics. Fetal placental weight, lung weight and 
relative muscle mass showed significant heterosis. Heterosis in fetal placental weight was 
associated with a polar overdominance imprinting pattern of IGF2R and AIRN in cotyledon 
with highest expression in B. indicus (sire) × B. taurus (dam) group, whereas the transcript 
abundance in the other reciprocal was close to purebred groups. In hybrid genetic groups, 
expression of IGF2R and AIRN in cotyledon was positively correlated with weight of fetal 
placenta and negatively correlated with placental efficiency, defined as fetal to placental 
weight ratio. H19 expression in skeletal muscle was significantly affected by the interaction 
between parental genomes. With respect to significant negative association between H19 
expression and muscle mass, the negative heterotic effect on H19 expression may explain the 
positive heterosis in relative muscle mass. Fetal genetics consistently influenced H19 
expression, which in B. indicus was between 1.5 to 2.2-fold higher than in B. taurus in all 
examined tissues, except brain. A negative relationship was observed between transcript 
abundance of H19 and weights of fetal tissues, except brain. These results suggest that H19 
could be a molecular driver for differential subspecies-specific fetal phenotypes. By in silico 
search, we found B. indicus-specific nucleotide polymorphisms at CpG sites of the consensus 
sequence for the first CTCF binding site within the imprinting control region (ICR) located 
upstream of H19 promoter. This led us to speculate that higher expression of H19 in B. 
indicus tissues could be attributable to partial or complete relaxation of imprinting resulting 
from epigenetic changes in the ICR. 
xv 
In conclusion, our results provide insight into the interplay between genetics and 
epigenetics and its consequences for genetic programming of phenotypic variation and 
heterosis. Significant interaction between parental genomes on expression of H19, a miRNA 
precursor and master regulator of an imprinted gene network, and negative relationship 
between H19 expression and fetal muscle mass suggested imprinted genes and miRNA 













Chapter 1                                         
Introduction and literature review
2 
1.1 Introduction 
Prenatal development consists of a series of orchestrated processes which leads to 
differentiation of multiple specialised tissues from a single-cell zygote. Gene expression 
patterns in the specialised cells during the process of differentiation are controlled by fetal 
genetics and epigenetics (Reik et al., 2001; Surani, 2001). Gene transcription at the genetic 
level is regulated by tissue-specific availability of transcription factors which bind specific 
regulatory DNA sequences and are thereby implicated in regulation of gene expression (Reik 
et al., 2001; Reik, 2007). Epigenetics is defined as stable transmission of cell information 
determined by gene expression patterns across cell division which occurs independent of 
DNA sequence (Nafee et al., 2008). The heritable epigenetic marks, including DNA 
methylation and histone modification, which create the epigenome, partition chromatin into 
active and inactive domains, and serve to store information as an epigenetic memory to 
regulate gene expression (Li, 2002). Genomic imprinting is the best example of epigenetic 
regulation of gene expression, which infringes Mendelian rules of inheritance, and is 
described as an imbalance in expression of alleles depending on parent-of-origin (Reik and 
Walter, 1998; Tilghman, 1999). 
It is well known that epigenetic parent-of-origin effects significantly contribute to 
phenotypic variation of postnatal growth traits in animals (Cockett et al., 1996; Van Laere et 
al., 2003; Kim et al., 2004; Neugebauer et al., 2010a; Neugebauer et al., 2010b; Imumorin et 
al., 2011). Therefore, epigenetics imposes a source of non-additive genetic variation on the 
phenotype, which is unidentified in the classic genetic models for genetic evaluation of 
animals leading to reduced accuracy of estimated genetic parameters. It has been 
demonstrated that the use of inappropriate quantitative genetic models for deriving breeding 
values and population (co)variances between relatives may result in biased estimation of 
genetic parameters for traits controlled by imprinted genes (Engellandt and Tier, 2002; 
Santure and Spencer, 2006). On the other hand, epigenetic modifications are strong 
candidates for the interaction between genetics and environment, which compromise genetic 
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evaluation and improvement programs of farm animals. Any changes in environmental 
conditions, including maternal factors and fetal nutrition, result in developmental adaptations 
through transient alterations in epigenetic status of the epigenome, which have a permanent 
impact on postnatal growth and development, a process termed “fetal programming” (Barker 
and Clark, 1997). Although the concept of fetal programming has the most implications in the 
context of human disease, there is growing evidence that animal postnatal performance has its 
origin in prenatal development and is affected by maternal environmental conditions (Young 
et al., 1998; Bell, 2006; Foxcroft et al., 2006; Wu et al., 2006; Gardner et al., 2007; Funston 
et al., 2010; Hill et al., 2010). While studies in the area of fetal programming have focused on 
the epigenetic link between intrauterine environment and fetal phenotype, genetic effects on 
epigenetic regulation of gene expression and its association with phenotypic variation in 
prenatal development and consequences for postnatal growth traits and heterosis remain 
largely unexplored. 
The insulin like growth factor 2 (IGF2) and insulin like growth factor 2 receptor 
(IGF2R) genes are the first identified imprinted genes, and have been studied extensively in 
many species. IGF2 and IGF2R are expressed from the paternal and maternal allele, 
respectively, and are vital regulators of prenatal development. The imprinted expression of 
IGF2 and IGF2R is regulated by the long non-coding RNA genes, H19 and AIRN, 
respectively. Several lines of evidence demonstrated that epigenetic status and expression of 
the imprinted genes changes in response to prenatal environmental conditions and these 
effects persist into postnatal life, suggesting that these genes are implicated in developmental 
programming of postnatal performance (Young et al., 2001; Micke et al., 2011a; Micke et al., 
2011b). However, expression pattern of these genes and their contribution to phenotypic 
variation and heterosis in hybrids remains unexplored. 
The focus of this research was to exploit an experimental model for the systematic 
analysis of fetal genetic and heterotic effects on tissue-specific transcript abundance of the 
genes controlled by genomic imprinting, and their link to prenatal phenotypic variation and 
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heterosis in the bovine. Additionally, this model facilitates analysis of the phenotypic patterns 
associated with the parent-of-origin (epi)genetic effects and their link to imprinted gene 
expression. Development of this model was achieved using reciprocal crosses of two 
phenotypically and genetically distinct subspecies of domesticated cattle, commonly known 
as Bos taurus (Angus) and Bos indicus (Brahman), in an attempt to attain maximum genetic 
diversity between parents. This model could be utilised to investigate the interplay between 
genetics and epigenetics to diversify prenatal phenotypes. 
 
1.2 Epigenetics 
Epigenetics describes the modifications and mechanisms beyond DNA sequence that 
cause heritable changes in gene expression patterns, and persist for one or more generation. 
(Bernstein et al., 2007). DNA methylation and histone posttranscriptional modifications are 
key components of the epigenetic machinery, which interplay with each other, and with 
chromatin remodelling complexes and non coding RNAs, to regulate vital biological 
processes, including differentiation (Delcuve et al., 2009). 
DNA methylation occurs on the 5’-cytosine of CpG dinucleotides across the genome. 
Methylation of CpG sites in the promoters is usually associated with reduced gene expression 
(Kass et al., 1997; Siegfried and Cedar, 1997; Bird, 2002). There are unmethylated CG-rich 
regions (CpG islands) in the genome that co-localise with the promoter of most constitutively 
expressed genes (Bird, 1986; Larsen et al., 1992; Antequera, 2003; Zhu et al., 2008). 
Although, the majority of CpG islands remain unmethylated, a small proportion acquire 
methylation during development, some of which play an essential role in X chromosome 
inactivation and genomic imprinting (Edwards and Ferguson-Smith, 2007; Reik, 2007). 
Genomic DNA methylation patterns are dynamic during development. There are two 
major cycles of epigenetic reprogramming, in which genome wide demethylation and de novo 
methylation occurs: during germ cell development and after fertilisation (Monk et al., 1987; 
Sanford et al., 1987; Howlett and Reik, 1991; Kafri, 1992; Rougier et al., 1998; Surani, 
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1998). A number of DNA methyltransferases (Dnmt) which transfer methyl group from s-
adenosyl methionine onto C5 position of cytosine residues in the CpG dinucleotides have 
been identified in mammals (Bestor, 2000). 
Histones are subject to posttranslational modifications, including acetylation (Sterner 
and Berger, 2000) and methylation of lysines (K) and arginines (R) (Zhang and Reinberg, 
2001). Histone acetylation is always associated with transcriptional activation (Sterner and 
Berger, 2000), whereas methylation of lysines may result in gene activation or repression 
(Bannister and Kouzarides, 2005). It is believed that histone modifications are associated with 
changes in the structure, position and composition of nucleosomes. This process which is 
termed chromatin remodelling influences accessibility of DNA to transcriptional machinery 
(Peterson and Laniel, 2004). 
Genome wide patterns of DNA methylation are the consequence of the interplay 
between DNA methyltransferases and chromatin remodelling machinery, including histone 
modifications (Dennis et al., 2001; Meehan et al., 2001; Geiman and Robertson, 2002; Klose 
and Bird, 2006). It is evident that histone methylation, which is thought to be affected by 
chromatin remodelling complexes, and other histone modifications such as acetylation and 
phosphorylation, is a prerequisite for proper DNA methylation patterns (Geiman and 
Robertson, 2002).  
 
1.3 Genomic imprinting 
Genomic imprinting is the best example of epigenetic regulation of gene expression 
which results in an imbalance in expression levels of alleles depending on their parent-of-
origin, and thus, violates Mendelian rules of inheritance (Sha, 2008). So far, a group of 70 
genes in human, 130 genes in mouse, 15 genes in ovine, 19 genes in bovine and 20 genes in 
porcine have been identified as imprinted (http://igc.otago.ac.nz/, www.geneimprint.com, 
www. mgu.har.mrc.ac.uk). In silico studies have predicted that 2.5% of mouse genes and 1% 
of human genes are subject to genomic imprinting (Luedi et al., 2005; Luedi et al., 2007). A 
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recent study has uncovered more than 1300 candidate imprinted loci with parent-of-origin-
specific allelic expression in mouse (Mus musculus castaneus/Mus musculus domesticus) 
brain (Gregg et al., 2010). 
In mammals, most imprinted genes are in close proximity on the chromosome and 
organised into clusters (Reik and Walter, 2001; Verona et al., 2003). Expression of imprinted 
genes within a cluster is co-ordinately controlled by regulatory sequences referred to as 
imprinting control regions (ICRs), which are differentially methylated regions (DMRs) or 
domains (DMDs) (Sutcliffe et al., 1994; Wutz et al., 1997; Thorvaldsen et al., 1998; Arima et 
al., 2001; Kanduri et al., 2002; Reinhart et al., 2002; Yatsuki et al., 2002; Williamson et al., 
2006; Lin et al., 2007; Shin et al., 2008). These regions, which act in cis, are sites of 
differential methylation in a parent-of origin-dependent manner (Holmes and Soloway, 2006). 
There are two types of DMRs: primary DMRs, which acquire methylation imprints in the 
germ cells during gametogenesis and maintain it during development, and secondary DMRs, 
which undergo erasure and establishment of new methylation imprints during embryogenesis 
(Kobayashi et al., 2006). The DMRs harbour binding sites for transcription regulatory 
proteins, such as methyl-CpG binding domains (MBDs), which target methylated DNA (Sha, 
2008). 
All ICRs in known imprinted clusters act in cis to repress expression of genes when 
unmethylated through different mechanisms (Koerner and Barlow, 2010). In the first 
mechanism, which has been observed in the Igf2/H19 imprinted cluster, the unmethylated 
ICR acts as an insulator that binds the zinc finger transcription factor CTCF to block Igf2 
promoter access to its enhancer located downstream of H19 gene (Hark et al., 2000). In the 
second model, which is represented in two imprinted clusters, Igf2r and Kcnq1, the 
unmethylated ICR contains an active promoter for the long non-coding RNAs, Airn and 
Kcnq1ot1, respectively, expression of which is associated with cis-silencing of the flanking 
genes (Sleutels et al., 2002; Sleutels et al., 2003; Mancini-DiNardo et al., 2006). 
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1.4 The insulin like growth factor family: General overview 
The insulin-like growth factor (IGF) family is part of a complex cell signalling system 
composed of ligands (IGF1 and IGF2, insulin), cell surface receptors (IGF1R and IGF2R, 
insulin receptor) and a group of six binding proteins (IGFBP1-6) in addition to IGFBP 
degrading proteases (Roith, 2003).  
IGF1 and IGF2 are single-chain peptides of 70 and 67 amino acids, respectively, which 
are organised into four domains designated as B, C, A and D (in order from N- to C-
terminus). Precursor forms of IGF1 and IGF2 contain the C-terminal E domain as well as N-
terminal signal peptide, which are cleaved off before secretion. IGF1 and IGF2 are involved 
in a number of vital biological processes, including mitogenesis, anti-apoptosis, cell growth 
and differentiation, cell migration and metabolism. Their functions are mediated through 
binding to the insulin-like growth factor type 1 receptor (IGF1R).  
Mechanisms of action and signal transduction pathways for IGF1R and the insulin 
receptor (IR) show significant similarities (Cheatham and Kahn, 1995; Leroith et al., 1995). 
These heterotetrameric glycoproteins belong to the tyrosine kinase subfamily of 
transmembrane receptors (Leroith et al., 1995). Two insulin receptor variant forms (IR-A and 
IR-B) resulting from alternative splicing of IR transcript have been identified (Sesti, 2000; 
Denley et al., 2003; Denley et al., 2005). As a result of the high level of similarity in 
structure, IGF1 αβ hemireceptor and insulin αβ hemireceptor are joined together to make up 
hybrid receptors in the tissues, but their functional roles in cell signalling are still unclear 
(Federici et al., 1997a; Federici et al., 1997b). 
IGF2R serves as a scavenger receptor which binds IGF2 at the cell surface and 
internalises it for lysosomal degradation (Scott and Firth, 2004). On the other hand, IGF2R 
acts as a dual purpose receptor which binds proteins containing mannose-6-phosphate (M6P) 
recognition sites, including lysosomal enzymes in the trans-Golgi network, and transports 
them to lysosome (Kornfeld, 1992).  
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So far, a group of six IGF-binding proteins (IGFBP1-6) have been described. The 
IGFBPs have different affinity for IGF1 and IGF2 (Firth and Baxter, 2002) and carry most 
(99%) of the IGF1 in the bloodstream. The majority of serum IGF1 and IGF2 (70-80%) 
during human postnatal life are bound to a 150 kDa ternary complex consisting of IGFBP3 
and a glycoprotein, acid labile subunit (ALS) (Frystyk, 2004). Ninety percent of IGFBP3 and 
55% of IGFBP5 circulate in heterotrimeric complexes containing ALS in human adults. All 
IGFBPs also circulate in the free form or in binary complexes with IGFs. Free and IGF-bound 
IGFBPs are able to pass across the endothelium and diffuse into tissues, while ternary 
complexes are believed to remain in blood vessels (Baxter et al., 2002; Firth and Baxter, 
2002). IGFBPs prolong the half-life of plasma IGF ligands and regulate their bioavailability 
to the receptors. IGFBPs bind IGFs with higher affinity than IGF receptors and so can 
compete with IGF receptors in binding IGFs and prevent receptor access to IGF1 and IGF2 
(Baxter, 2000; Firth and Baxter, 2002). This constitutes a mechanism to control IGF release in 
tissues and normal cell growth (Rajah et al., 1999). IGFs are released from IGFBPs and 
delivered to their receptors following degradation of IGFBPs by specific proteases or binding 
of IGFBPs to the extracellular matrix (ECM) (Hwa et al., 1999). 
 
1.5 Insulin-like growth factor 2 
1.5.1 Regulation of expression 
1.5.1.1 Transcriptional regulation: Genomic imprinting 
The Igf2 gene in mouse (Mus musculus domesticus) shows imprinted expression and is 
predominantly expressed from paternal allele, whereas expression from the maternal allele is 
repressed (DeChiara et al., 1991). Mouse Igf2 is part of a conserved imprinted cluster which 
consists of five imprinted genes. The gene is flanked 5’ by Ins2 and 3’ by H19. The H19 
gene, which encodes a long non-coding RNA, is located 90 kb downstram of Igf2 and is 
maternally expressed (Bartolomei et al., 1991). IGF2 and H19 imprinted expression is 
conserved in human (Rachmilewitz et al., 1992; Giannoukakis et al., 1993; Ohlsson et al., 
9 
1993), rat (Overall et al., 1997), porcine (Li et al., 2008), ovine (Ovis aries) (Feil et al., 1998; 
McLaren and Montgomery, 1999; Young et al., 2003) and bovine (B. taurus/B. gaurus) 
(Dindot et al., 2004a; Dindot et al., 2004b; Zhang et al., 2004). Observations on nascent RNA 
levels at the initial transcription sites in mouse (Mus musculuc domesticus) embryonic liver 
cells revealed numerous transcription patterns for Igf2 and H19, including monoallelic and 
biallelic expression. This suggests that imprinted monoallelic expression of Igf2 and H19 is 
likely to be controlled at both transcriptional and post-transcriptional levels (Jouvenot et al., 
1999).  
 
1.5.1.1.1 Differentially methylated regions 
In mouse (Mus musculus domesticus/Mus spretus), there are three DMRs within the 
imprinted domain encompassing Igf2, two of which (DMR1 and DMR2) lie within the Igf2 
gene with extensive paternal methylation (Feil et al., 1994; Moore et al., 1997). DMR1 is a 
CpG-rich element with tandem repeat sequences that lies 3 kb upstream of mouse (Mus 
musculus domesticus) Igf2 P1 promoter and reveals mosaic patterns of methylation in sperm-
derived DNA. DMR1 is believed to have a role in silencing the maternal allele, since deletion 
of this region led to biallelic expression of Igf2 in mesodermally derived tissues, except 
muscle, without changing H19 imprinting status or expression (Constancia et al., 2000). 
Differential methylation of DMR1 on the transcriptionally active paternally-derived allele 
gives rise to the proposal that DMR1 contains repressor binding sites interacting with trans-
acting repressors when unmethylated. A possible role for the protein GCF2 as a trans-acting 
repressor interacting with DMR1 has been elucidated (Eden et al., 2001). However, the role 
of DMR1 in primary imprinting control of Igf2 remains controversial by the fact that targeted 
deletion of mouse (Mus musculus domesticus/Mus musculus castaneus) H19 causes loss of 
imprinting of Igf2 (Leighton et al., 1995a). DMR2, which is predominantly methylated in 
sperm-derived DNA, is situated close to the downstream part (last exon) of Igf2 and appears 
to be involved in tissue-specific repression of the maternal allele. The methylation intensity of 
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DMR2 in fetal tissues changes depending on the expression level of Igf2 in the tissues (Feil et 
al., 1994). DMR2 does not appear to have a primary role in Igf2 imprinting, as disruption of 
maternal DMR2 does not influence imprinting of Igf2. The third DMR (DMR0), located 
upstream of DMR1, is differentially methylated on the maternal allele in the mouse (Mus 
musculus domesticus/Mus spretus) placenta, whereas it is heavily methylated in both alleles in 
fetal tissues. Differential parental methylation of DMR0 in placenta is linked to the expression 
of H19 in cis, whereas H19 knockout does not have any effect on the placental DMR1 and 
DMR2 methylation. This can be interpreted as a tissue-specific mechanism involved in the 
regulation of imprinting (Moore et al., 1997). The differentially methylated regions 
homologous to the mouse DMR0 and DMR2 with the same differential methylation pattern 
were identified in human (Reik et al., 1995; Sullivan et al., 1999; Cui et al., 2002). Moreover, 
a region homologous to mouse DMR1 containing CpG island but without tandem repeats was 
identified in human. This region that spans exons 2 and 3 shows complete demethylation 
(Moore et al., 1997). The presence of DMR2 and also DMR1 with the differential 
methylation on the paternal allele, has been elucidated in porcine (Han et al., 2008a). 
However, IGF2 imprinting in adult porcine liver, muscle and kidney was not dependent on 
methylation status of the DMR1 and DMR2 (Braunschweig et al., 2011). In addition, an 
intragenic DMR within exon 10 of bovine IGF2, homologous to the mouse DMR2, has been 
found with significant difference in methylation between oocyte (16%) and sperm (99%) 
(Gebert et al., 2006).  
 
1.5.1.1.2 Imprinting control region 
A paternally methylated DMR is located upstream of H19 in mouse (Mus musculus 
domesticus/Mus musculus castaneus). This conserved DMR which acts as a cis-acting 
imprinting control region (ICR) is one of the major elements determining IGF2 and H19 
imprinting as its deletion abolishes both Igf2 and H19 imprinted expression (Bartolomei et al., 
1993; Thorvaldsen et al., 1998). The ICR harbours binding sites for the CTCF, a zinc-finger 
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transcription factor, which acts as an insulator (Kurukuti et al., 2006). The conserved DMR 
upstream of the H19 gene has been identified in ovine (Ovis aries) (Young et al., 2003), 
porcine (Sus scrofa) (Braunschweig et al., 2011), bovine (B. taurus/B. indicus) (Curchoe et 
al., 2009; Hansmann et al., 2011; Robbins et al., 2012) and human (Jinno et al., 1996; Vu et 
al., 2000). 
Several models have been suggested to explain the mechanisms underlying imprinting of 
the Igf2/H19 gene domain. In the boundary model (Katharine, 2003), imprinting of Igf2 in 
endoderm-derived tissues is believed to be controlled by interplay between tissue-specific 
enhancers, which are located downstream of H19 (Yoo-Warren et al., 1988), and ICR. The 
unmethylated ICR on the maternal allele functions as a boundary which blocks the interaction 
between downstream enhancers and the Igf2 promoter by binding to CTCF. Methylation of 
CTCF binding sites on the paternal allele prevents CTCF binding and allows transcription of 
Igf2 induced by the enhancers (Bell and Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 
2000; Szabu et al., 2000; Pant et al., 2003). Paternal and maternal transmission of the 
enhancer deletion leads to loss of expression of Igf2 and H19, respectively, in tissues of 
endodermal origin (Leighton et al., 1995b). 
A chromatin model has been suggested to explain mechanisms underlying imprinted 
expression of Igf2 and H19. In this model, allelic expression of the Igf2 and H19 is regulated 
by the interaction between promoters and the enhancers which takes place possibly by 
forming loop-like structures along chromatin and is determined by the methylation status of 
H19 DMR (ICR). The paternally derived methylated DMR suppresses expression of H19 by 
spreading inactive chromatin state on its promoter allowing Igf2 promoter to access its 
enhancer. The maternally derived unmethylated DMR prevents interaction between the Igf2 
promoter and the enhancers probably by forming a complex with insulator proteins leaving 
enhancers accessible to the H19 promoter (Sasaki et al., 2000). 
Preferential interaction of the unmethylated H19 DMR with Igf2 DMRs, which are 
influenced by the epigenetic modifications of DMRs involving binding of protein factors, 
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partitions Igf2 and H19 into active and silent chromatin loops (Murrell et al., 2004; Kurukuti 
et al., 2006; Qiu et al., 2008). In the enhancer tracking model, enhancers move over the length 
of chromosomes to recognise the promoters of relevant genes. In this model, insulator 
sequences located between enhancer and promoters stop the enhancer tracking along the 
chromosome (Engel et al., 2008). There is evidence that cohesion, a protein involved in the 
cohesion of chromatids during cell division, co-localises with the CTCF at the ICR and plays 
an important role in facilitating and stabilizing CTCF-mediated chromatin looping. Gene 
depletion of cohesion in human abolished the chromatin conformation and was associated 
with the alteration in IGF2 expression (Nativio et al., 2009). 
 
1.5.1.2 Posttranscriptional regulation 
Although the complex patterns of IGF2 transcription are thought to be involved in the 
regulation of expression at the transcription level, it is speculated that alternative 5’ 
untranslated regions (5’UTRs) may be involved in the posttranscriptional regulation of gene 
expression, which influence mRNA translation (van der Velden and Thomas, 1999). A family 
of three IGF2 mRNA binding proteins (IMP1, IMP2, IMP3) have been found in human that 
bind to the 5’UTR of the P3 derived mRNA (Nielsen et al., 1995). The IGF2 mRNA binding 
proteins have been found in both human and mouse and are thought to play an important role 
in temporal and spatial regulation of gene expression during late mammalian development. 
The P4 derived transcripts are constitutively translated and maintain IGF2 generation at 
a basal level in all tissues, whereas translation of P3 derived transcripts is regulated in a 
tissue- and developmental stage-specific manner (Nielsen et al., 1999). It has turned out that 
translation of human P2 derived transcripts is carried out in an eukaryotic translation initiation 
factor 4E (eIF4E) independent fashion which involves an internal ribosome entry site (IRES) 
allowing for translation initiation in the middle of the messenger RNA. Since cap-dependent 
translation may be compromised during cell division, the P2 derived transcripts may maintain 
IGF2 generation in the growing tissues of the embryo (Pedersen et al., 2002). These data 
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show that the measurement of mRNA level per se does not necessarily reflect the total IGF2 
protein expression in tissues. Further studies are required to show mechanisms controlling 
promoter-specific translation of IGF2 in different tissues and developmental stages. 
 
1.5.2 Tissue, developmental stage, and promoter-specific expression and 
imprinting 
1.5.2.1 Tissue and developmental stage-specific expression of IGF2 global 
transcripts 
Developmental stage and tissue-specific imprinted expression of IGF2 in a number of 
species is shown in Table 1.1. The mouse Igf2 transcript is first seen at the two-cell stage of 
the embryo (Mizuki Ohno, 2001) and is frequently expressed shortly after implantation in the 
primitive endoderm, extraembryonic mesoderm, the anterior-proximal and lateral mesoderm 
cells and then in the mesoderm-derived tissues, including heart and somites (Lee et al., 1990). 
In bovine, IGF2 mRNA is present in mature oocytes and in the embryo throughout 
preimplantation and implantation period (Watson et al., 1992; Wang et al., 2009). In bovine 
fetuses, IGF2 expression increases substantially by Day-180 of gestation. In bovine Day-150 
fetuses, expression is higher in heart, liver and muscle than in brain (Kawase et al., 2000). 
Several lines of evidence have demonstrated tissue-specific and developmental 
regulation of IGF2 with highest expression level in prenatal tissues of rat (Adams et al., 1983; 
Brown et al., 1986; Soares et al., 1986; Gray et al., 1987), bovine (Boulle et al., 1993), ovine 
(Stylianopoulou et al., 1988a; O'Mahoney et al., 1991; Delhanty and Han, 1993) and human 
(Schofield and Tate, 1987). In a study to analyse the quantitative expression level of IGF2 in 
bovine fetal tissues using northern blot and dot blot, it has been demonstrated that although 
liver IGF2 expression level does not significantly change, muscle IGF2 transcripts declined 
steadily after Day-150 of gestation. Also, the quantity of IGF2 transcripts in bovine liver and 
muscle was remarkably reduced in postnatal, compared to prenatal developmental stage, with 
the postnatal decrease in expression being more severe in muscle compared to liver (Boulle et 
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al., 1993). In human, the level of IGF2 transcripts during the first and second trimester of 
pregnancy was higher in muscle, compared with placenta, and was the lowest in fetal brain 
(Goshen et al., 1993). Dot blot analysis of total RNA in ovine fetal tissues has revealed 
reduction of IGF2 from Day-80 to Day-135 of gestation in liver, heart, spleen, skeletal 
muscle, kidney, and lung, whereas expression in placenta remained constant (O'Mahoney et 
al., 1991). Expression of IGF2 mRNA in ovine liver and kidney showed an increase from 
Day-50 to Day-100, then a decrease in late gestation (Day-120 to 145), while the mRNA level 
in muscle and choroid plexus declined as prenatal age advanced (Delhanty and Han, 1993). 
The relative abundance of rat IGF2 transcripts was highest in fetal muscle, lung and liver and 
lowest in brain, heart and kidney (Brown et al., 1986). 
In human placenta, IGF2 is transcribed in chorionic mesoderm and first trimester villous 
cytotrophoblast (Han, 1996), whereas in rhesus monkey placenta, IGF2 is expressed in 
syncytiotrophoblast but not in chorionic mesoderm (Coulter and Han, 1996b; Coulter and 
Han, 1996a). In rodents, Igf2 is detectable in the fetal mesodermal part of placenta and the 
trophoblast of labyrinth (Han and Carter, 2000). In ovine, IGF2 mRNA is found in the fetal 
mesoderm close to trophoblast and also in the stroma of maternal caruncles (Reynolds et al., 
1997). 
Igf2 is downregulated after birth in rodents (DeChiara et al., 1991). IGF2 in human 
continues to be expressed after birth with liver as the main source of IGF2 (de Pagter-
Holthuizen et al., 1987).  
 
1.5.2.2 Tissue and developmental stage-specific expression of IGF2 
promoter-specific transcripts 
Expression of IGF2 promoter-specific transcripts at different developmental stages and 
in different tissues of the studied species is summarized in Table 1.2. In most species, 
including human, mouse, rat, porcine, ovine and bovine, IGF2 is transcribed from distinct 
promoters which initiate transcription from different 5’ non-coding exons. This complex 
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promoter-specific transcription, which involves alternative splicing and polyadenylation, is 
believed to play an important role in regulation of transcription of IGF2 in a tissue and 
developmental stage-specific manner. In human (Holthuizen et al., 1990), bovine (Curchoe et 
al., 2005; Goodall and Schmutz, 2007), porcine (Amarger et al., 2002) and ovine (Ohlsen et 
al., 1994), transcription from four promoters (P1-4) gives rise to a family of mRNA 
transcripts with different untranslated exons. In mouse, four distinct promoters (P0, P1, P2 
and P3) initiate transcription from alternative untranslated exons, all of which splice onto the 
common protein-coding exons (Rotwein and Hall, 1990; Moore et al., 1997). Recently, a 
novel mesoderm-specific promoter (Igf2 Pm) has been identified in mouse whose 
transcription is initiated from a novel untranslated exon which is located downstream of exon 
U2 (Giang Tran et al., 2012). A novel IGF2 promoter which appears to be equivalent to the 
mouse placental-specific P0 promoter (Moore et al., 1997) has been found to be active 
specifically in skeletal muscle of the human fetus (Monk et al., 2006b). 
In human, P2, P3 and P4 promoters are actively transcribed and drive transcripts in 
tissues during prenatal development, whereas P1 promoter is only active in human adult liver 
(Pedersen et al., 2002). Expression patterns of IGF2 alternative transcripts in bovine display 
considerable changes depending on the tissue and developmental stage. Three splice variants 
derived from P1 promoters were solely seen in the pre-term and postnatal liver, which is in 
agreement with the observation of a 4.4 kb adult liver-specific transcript reported previously 
(Boulle et al., 1993), and the transcripts derived from P2, P3 and P4 promoters were observed 
in the liver and other tissues from newborn calves to 19 month old steers (Goodall and 
Schmutz, 2007). Contrary to these observations, in a later study, it was demonstrated that P1 
derived transcripts are expressed in all bovine pre- and postnatal tissues, including liver, heart, 
lung, brain and kidney (Curchoe et al., 2005). These contrary results can be explained by the 
utilisation of different primer pairs for amplification of different exonic regions of P1 derived 
transcripts. Curchoe et al. (2005) used primers inside exon 3, whereas Goodall and Schmutz 
(2007) utilised the forward primer in exon 1 and the reverse primer in exon 8. It appears that 
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primers spanning exons 1 and 8 specifically amplify P1 derived transcripts, which display 
evolutionarily conserved expression in postnatal liver. On the other hand, the primers located 
in exon 3 are supposedly able to amplify any putative transcripts containing exon 3. 
 
1.5.2.3 Tissue, developmental stage, and promoter-specific imprinting 
Developmental stage and tissue-specific imprinting of IGF2 global and promoter-
specific transcripts are shown in Tables 1.1 and 1.2. It is evident that monoallelic expression 
of the Igf2 gene in mouse (Mus musculuc domesticus/Mus musculus molossinus) is 
established at the blastocyst stage, while both alleles are transcriptionally active in the morula 
(Mizuki Ohno, 2001). In mouse (Mus musculuc domesticus), the Igf2 gene displays biallelic 
expression in choroid plexus and leptomeninges of brain (DeChiara et al., 1991). Monoallelic 
expression of ovine (Ovis aries) IGF2 occurs only after the blastocyst stage, before which 
both paternal and maternal copies can be detected (Thurston et al., 2008). Conserved 
imprinted expression of ovine (Ovis aries) IGF2 and H19 has been documented at Day-25 of 
gestation (Young et al., 2003). The IGF2 gene is imprinted in ovine (Ovis aries) fetal kidney, 
spleen and liver, and also in the kidney of juveniles but is biallelically expressed in fetal brain 
and adult liver (McLaren and Montgomery, 1999). In domestic pig, monoallelic paternal 
expression of IGF2 was demonstrated using pyrosequencing in Day-30 embryos (Bischoff et 
al., 2009). 
Promoter-specific imprinting of IGF2 has been studied in several species. In mouse 
(Mus musculus/Mus spretus), Igf2 P1, P2 and P3 drive monoallelic paternal expression in all 
tissues, except the central nervous system (CNS), where biallelic expression from all 
promoters is observed (Hu et al., 1995). In human, P2, P3 and P4 promoters direct 
monoallelic expression in fetal tissues. Biallelic expression of four promoters of IGF2 in brain 
(leptomeninges and choroid plexus) has been reported in human (Ohlsson et al., 1994; Zhan 
et al., 1998). Moreover, the P1 promoter in human directs biallelic expression in postnatal 
liver (Vu and Hoffman, 1994; Ekstrom et al., 1995). Monoallelic expression from P1 and 
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biallelic expression from other promoters was observed in tissues (heart, liver, brain, lung, 
kidney and muscle) of 1 week old porcine (Li et al., 2008). Analysis of imprinted expression 
of IGF2 during ovine (Ovis aries) development has demonstrated that expression of imprinted 
fetal transcripts in liver switches to biallelic expression after birth, which mimics the prenatal 
and postnatal imprinted expression pattern of IGF2 in human and bovine (McLaren and 
Montgomery, 1999). IGF2 monoallelic gene expression was seen in all examined fetal tissues 
of bovine (B. taurus), including liver, kidney, heart, lung and placenta, with the exception of 
brain, which showed biallelic expression, while more leaky expression from maternal allele or 
biallelic expression was observed in adult tissues (Curchoe et al., 2005). Loss of imprinting 
(LOI) of P1 derived transcripts was observed in bovine (B. taurus) fetal liver at term and 
postnatal liver (Goodall and Schmutz, 2007). A study of promoter-specific loss of imprinting 
in heterozygous calves using the single nucleotide polymorphism (SNP) in exon 3 showed 
biallelic expression of the P1 derived transcript in liver and monoallelic expression in 
placenta, lung and heart (Curchoe et al., 2005). The difference in imprinting status of 
transcripts containing exon 3 between liver and other tissues may result from tissue-specific 
differences in transcripts containing exon 3 and, as a result, their imprinting status. The 
majority of transcripts containing exon 3 in postnatal liver likely belong to IGF2 P1 promoter, 
whereas in other tissues and developmental stages, they may derive from other overlapping 
genes and/or IGF2 promoters. 
Biallelic expression of the P3 derived transcript was observed in brain of fetus, heart of 
calf, and adult heart and liver, whereas loss of imprinting of P4 derived transcript occurred in 
brain of fetus, kidney of calf and adult liver and lung, suggesting that in bovine (B. taurus), 
P3 and P4 promoters direct loss of imprinting (Curchoe et al., 2005). Evaluation of allelic 
expression of IGF2 in a Bos taurus and Bos gaurus intercross, revealed paternal expression of 
IGF2 in both placental and fetal tissues, including liver, lung and brain at Day-72 of gestation 
(Dindot et al., 2004b). Preferential expression of IGF2 from the paternal allele was also 
observed at Day-40 of gestation in nuclear transfer derived fetuses generated from an 
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interspecies cross between Bos taurus and Bos gaurus (Dindot et al., 2004a). Further 
quantitative studies are needed to confirm promoter-specific loss of imprinting at different 
developmental stages. 
 
1.5.3 Role of IGF2 in development 
1.5.3.1 Prenatal development 
Evidence for the importance of Igf2 in prenatal development has been provided by 
mouse gene knockout models. The crucial role of Igf2 in mouse (Mus musculus domesticus) 
embryonic development has first been described by targeted disrupted of the gene on the 
paternal chromosome, which led to a significant reduction in birth weight (Dechiara et al., 
1990). Mouse (Mus musculuc domesticus) offspring that inherited a paternally disrupted Igf2 
allele were stunted in growth after birth, whereas transmission of a deleted maternal allele had 
no significant effects on progeny (DeChiara et al., 1991). Studies in human demonstrated 
significant association of polymorphisms in the IGF2 gene with birth weight (Sayer et al., 
2002; Nagaya et al., 2009; Adkins et al., 2010). 
The role of Igf2 in mesoderm differentiation has been documented in mouse (Morali et 
al., 2000). Extensive studies have indicated the important role of IGF2 in muscle development 
during embryogenesis. Using a fusing skeletal muscle cell line in mouse, it was demonstrated 
that a switch takes place from low expression levels during myoblast proliferation to 
remarkably high expression levels over differentiation into myotubes. Disruption of Igf2 
mRNA by RNA interference, has blocked differentiation of multinucleated myofibers from 
myocytes and generation of muscle structural proteins (Wilson et al., 2003). Suppression of 
Igf2 expression results in downregulation of the genes targeted by MyoD via inhibition of the 
recruitment of transcriptional coactivators to the specific promoter elements of the muscle-
specific genes, including myogenin. This suggests IGF2-induced signalling influences 
differentiation by regulating transcription factors involved in myogenesis (Wilson and 
Rotwein, 2006). Igf2 is co-expressed with the fast myosin in the majority of myotubes and is 
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essential for proper specification of development of fast skeletal muscle fibers (Merrick et al., 
2007). 
Studies on how changes in IGF2 expression affect bovine prenatal development are 
limited. Bovine embryos produced by in vitro procedures may suffer from developmental 
abnormalities such as large offspring syndrome, which may be caused by dysregulation of the 
genes critical for prenatal development as a consequence of aberrant epigenetic alterations, 
including DNA methylation and histone modification (Niemann and Wrenzycki, 2000; 
Niemann et al., 2002; Wrenzycki et al., 2004). Expression level of IGF2 transcripts increased 
dramatically at Day-63 of gestation in bovine fetuses generated by in vitro fertilisation (IVF) 
compared with their in vivo counterparts (Blondin et al., 2000). Aberrant expression of IGF2 
was also observed in tissues of calves derived from somatic cell nuclear transfer (SCNT) that 
died shortly after birth (Yang et al., 2005). It is known that IGF2 imprinting is conserved in 
B. gaurus/B. taurus hybrids (Dindot et al., 2004b). A differentially methylated region 
corresponding to mouse DMR2 was identified in the last exon of bovine IGF2, which is 
methylated in sperm but not in oocytes (Gebert et al., 2004; Gebert et al., 2006). Methylation 
pattern of this DMR was shown to be reprogrammed in a sex-specific manner in in vivo 
produced and SCNT-derived embryos (Gebert et al., 2009). Insufficient methylation 
reprogramming of the DMR could be associated with developmental abnormalities in 
embryos derived by SCNT (Rideout et al., 2001). 
Several lines of evidence show a critical role for Igf2 in structural and functional 
development of placenta. One of the Igf2 transcripts derived from the P0 promoter is 
specifically expressed in the mouse labyrinthine trophoblast, which acts as an exchange 
barrier in placenta (Moore et al., 1997). Placental-specific P0 derived Igf2 transcript is 
responsible for regulation of placental growth, and mice lacking this transcript exhibit 
decreased placental size and, as a consequence, retarded fetal growth in late gestation. 
Increased placental efficiency, which most likely results from elevated transport of glucose 
and amino acids as a consequence of an upregulated transporter genes, including Slc2a3 and 
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Slc38a4, was also observed in P0-deficient mice (Constancia et al., 2005). Such an increased 
expression of placental transporter genes is not observed in knockout fetuses that lack fetal 
Igf2 and therefore have lower demand for nutrients. The P0 transcript was proposed to 
determine transfer capacity of the mouse placenta for nutrient exchange by regulating the 
development of the exchange barrier and therefore placental permeability (Constancia et al., 
2002; Constancia et al., 2005). At embryonic Day-19, a reduction in diffusing capacity by 
40%, in placental weight by 66%, and in birth weight by 76% has been reported in knockout 
mice for P0 promoter. Furthermore, there is a decrease in passive diffusion capacity of 
placentas lacking the P0 promoter, due to a reduced surface area and thickened exchange 
barrier (Sibley et al., 2004).  
 
1.5.3.2 Postnatal growth 
Imprinted quantitative trait loci (iQTL) effects linked to IGF2, on postnatal growth 
related phenotypes, including body composition (de Koning et al., 2000), heart weight and 
skeletal muscle growth (Jeon et al., 1999), muscle mass and fat deposition (Nezer et al., 1999; 
Nezer et al., 2003), have been detected in porcine intercross experiments. A mutation in a 
CpG island located in intron 3 of IGF2 explains the QTL effect of IGF2 as a quantitative trait 
nucleotide (QTN). Individuals carrying the mutant copy derived from the sire, display a 3-
fold higher expression level of IGF2 in skeletal muscle after birth, and consequently have a 
significantly increased muscle mass (Van Laere et al., 2003). Further experiments in porcine 
have revealed an association of IGF2 polymorphisms with postnatal growth traits (Kolarikova 
et al., 2003; Hou et al., 2010). 
In bovine, QTL effects associated with meat traits have been mapped to IGF2 (MacNeil 
and Grosz, 2002; Casas et al., 2003). Furthermore, single nucleotide polymorphisms within 
the IGF2 gene have been associated with bovine carcass and meat traits (Zhao et al., 2002; 
Goodall and Schmutz, 2003; Han et al., 2008b; Sherman et al., 2008; Magee et al., 2010; 
Zwierzchowski et al., 2010), and grip strength in adult man (Sayer et al., 2002). 
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Table 1.1 Tissue and developmental stage-specific imprinting and expression of IGF2 global 









Human Embryo Trophoblast Insitu 
hybridisation 
High steady state in trophoblast after 
implantation 
ND (Ohlsson et al., 
1989b) 
       





villous cytotrophoblasts (low) 
ND (Ohlsson et al., 
1989a) 
       
Human Embryo Placenta Insitu 
hybridisation, 
Northern blot 
Expressed Biallelic (till 10 
weeks), 
monoallelic 
(after 10 weeks) 
(Jinno et al., 
1995) 
       









(Ohlsson et al., 
1993) 
       





- Kidney: High in metanephric 
blastema (6 weeks) 
- Cytotrophoblast: Increased between 
18-69 days 
- Liver: Constant within the period 
- Lung: Low in airway epithelia 
before 12 weeks 
ND (Brice et al., 
1989) 
       





Reduced from 6 till 15 weeks ND (Brice et al., 
1989) 
       






Northern blot Expressed ND (Monk et al., 
2006b) 
       








Expressed ND (Schofield and 
Tate, 1987) 
       
Human Fetus (term) Umbilical 
cord blood 
cells 
PCR-RFLP Expressed Polymorphic 
imprinting 
(Giannoukakis 
et al., 1996) 
       








- Postnatal decline  
- Developmental shift in promoter 
usage in adult liver 
ND (Schofield and 
Tate, 1987) 
       








(Wu et al., 
1997) 










Increased by Day-35 ND (Reynolds et al., 
1997) 











Northern blot - Decreased with fetal age ND (Delhanty and 
Han, 1993) 














- Adult liver-specific transcript 
- Decreased from Day-80 to 135 of 
gestation in tissues except placenta 
ND (O'Mahoney et 
al., 1991) 










Decreased after Day-35 in fetal 
mesoderm of placenta 
ND (Reynolds et al., 
1997) 
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121, 130, 150) 
Liver RT-PCR Expressed Monoallelic (McLaren and 
Montgomery, 
1999) 














- Adult liver-specific transcript 
- Postnatal decrease 
ND (O'Mahoney et 
al., 1991) 












Northern blot - Postnatal decrease 
- Specific transcript in adult liver 
ND (Delhanty and 
Han, 1993) 





Liver RT-PCR Expressed Biallelic (McLaren and 
Montgomery, 
1999) 
       
Bovine Embryo (2 cell, 
16 cell, 
blastocyst)  
- RT-PCR Expressed ND (Watson et al., 
1992) 
       
Bovine Embryo 
(blastocyst) 
- RT-PCR Low 
 
ND (Kawase et al., 
2000) 







Dot blot - Constant in liver 
- Increased at Day-150 then 
decreased 
ND (Boulle et al., 
1993) 







RT-PCR High ND (Kawase et al., 
2000) 








RT-PCR Expressed Paternal 
expression 
(Dindot et al., 
2004b) 








Dot blot Downregulation ND (Boulle et al., 
1993) 




Fetus (E14-17) Brain RFLP, 
Northern blot 
Influence of parental species 
background on allelic expression 
Biallelic (Hemberger et 
al., 1998) 
       
Mouse Fetus Lung RT-PCR and 
In situ 
hybridisation 
Expressed ND (Maitre et al., 
1995) 
       






Downregulation with age ND (Lui et al., 
2008) 
       
Mouse Postnatal 
(early, adult) 
Lung RT-PCR and 
In situ 
hybridisation 
Not expressed ND (Maitre et al., 
1995) 









- Mesoderm (Muscles and 
chondrocytes) 
- Endoderm (liver and bronchial 
epithelium) 
- Ectoderm: (choroid plexus) 
ND (Stylianopoulou 
et al., 1988a) 
       
Rat Fetus (Day-16-
22) 



















- Higher in liver than lung (Day-
20) 
- Decreased in late gestation (lung) 
ND (Batchelor et 
al., 1995) 

















(Overall et al., 
1997) 












Higher in fetal muscle, lung, liver, 
and lower in brain, kidney, heart 
ND (Brown et al., 
1986) 
       






Northern blot Multiple transcripts in fetal tissues ND (Soares et al., 
1986) 
       
Rat Postnatal (Day-





Northern blot - Multiple transcripts in neonatal 
tissues 
- Repression in adult tissues except 
brain 
ND (Soares et al., 
1986) 












- Higher in neonatal muscle, lung, 
liver, and lower in brain, kidney, 
heart 
- Lower postnatal expression in 
lung, kidney, brain stem 
- Continuous high level through 
Day-22 after birth in muscle, liver, 
heart 
ND (Brown et al., 
1986) 









Choroid plexus/leptomeninges ND (Stylianopoulou 
et al., 1988b) 
       
Rat Postnatal (60 
days) 
Lung Northern blot Suppressed ND (Moats-Staats et 
al., 1995) 







Northern blot Different transcript lengths ND (Soares et al., 
1985) 
       
Rat Postnatal (Day-
9) 




Low ND (Batchelor et 
al., 1995) 

















(Overall et al., 
1997) 
       
Rhesus Fetus (Day-65 
till term) 
Placenta In situ 
hybridisation 
No change with gestational age ND (Coulter and 
Han, 1996b) 






Table 1.2 Tissue and developmental stage-specific imprinting and expression of IGF2 




















        




        
Human P2 Fetus Liver, 
placenta 
Semi-qPCR Transcript containing exon 4b 
in liver and placenta 
ND (Mineo et 
al., 2000) 
        






- P1-3: Peaking after birth (2 
months) 
- P4: Peaking in fetus 
ND (Li et al., 
1996) 
        
Human P1-4 Fetus (11-17 
weeks) 
Brain PCR-RFLP All promoters in brain Biallelic (Zhan et 
al., 1998) 
        











        








- P1 in choroid 
plexus/leptomeninges and 
liver 




        
Human P1-4 Fetus (7 weeks) Liver Nuclease 
protection 
assay 









        
Human P1, P3 Fetus (6-12 
weeks) 




        
Human P2-4 Fetus Placenta Nuclease 
protection 
assay 
- P3: Higher compared to P4 






        







Northern blot All tissues except brain ND (Monk et 
al., 
2006b) 
        







Northern blot Specific in liver ND (Monk et 
al., 
2006b) 
        




        






- P1, P2, P4: Postnatal 
decrease after 2 months, 
constant level after 18 months 
- P3: Postnatal rapid decline 
after 2 months, no expression 
at 18 months 
ND (Li et al., 
1996) 
        






















        









- P2, P3, P4 in early 
postnatal: liver, 
choroid plexus and 
paraganglia 













        








All promoters Monoallelic 
(P2, P3, P4 in 
infant), 





        
Human P1, P3 Postnatal 
(adult) 
Brain RT-PCR - P3 (predominant) 






        





- P3: Higher compared 
to P4 































RT-PCR Expressed ND (Curchoe 
et al., 
2005) 








RT-PCR - Truncated form in 
most tissues 
- Full length transcript 



































RT-PCR Truncated form in 





















P1-4 Fetus (113-280 
days) 
Liver Northern blot - P1: Specific in 
preterm  






















RT-PCR All tissues except newborn heart ND (Curchoe 
et al., 
2005) 
























RT-PCR - Truncated form in most tissues 
- Full length transcript in 
















RT-PCR - 19 months: Brain, kidney, liver, 
muscle 































RT-PCR Adult liver and brain (weak) ND (Curchoe 
et al., 
2005) 
























RT-PCR - Truncated form in adult brain 
and liver 


























- P1-4: Newborn to 19-months  
- P1: Specific in postnatal liver 
ND (Boulle et 
al., 1993) 
        





RT-PCR - Exons 1, 3: Brain and placenta 





        










        





RT-PCR Expressed ND (Amarger 
et al., 
2002) 
        





RT-PCR - Exon 1: Liver (strong) 
- Exons 1, 3: Liver (strong), 
muscle and kidney 

























        





RT-PCR Expressed ND (Amarger 
et al., 
2002) 












(Li et al., 
2008) 




P1-4 Fetus (Day-75) Liver RT-PCR - P1: Not expressed 
- P2 (exon 4-5), P3 and P4: 
Expressed 
ND (Ohlsen et 
al., 1994) 




P1-4 Postnatal (adult) Liver RT-PCR - P1, P2 (exon 4-5), P3 and P4: 
xpressed 
ND (Ohlsen et 
al., 1994) 
* ND: not determined 
 
Taken together, these observations suggest that the IGF2 significantly influences 
postnatal productive traits in domestic animals, however, it remains to be understood whether 
IGF2 directly affects postnatal growth, or postnatal manifestation of growth traits results from 
the effect of IGF2 on prenatal development and fetal programming. 
 
1.6 H19 expression and role in development 
The H19 gene is located downstream to the IGF2 gene being part of an imprinted cluster 
and organised into 5 exons with a total length of 2373 bp in bovine. The sequence of H19 
shows high conservation between bovine, ovine and porcine (Zhang et al., 2004). The gene 
encodes a long RNA of 2048 bp length (in bovine), which is exported to the cytoplasm and 
shows common features of RNA polymerase 2 derived mRNAs undergoing polyadenylation 
and splicing, however, the transcript lacks a conserved open reading frame (ORF) (Brannan et 
al., 1990; Hurst and Smith, 1999). 
The gene is imprinted on the paternal chromosome and expressed from the maternal 
allele in human (Rachmilewitz et al., 1992; Zhang and Tycko, 1992; Kalscheuer et al., 1993), 
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mouse (M. m. domesticus/M. m. castaneus/M. m. musculus/M. spretus) (Bartolomei et al., 
1991), bovine (B. taurus/B. indicus) (Zhang et al., 2004; Robbins et al., 2012), porcine (Li et 
al., 2008) and ovine (Ovis aries) (Young et al., 2003). A considerable variation in H19 allelic 
expression was observed in human placenta ranging from 1-25%, which was higher in the 
first trimester compared to term placenta (Buckberry et al., 2012). Results of an earlier study 
revealed that H19 loss of imprinting in human placenta is cell-type-specific and occurs in the 
extravillous cytotrophoblasts without affecting IGF2 imprinting status (Adam et al., 1996). 
The imprinted expression of IGF2/H19 domain is regulated by a differentially methylated 
ICR which lies upstream of H19 promoter (Tremblay et al., 1995; Tremblay et al., 1997; 
Thorvaldsen et al., 1998). 
High expression of H19 in fetal tissues derived from mesoderm and endoderm followed 
by postnatal downregulation has been documented in mouse (Pachnis et al., 1984; Poirier et 
al., 1991), which is closely linked to the expression pattern of the adjacent Igf2 (Lee et al., 
1990). Similar tissue-specific and developmental expression patterns have been reported in 
ovine (Lee et al., 2002) and bovine (Khatib and Schutzkus, 2006). Results from human 
studies have postulated that the expression pattern of H19 changes depending on the tissue 
and prenatal developmental stage (Goshen et al., 1993; Lustig et al., 1994). 
The conserved structure and sequence of H19 across species suggests a functional role 
for non coding RNA (Juan et al., 2000). It has been demonstrated that H19 serves as a 
miRNA precursor (miR-675) (Cai and Cullen, 2007) which is also conserved in marsupials 
(Smits et al., 2008), suggesting its possible involvement in posttranscriptional regulation of 
gene expression. The H19 was shown to be associated with polysomes in numerous cell types 
in human and mouse, suggesting a trans-functional role for H19 in regulation of IGF2 
translation (Li et al., 1998). This strongly argues against the hypothesis that H19 transcription 
serves to silence expression of IGF2 in cis (Webber et al., 1998). Another clue to the 
involvement of H19 in posttranscriptional regulation of IGF2 comes from the observation that 
H19 has binding sites for the oncofetal IGF2 mRNA binding proteins (IMPs) (Runge et al., 
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2000). This is further supported by the evidence that H19 functions as a trans regulator of the 
newly described imprinted gene network (IGN) in mouse skeletal muscle and is involved in 
downregulation of the growth regulatory imprinted genes in the IGN (Gabory et al., 2009). 
Processing of the miR-675 from H19 was shown to be developmentally regulated and 
exclusive expression of miR-675 in placenta coincides with ceased placental growth. 
Furthermore, in the mouse lacking H19, placental growth persists and the miRNA targets, 
including Igf1r, show upregulation (Keniry et al., 2012). Further evidence of a growth 
inhibitory role of H19 in placenta has come from the observation that H19 suppresses 
trophoblast proliferation via miR-675 mediated targeting of the Nodal Modulator 1 (NOMO1) 
and its downregulation (Gao et al., 2012). 
An antisense to H19 transcript (91H) with the potential length of 120 kb has been 
identified in mouse and human. This transcript, which is unstable and nuclear localised, is 
predominantly expressed from the maternal allele and is implicated in regulation of IGF2 
expression, since its downregulation results in reduced expression of IGF2 (Berteaux et al., 
2008). Upregulation of the mouse Igf2 by 91H occurs in trans through activation of a novel 
mesodermal-specific promoter (Igf2 Pm) which is located downstream of Igf2 exon U2. 
Enhanced expression of Igf2 by 91H is countered by overexpression of H19 (Giang Tran et 
al., 2012). 
Evidence for the importance of H19 in embryonic development came from the 
demonstration that H19 knockout mice (Mus musculus domesticus/Mus musculus castaneus) 
displayed over expression of Igf2 due to activation of the maternal allele, and a 27% rise in 
birth weight, when the disrupted H19 allele belongs to the mother. However, it was not clear 
whether loss of H19 function or gain of Igf2 maternal allele expression contributes to somatic 
overgrowth (Leighton et al., 1995a; Ripoche et al., 1997). Although it is known that H19 is a 
negative regulator of growth in human and mouse, there is no evidence for the effect of 
variation in H19 expression on growth of tissues during prenatal development and its 
programming potential for postnatal performance in animals. A splice variant of H19 lacking 
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exon 4 has been described in human with the spatial expression being subject to genetic 
background and its parent-of-origin (Lin et al., 1999). Significant association of maternal 
genetics genotyped by the SNPs in H19 gene with offspring birth weight was shown in 
human. Also, a significant association of SNPs with birth weight was found depending on 
whether the allele is paternally or maternally transmitted (Adkins et al., 2010). 
 
1.7 Insulin-like growth factor 2 receptor 
1.7.1 Mechanisms underlying genomic imprinting 
Igf2r is part of an imprinted cluster that comprises several imprinted genes, including 
Slc22a2 and Slc22a3, extending over 400 kb (Sleutels et al., 2002). In mouse (Mus musculus 
domesticus), there are two differentially methylated regions (DMRs) in this domain; DMR1, 
which lies within the promoter of Igf2r sense transcript, contains a secondary imprint with its 
paternal hypermethylation pattern being established after implantation, and DMR2, located in 
intron 2, which is within a CpG island and acts as an imprinting control region (ICR), and 
contains the primary imprint with a maternally-derived hypermethylation pattern established 
during oogenesis (Stoger et al., 1993). The DMR2 encompasses the promoter for a long non-
coding RNA gene which is transcribed in an antisense direction to Igf2r, designated as 
antisense Igf2r non-coding RNA (Airn) (Sleutels et al., 2002). The CpG island within intron 2 
of Igf2r is essential for Airn transcript initiation and elongation and retains an unmethylated 
state of the Airn promoter on the paternal allele (Koerner et al., 2012). 
As in the mouse, two CpG islands have been found in human IGF2R. Unlike the mouse, 
the region 1 located in the promoter of the sense IGF2R is not methylated on both parental 
alleles, while the region 2, which is located within intron 2, is differentially hypermethylated 
on the maternal allele and can explain biallelic expression of IGF2R in human (Riesewijk et 
al., 1996). Conservation of the ICR within intron 2 of IGF2R has been shown in bovine with 
high sequence homology to mice and ovine (Long and Cai, 2007). Expression of AIRN 
transcript has been postulated in all bovine fetal tissues (Suteevun-Phermthai et al., 2009). 
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Igf2r and Airn show reciprocal imprinted expression patterns in mouse (Mus 
musculus/Mus spretus) fetal, placental and adult tissues with maternal expression of Igf2r and 
paternal expression of Airn (Barlow et al., 1991). Two other genes in the imprinted cluster, 
Slc22a2 and Slc22a3, display monoallelic maternal expression only in extraembryonic tissues 
and are biallelically expressed in embryonic and fetal tissues (Regha et al., 2006). In mouse 
(Mus musculus domesticus), Igf2r is expressed from both alleles before implantation from the 
two-cell stage onwards (Harvey and Kaye, 1991), but imprinted expression of Igf2r arises 
during implantation (Lerchner and Barlow, 1997). It is now evident that expression of Airn is 
required for silencing of Igf2r, Slc22a2 and Slc22a3 paternally derived alleles (Sleutels et al., 
2002). In the central nervous system of the neonatal mouse (Mus musculus domesticus/Mus 
musculus musculus) and of the mouse fetus, Igf2r is biallelically expressed notwithstanding 
the imprinted expression of Airn and presence of the differentially methylated ICR. There is 
evidence that Igf2r relaxation of imprinting in the CNS occurs in a tissue-specific manner and 
is associated with neuron-specific histone modifications in the DMR1 and absence of the 
Airn, whereas reciprocal imprinted expression of Igf2r and Airn takes place in glial cells and 
fibroblasts (Yamasaki et al., 2005). 
Studies on expression of Igf2r in mouse ES cells revealed initially low expression from 
both paternal and maternal alleles. During differentiation of ES cells, the maternally-derived 
allele exhibits a 10-fold increase in expression, while expression of the paternally derived 
allele remains at the same initial low level, suggesting an expression bias as the cause of 
imprinted expression of Igf2r (Latos et al., 2009). 
The DMR2 on the paternal allele is marked by H3K4 methylation and H3 acetylation, 
but on the maternal allele is marked by H3K9 methylation (Fournier et al., 2002). It has been 
proposed that histone modifications specific to the promoters of IGF2R and AIRN are more 
critical than differentially methylated regions and AIRN non-coding RNA to determine 
imprinted expression of IGF2R in human and mouse (Mus musculus domesticus/Mus spretus) 
(Vu et al., 2004). 
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The Airn in mouse shows the characteristics of messenger RNAs that is, it is capped and 
polyadenylated, is transcribed by RNA polymerase II and undergoes alternative splicing 
resulting in four splice variants all of which originate from a promoter located within intron 2 
of Igf2r. The majority of the Airn escape from splicing leading to a mature 108 kb noncoding 
RNA which is not able to enter the cytoplasm. These observations raise the possibility that the 
act of transcription, not the RNA itself, may play a role in silencing of the maternal alleles in 
cis (Seidl et al., 2006). Recent evidence confirms that Igf2r silencing results from 
transcriptional overlapping with Airn which interferes with recruitment of RNA polymerase II 
to Igf2r promoter and does not require splice variants or full length nuclear localised RNA 
product (Latos et al., 2012). 
 
1.7.2 Expression and imprinting status in prenatal development 
IGF2R expression is first detected in the bovine blastocyst but is expressed at very low 
levels. However, a number of studies showed the presence of IGF2R transcript in all stages of 
bovine preimplantation embryos from mature oocyte (Watson et al., 1992; Wang et al., 2009). 
IGF2R protein was detected in the cytoplasmic membrane of immature and matured oocytes, 
and two-cell stage embryos. In the bovine blastocyst stage, IGF2R protein is distributed in the 
trophectoderm whereas is less abundant in the inner cell mass (Wang et al., 2009). IGF2R 
mRNA has been detected in the mesodermal tissues of ovine placenta at Day-40 of gestation, 
and its abundance was reduced towards late gestation (Day-140) (Lacroix et al., 1995). 
IGF2R expression occurs in the microvillous and plasma membrane of human trophoblast 
(Fang et al., 1997). 
Analysis of IGF2R expression in bovine fetal tissues by RT-PCR showed that this gene 
is highly expressed between the Day-30 and Day-180 of gestation with less expression 
obtained in brain than in liver, heart and muscle at Day-150 of gestation (Kawase et al., 
2000). In bovine fetuses, IGF2R mRNA expression was shown to be higher in liver, lung, 
kidney and placenta compared with brain and heart (Suteevun-Phermthai et al., 2009). 
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However, immunoblotting revealed that IGF2R protein is highly expressed in tissues of 
bovine fetuses at midgestation with the highest expression in heart (10-28 weeks) (Pfuender et 
al., 1995). In human, IGF2R expression is present during preimplantation stages of 
development, including the oocyte (Lighten et al., 1997). Study of tissue-specific expression 
of IGF2R in rat revealed highest expression of transcript and protein in embryonic heart 
(Senior et al., 1990). In contrast, quantitative analysis of IGF2R expression in bovine Day-75 
of gestation showed higher expression in liver, lung, kidney and cotyledon compared with 
heart and brain (Suteevun-Phermthai et al., 2009). The IGF2R concentration in rat fetal 
tissues was highest in heart, placenta, lung, muscle, kidney, liver and brain, respectively 
(Sklar et al., 1989). This corresponds to expression level of mRNA in fetal rat tissues which 
was highest in heart, muscle, lung, kidney, liver, brain, respectively (Sklar et al., 1992). 
Imprinting status of IGF2R in different tissues and developmental stages of the studied 
species has been summarised in Table 1.3. In mouse (Mus musculus/Mus spretus), Igf2r is 
paternally imprinted in peripheral tissues but shows biallelic expression in the CNS (Hu et al., 
1998). Imprinting status of the human IGF2R remains ambiguous. An early investigation of 
imprinting status of human IGF2R using a polymorphic dinucleotide repeat and a 
tetranucleotide insertion/deletion within the 3’UTR has revealed biallelic expression of the 
gene in the fetal tissues of lung, kidney, brain, liver, heart and muscle (Kalscheuer et al., 
1993). Because the reverse transcriptase PCR (RT-PCR) was employed in this study, the 
quantitative differences in expression between paternal and maternal alleles could not be 
determined. Also, a number of other investigations have demonstrated that human IGF2R is 
not imprinted (Ogawa et al., 1993; Treacy et al., 1996; Killian et al., 2001a). However, 
further studies in human showed that IGF2R imprinting is a polymorphic trait, and IGF2R is 
imprinted in some individuals (Xu et al., 1993; Xu et al., 1997; Oudejans et al., 2001; Monk 
et al., 2006a). Polymorphic imprinting of IGF2R suggests that epigenetic regulation of this 
gene is modified as a consequence of genetic background and/or environmental conditions. 
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Tissue Marker Method Imprinting status Reference 
Human Fetus (11-24 
weeks) 
Lung, kidney, 





In/Del in 3’UTR 
PCR and gel 
electrophoresis 
Biallelic (Kalscheuer et 
al., 1993) 
       
Human Fetus (12-17 
weeks) 
Muscle, kidney Tetranucleotide 
In/Del in 3’UTR 
PCR and gel 
electrophoresis 
Biallelic (Ogawa et al., 
1993) 
       











(Xu et al., 1993) 
       
Human Fetus (7-20 
weeks, term 
placenta) 
Kidney, placenta CA repeat 
polymorphism 




fetus, loss of 
imprinting in term 
placenta 
(Xu et al., 1997) 
       
Human Fetus (6-8 
weeks) 
Placenta ACAA In/Del in 
3’UTR 




(Oudejans et al., 
2001) 
       
Human Fetus (first 
trimester) 
Kidney SNPs in exons 6, 9, 
12, 16, 34, 40, 





Biallelic (Killian et al., 
2001a) 
       
Human Fetus (6-12 
weeks, 37-42 
weeks) 
Placenta SNPs Pyrosequencing Biallelic (Buckberry et 
al., 2012) 




In/Del in 3’UTR 
PCR and gel 
electrophoresis 
Biallelic (Ogawa et al., 
1993) 









dosage and protein 
measurement 
Lower expression 
(50 %) compared 
with control 
(Treacy et al., 
1996) 
       
Human Postnatal White blood cell CA repeat 
polymorphism 




(Xu et al., 1993) 




Fetus (8 weeks) Brain, liver, 
muscle, kidney 






       
Porcine Fetus Liver SNP in exon 48 PCR-sequencing Monoallelic (Killian et al., 
2001a) 















       
Porcine Postnatal 
(piglet, hog) 
- SNP in exon 48 PCR-RFLP-SSCP Maternal 
expression 
(Li et al., 2010) 






- Parthenogenesis Northern blot Higher expression 
in parthenogenetic 
samples 
(Young et al., 
2003) 








Parthenogenesis Semi-qPCR Higher expression 
in parthenogenetic 
fetus 
(Thurston et al., 
2008) 




Fetus Liver SNP in exon 19 PCR-sequencing Monoallelic (Killian et al., 
2001a) 












































       
Bovine Fetus Liver SNP in exon 48 PCR-sequencing Monoallelic (Killian et al., 
2001a) 




Pre- (E4.5) and 



















Fetus (Day-15) - Deletion on 
maternal 
chromosome 
Northern blot Maternal 
expression 
(Barlow et al., 
1991) 













Monoallelic (Lerchner and 
Barlow, 1997) 



























Fetus (E15) Liver, kidney, 
heart, lung, 
muscle, CNS 
RFLP PCR-RFLP and 
gel 
electrophoresis 




(Hu et al., 
1998) 

















(Hu et al., 
1999) 


































RFLP PCR-RFLP and 
gel 
electrophoresis 




(Hu et al., 
1998) 
 
The discrepancy in imprinting status of IGF2R in human studies may be due to different 
experimental methods or different markers used for imprinting analysis. For example, it was 
shown that the results of imprinting analysis of the IGF2R employing the CA repeat 
polymorphism at the 3’ untranslated region of IGF2R (Goto et al., 1992) are not reliable since 
one of the primers to amplify the DNA fragment flanking this SNP was located on the ACAA 
In/Del. Also, it has been speculated that stochastic amplifications in PCR cycles beyond 35 
cycles due to low amounts of the template may render the imprinting results difficult to 
interpret (Killian et al., 2001b). 
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Recently, a pyrosequencing approach to quantify allelic expression of IGF2R revealed 
equal transcript abundance of paternal and maternal alleles in the first trimester and term 
placenta (Buckberry et al., 2012), which is consistent with previously reported biallelic 
expression of IGF2R in human term placenta (Daelemans et al., 2010). Biallelic expression of 
IGF2R observed in porcine fetal and adult tissues (Braunschweig, 2012) is in contrast to the 
previously reported monoallelic IGF2R expression in fetal liver of porcine (Killian et al., 
2001a) and tissues of piglets (Li et al., 2010). Since the fetal and postnatal age is not clear in 
the latter (Killian et al., 2001a), the conflicting results obtained in these studies may be the 
outcome of different developmental stages at which allelic expression of IGF2R was 
measured. 
Imprinted maternal expression of IGF2R was found to be conserved in the ovine (Ovis 
aries) fetus (Killian et al., 2001a; Young et al., 2003). In this species, IGF2R is biallelically 
expressed in the blastocyst, while monoallelic imprinted expression is observed in concepti 
from Day-21 (Thurston et al., 2008). Monoallelic expression of IGF2R was shown in fetal 
liver of ovine (Ovis aries), bovine and porcine (Killian et al., 2001a). Apart from biallelic 
expression of IGF2R in the brain of newborn calves, predominant monoallelic expression of 
IGF2R in all tissues (heart, brain, liver, spleen, lung, cotyledon, intercotyledon) of fetuses at 
different developmental stages (Days-25, 45 and 75 of gestation) and neonatal calves was 
observed, though the parental origin of the expressed allele was not determined due to lack of 
parental tissues (Suteevun-Phermthai et al., 2009).  
 
1.7.3 Role in prenatal development 
IGF2R is a multifunctional protein that is known to be implicated in multiple cellular 
processes in addition to regulation of IGF2 bioavailability. Some of the known cellular 
pathways involving IGF2R include T-cell induced apoptosis through granzyme B uptake 
(Motyka et al., 2000), endocytosis and trafficking lysosomal enzymes (Kornfeld, 1992; Hille-
Rehfeld, 1995; Le Borgne and Hoflack, 1998; Dahms and Hancock, 2002), endothelial-cell 
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migration and angiogenesis through binding proliferin (Groskopf et al., 1997), growth 
inhibition and apoptosis induced through binding retinoid acid (Kang et al., 1999), proteolytic 
activation of latent form of transforming growth factor-1 (TGF-β1), which is a growth 
inhibitor (Dennis and Rifkin, 1991; Ghahary et al., 1999; Godár et al., 1999; Leksa et al., 
2005), control of cell invasion and migration through binding urokinase-type plasminogen 
activator receptor (uPAR) as well as targeting uPAR to lysosomes for degradation (Nykjær et 
al., 1998; Godár et al., 1999; Leksa et al., 2002; Schiller et al., 2009), regulation of 
plasminogen activation (Godár et al., 1999; Leksa et al., 2002), T-cell activation via binding 
dipeptidyl peptidase IV (CD26) on the cell surface (Ikushima et al., 2000) and inducing 
transendothelial cell migration by binding soluble CD26 released from T-cells (Ikushima et 
al., 2002). Although the mitogenic function of IGF2 is believed to be exerted through IGF1R 
(Nakae et al., 2001) and insulin receptor isoform A (Frasca et al., 1999), a number of 
researchers have raised the controversial suggestions that IGF2R is involved in cellular IGF2 
signalling (Murayama et al., 1990; Kornfeld, 1992; Minniti et al., 1992; Nishimoto, 1993; 
Ikezu et al., 1995; Groskopf et al., 1997; Zhang et al., 1997; Ikushima et al., 2000; Tsuruta et 
al., 2000; McKinnon et al., 2001; Zygmunt et al., 2005; Chu et al., 2008; Sferruzzi-Perri et 
al., 2008; Maeng et al., 2009; Harris et al., 2011). The functions of IGF2R are more 
complicated considering different cell types that have been exploited in these studies. In fact, 
specific roles of the IGF2R may be more complex and vary with tissue and developmental 
stage. Therefore, it is necessary to investigate tissue-specific association of IGF2R transcript 
abundance with organ growth at specific stages of development. 
A significant association of polymorphisms within IGF2R with birth weight was 
observed in human (Kaku et al., 2007; Adkins et al., 2010), whereas inconsistent results were 
obtained in other studies (Kukuvitis et al., 2004; Petry et al., 2005). The critical role of Igf2r 
gene in prenatal development has been documented in knockout mouse experiments and by 
the observation of aberrant expression of the gene in some growth-related disorders. Mice 
with a disrupted Igf2r gene suffer from overgrowth syndrome and die shortly after birth (Lau 
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et al., 1994; Wang et al., 1994; Ludwig et al., 1996), whereas mosaic mice with tissue-
specific disruption (liver, skeletal and cardiac muscle) in Igf2r possess no obvious 
abnormality (Wylie et al., 2003). Death before birth accompanied by organomegaly and 
congenital heart defects, hyperdactyly and kinky tail have been shown in the mice lacking 
functional Igf2r, suggesting a key role for Igf2r in differentiation and organogenesis during 
prenatal development, a function that needs to be further investigated (Lau et al., 1994; Wang 
et al., 1994). Heart failure as a result of cardiac hyperplasia is the major cause of death in the 
Igf2r null mice, suggesting a critical role for Igf2r in heart.  
A soluble type of IGF2R (sIGF2R) comprising the extracellular domain of cellular 
IGF2R has been reported in the serum and amniotic fluid of rat (Kiess et al., 1987), ovine 
(Gallaher et al., 1994), bovine (Li et al., 1991), monkey (Gelato et al., 1988) and human 
(Causin et al., 1988). This isoform which is a truncated form resulting from proteolytic 
cleavage of transmembrane and intracellular domains of the cell membrane IGF2R has been 
shown to block IGF2-induced DNA synthesis (Scott and Weiss, 2000). Soluble IGF2R 
(sIGF2R) appears to take part in regulating bioavailability of IGF2, as it accounts for 50% of 
total IGF2 binding in fetal ovine blood but is dramatically downregulated in adults (Gelato et 
al., 1989; Gallaher et al., 1994). The ratio of cord blood IGF2 to soluble IGF2R was shown to 
be positively related to placental and birth weight (Ong et al., 2000). Transgenic mice which 
express a mutated Igf2r complementary DNA encoding a soluble receptor showed decreased 
size of organs (Zaina et al., 1998). It has been suggested that reduction of organ size as a 
result of increased levels of sIGF2R occurs through both IGF2-dependent and IGF2-
independent pathways (Zaina and Squire, 1998). 
 
1.7.4 Expression and role in postnatal growth 
IGF2R expression is downregulated in rat postnatal tissues (Kiess et al., 1987; Sklar et 
al., 1989; Senior et al., 1990; Sklar et al., 1992). Developmental downregulation of soluble 
IGF2R protein was reported postnatally in human, bovine, ovine and monkey serum (Gelato 
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et al., 1988; Gelato et al., 1989; Li et al., 1991; Xu et al., 1998; Costello et al., 1999). Igf2r 
was shown to be expressed throughout mouse growth plate and is postnatally upregulated 
with age in the growth plate, perichondrium and bone, whereas Igf2 expression is 
downregulated with age (Parker et al., 2007; Andrade et al., 2010). 
Studies of the association between polymorphisms in IGF2R and phenotypic traits are 
rare and the results are inconsistent. In an attempt to examine single nucleotide 
polymorphisms in IGF2R affecting beef performance traits in the bovine, none of the studied 
SNPs were significantly associated with meat production traits (Magee et al., 2010). The 
reliability of these results may be questioned since the imprinting effects were not included in 
the model used for association analysis. In a subsequent study, the SNPs located in the 
intronic regions of IGF2R were shown to be associated with body size traits and carcass 
weight and angularity (Berkowicz et al., 2012). A polymorphism resulting in a missense 
mutation has been reported in human which was associated with height and weight gain in 
children (Petry et al., 2005). 
 
1.8 Imprinted genes and genetic programming of postnatal 
performance: Implications for heterosis 
It has been documented that postnatal growth and health is largely determined by 
prenatal development, which is in turn subject to fetal genetics, epigenetics and maternal 
factors, a process termed “fetal programming” (Barker and Clark, 1997). What was initially 
known as fetal programming is now believed to occur throughout development and includes 
oocyte programming (Gilchrist et al., 2004; Krisher, 2004; Sirard et al., 2006; Doblado and 
Moley, 2007; Jungheim et al., 2010; Parry and Singson, 2011; Tian and Diaz, 2013), embryo 
(fetal) programming (Barker, 2004; Simmons, 2006) and early postnatal programming (Neu 
et al., 2007; Nilsson et al., 2008; Baum, 2010; Wright, 2010). In addition, there is increasing 
evidence of intergenerational programming and paternal influence on intrauterine 
development (Godfrey et al., 2001; Drake and Walker, 2004; Veena et al., 2004; Drake et al., 
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2005; Temple et al., 2006; Whitaker et al., 2010). Although the concept of fetal programming 
has long been developed in human epidemiological research there is growing evidence that 
animal postnatal performance has its origin in prenatal development and is affected by 
maternal environmental conditions (Young et al., 1998; Bell, 2006; Foxcroft et al., 2006; Wu 
et al., 2006; Gardner et al., 2007; Funston et al., 2010; Hill et al., 2010). Altered epigenetic 
modifications of imprinted genes, including those in IGF system, in response to maternal 
environmental stimuli are believed to impact on prenatal development with long-term 
consequences for postnatal phenotype (Dean et al., 1998; Brameld et al., 2000; Khosla et al., 
2001; Young et al., 2001; Wu et al., 2004; Dong et al., 2005; Kwong et al., 2006; Igwebuike, 
2010; Micke et al., 2011a; Micke et al., 2011b). 
Most studies in the area of fetal programming have focused on the epigenetic link 
between intrauterine environment and fetal phenotype, and the role of imprinted genes in 
genetic programming of variation in pre- and postnatal growth traits remains largely 
unexplored. There is evidence that genetics impacts on expression of imprinted genes 
(Hemberger et al., 1998; Van Laere et al., 2003). Further evidence for genetic effects on 
imprinted genes comes from association of genetic polymorphisms within imprinted gene loci 
and phenotypes (Zhao et al., 2002; Han et al., 2008b; Sherman et al., 2008; Zwierzchowski et 
al., 2010; Berkowicz et al., 2012) and also imprinted QTL effects mapped to IGF2 on 
growth-related phenotypes in porcine (Jeon et al., 1999; Nezer et al., 1999; Van Laere et al., 
2003). 
Changes in (epi)genetic mechanisms implicated in regulation of gene expression as 
caused by intra-species hybridisation are likely to be significant contributors to postnatal 
phenotype, including heterosis. Heterosis is defined as superiority of hybrids in a trait 
compared to the average of their parental purebreds (Veitia and Vaiman, 2011). Mendelian 
genetic models have been used to describe non-additive gene expression and heterosis 
(Davenport, 1908; Shull, 1908; Bruce, 1910; Keeble, 1910; Jones, 1917; Powers, 1944; Crow, 
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1948; Hochholdinger and Hoecker, 2007) and models with non-Mendelian (epi)genetic 
effects, including parent-of-origin imprinting effects, have not yet been viewed. 
A model of reciprocal crosses between two genetically distant groups has been used in 
most studies to examine parent-of-origin (iQTL) effects on phenotypes. In such models, the 
parent-of-origin effects on phenotypes are analysed based on the difference between two 
reciprocal groups, which is interpreted as the effects of parent-of-origin dependent gene 
expression associated with genomic imprinting (Wolf et al., 2008b). Significant heterosis for 
birth weight (Brown et al., 1993) and significant differences between reciprocal hybrids for 
growth and carcass characteristics of calves (Rohrer et al., 1994; Amen et al., 2007a; Amen et 
al., 2007b) have been detected in a bovine model using Bos taurus × Bos indicus crosses. 
Accumulating evidence suggests that the difference between reciprocals could be attributed to 
non-Mendelian epigenetic inheritance of imprinted genes (Jiang et al., 2007; Loschiavo et al., 
2007; Cheverud et al., 2008; Hager et al., 2008; Wolf et al., 2008a). However, the role of 
imprinted genes in driving heterotic phenotypes has not been investigated. 
Reciprocal intra-species hybridisation models enable the study of associations of parent-
of-origin imprinting patterns and heterotic phenotypes at the molecular and phenotypic level. 
This can provide insights into the molecular basis of natural phenotypic variation and is 
relevant not only in studies aimed at understanding molecular mechanisms involved in 
heterosis, but is also likely to shed light on the (epi)genetic architecture and prenatal 
programming of complex traits associated with growth and disease in human. 
Bovine provide a unique animal model for studying parent-of-origin epigenetic effects 
on complex traits in human because of generally outbred genetics, similar reproductive 
characteristics, including singleton pregnancies, similar gestation length and lifetime 
reproductive performance. Bovine are one of the most important agricultural species 
providing foods for nearly 6.6 billion humans globally (Elsik et al., 2009). The bovine has 
become an important model organism for assisted reproductive technologies, including in 
vitro fertilization (IVF) (Ménézo and Hérubel, 2002). There are two genetically and 
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phenotypically distinct subspecies of bovine (Lin et al., 2010), which provide an excellent 
source of genetic diversity for the study of genomic imprinting, the interplay of genetics and 




1.9 Hypothesis and research objectives 
The IGF2 and IGF2R belong to the insulin like growth factor system and are the best 
known imprinted genes in ruminants. Although it is understood that imprinted genes are 
implicated in environmental programming of postnatal growth little is known about their role 
in (epi)genetic programming of phenotypes, and effect of genetics on expression of imprinted 
genes and its consequence for non-additive heterotic gene expression and phenotypic 
variation of growth-related traits in prenatal development has not been examined. 
In this thesis, we hypothesised that 
i) Expression of imprinted genes in tissues of B. taurus/B. indicus prenatal 
development is subject to fetal genetics. 
ii) Heterosis, i.e., the superiority of F1 hybrids compared to their parents, in 
B. taurus/B. indicus growth traits is (epi)genetically programmed in prenatal 
development through changes in expression patterns of imprinted genes. 
 
The objectives of this work were: 
i. to perform a comparative in silico analysis of promoter-specific transcripts and 
splice variants of the imprinted IGF2 and AIRN genes. 
ii. to evaluate tissue-specific changes in transcript abundance of imprinted genes, IGF2 
global and promoter-specific transcripts, IGF2R, and their regulatory long non-
coding RNA imprinted genes, H19 and AIRN across pre- and postnatal 
developmental stages. 
iii. to analyse the effect of fetal genetics and heterosis on fetal weight and weight of 
fetal tissues and also on tissue-specific expression of the imprinted genes. 
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Chapter 2                                        
Comparative in silico analysis of IGF2 
promoter-specific transcript variants and 
AIRN transcripts in bovine 
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2.1 Introduction 
The bovine insulin-like growth factor 2 gene (IGF2) spans 18606-bp on the distal end of 
chromosome 29 (Schmutz et al., 1996; Goodall and Schmutz, 2003). IGF2 is a major 
regulator of prenatal development (Dechiara et al., 1990; Vrana et al., 1998; Sayer et al., 
2002; Nagaya et al., 2009; Adkins et al., 2010) and a QTL affecting postnatal performance 
(Jeon et al., 1999; Nezer et al., 1999; de Koning et al., 2000; Nezer et al., 2003; Van Laere et 
al., 2003). The gene is subject to a complex transcription regulation through genomic 
imprinting, promoter-specific transcription, differential splicing and alternative 
polyadenylation (Ikejiri et al., 1991; Hu et al., 1996; Li et al., 1996; Overall et al., 1997; Yun 
et al., 1998; Constancia et al., 2005; Curchoe et al., 2005; Thurston et al., 2008; Buckberry et 
al., 2012). 
The IGF2 gene is part of an evolutionarily conserved domain that is linked to INS and 
H19 genes on its upstream and downstream sides, respectively. These three genes cover a 
region of approximately 150 kb on human chromosome 11 and mouse chromosome 7 (Zemel 
et al., 1992; Onyango et al., 2000). In mouse, the gene comprises upstream exons U1 and U2, 
previously known as pseudo-exons, followed by six exons (Rotwein and Hall, 1990). The 
IGF2 gene is composed of 10 exons in human (Mineo et al., 2000), bovine (Goodall and 
Schmutz, 2007) and porcine (Amarger et al., 2002). In all species, the IGF2 protein is 
translated from the last three exons.  
In all species studied, including human, mouse, rat, porcine, ovine and bovine, IGF2 is 
transcribed from distinct promoters which initiate transcription from different 5’ non-coding 
exons. This complex promoter-specific transcription, which involves alternative splicing and 
polyadenylation, is believed to play an important role in regulation of transcription of IGF2 in 
a tissue and developmental stage-specific manner (Davies, 1994; Vu and Hoffman, 1994; 
Ekstrom et al., 1995; Li et al., 1996; Curchoe et al., 2005; Li et al., 2008a; Giang Tran et al., 
2012). In human (Holthuizen et al., 1990), bovine (Curchoe et al., 2005; Goodall and 
Schmutz, 2007), porcine (Amarger et al., 2002) and ovine (Ohlsen et al., 1994), transcription 
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from four promoters (P1-4) gives rise to a family of mRNA transcripts with different 
untranslated exons. A developmental switch in IGF2 promoter usage occurs in bovine (Boulle 
et al., 1993), ovine (O'Mahoney et al., 1991; Ohlsen et al., 1994), porcine (Amarger et al., 
2002) and human (Depagterholthuizen et al., 1987; Pedersen et al., 2002; Monk et al., 2006) 
in which transcription from the P2, P3 and P4 promoters falls sharply after birth and the P1 
promoter becomes active in liver at the time of birth. Furthermore, a fifth promoter (P0) has 
been characterised upstream of human IGF2 exon 2 (Monk et al., 2006). In mouse, 
transcription of IGF2 is initiated by three promoters (P1-3) in fetal tissues as well as a 
promoter (P0) that is only active in placenta (Rotwein and Hall, 1990; Moore et al., 1997). 
Bovine IGF2R is located on the distal end of chromosome 9 at position 9q26. It is a 
large gene with 48 exons spanning 102612 bp. The transcript length is 9075 bp with 7500 bp 
encoding the mature IGF2R protein. The IGF2R/Igf2r shows imprinted expression and is 
expressed from maternal allele in the studied animal species (Barlow et al., 1991; Killian et 
al., 2001; Young et al., 2003; Bebbere et al., 2013). In mouse (Mus musculus domesticus), 
imprinted expression of Igf2r is regulated by the reciprocally imprinted paternally expressed 
long non-coding RNA, Airn. The promoter of Airn is located in intron 2 of Igf2r gene and is 
transcribed in an antisense direction to Igf2r (Sleutels et al., 2002). Although, AIRN was 
shown to be expressed in bovine prenatal development (Suteevun-Phermthai et al., 2009; 
Farmer et al., 2013), its gene and transcript structure and regulatory effect on IGF2R 
imprinted expression remains unclear. 
Several sense and antisense transcripts have been characterised in the region 
encompassing INS/IGF2 in mouse, human and porcine (Moore et al., 1997; Braunschweig et 
al., 2004; Monk et al., 2006). Many of these transcripts, which overlap exonic regions of 
IGF2 transcripts, have not been identified in bovine and therefore complicate analysis of 
expression of IGF2 promoter-specific transcripts. In order to be able to identify the putative 
previously unknown transcripts in bovine and to design appropriate primers for specific 
amplification of IGF2 promoter-specific transcripts, we performed a comprehensive 
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comparative analysis of sequence and exon/intron structures of the known transcripts 
surrounding the INS/IGF2 gene domain in bovine, human, porcine and mouse using previous 
findings from literature and sequence information available in public databases.  
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2.2 Materials and methods 
Sequences and exon/intron structures of the studied genes and transcripts, including 
IGF2 promoter-specific transcripts, INSIGF2 hybrid transcripts, IGF2 antisense transcripts 
for human (Homo sapiens), bovine (Bos taurus), mouse (Mus musculus) and porcine (Sus 
scrofa) were retrieved from literature and the public databases, National Center for 
Biotechnology Information (NCBI) GenBank database (www.ncbi.nlm.nih.gov/genbank/) and 
Ensembl project database (http://www.ensembl.org). Sequence similarity search between 
bovine and other species was carried out using Basic Local Alignment Search Tool (BLAST) 
at http://blast.ncbi.nlm.nih.gov/ (Altschul et al., 1990). The dbEST of NCBI GenBank 
(Boguski et al., 1993) was used to explore the Expressed Sequence Tags (ESTs) 
corresponding to the putative IGF2R antisense transcript (AIRN) and IGF2 antisense 
transcript (IGF2AS) in bovine. The corresponding ESTs were identified using sequence 
similarity search by BLAST against bovine EST database (http://blast.ncbi.nlm.nih.gov/). 
CTCF-binding sites within the ICR upstream of H19 gene, were predicted with 
CTCFBSDB (Bao et al., 2008). Comparison of the sequences of seven CTCF binding sites 
between Bos taurus and Bos indicus was performed using BLAST with Bos indicus genome, 




Comparative exon/intron structure of INS/IGF2 for human, bovine, porcine and mouse is 
shown in Figure 2.1. The IGF2 gene shows structural homology in the studied species. The 
gene shows more similarity between human, bovine and porcine as compared with mouse and 
is composed of 10 exons (exons 1 to 9 in human and porcine with exon 4b corresponding to 
exon 5 in bovine). In human, bovine and porcine, the first upstream seven exons are not 
translated and are part of the 5’UTR in the transcripts derived from different promoters. In 
human, bovine and porcine, four promoters (P1, P2, P3 and P4) drive transcription from the 
leading exons 1, 4, 5 (exon 6 in bovine) and 6 (exon 7 in bovine), respectively. A novel 
promoter (P0) has been found in human that drives transcription from a region upstream to 
exon 2 in fetal skeletal muscle. Despite the complexity in transcription, all promoter-specific 
transcripts possess the protein coding exons 7, 8 and 9 (8, 9 and 10 in bovine) and lead to the 
same protein. A conserved microRNA (MIR483) is in intron 7, 8 and 4 of human, bovine and 
mouse, respectively. The respective microRNA has not been reported in pig. 
In mouse, promoters P1, P2 and P3 drive transcription from untranslated exons 1, 2 and 
3, respectively, which are extended to the protein coding exons 4, 5 and 6. Furthermore, a 
transcript consisting of the upstream exons U1 and U2 and the last three protein coding exons 
is derived from promoter P0 located upstream of exon U1 (Figure 2.1). 
Sequence information of IGF2 transcripts in the studied species was extracted from 
public databases. For human, the transcript containing exon 1 derived from P1 promoter was 
not found in NCBI and Ensembl databases. Two transcripts initiating from upstream region to 
exon 2 and containing exon 3, as well as two transcripts initiating from the leader exon 3, 
were found in human with different polyadenylation sites (Figure 2.2). Three transcripts with 
different transcription initiation and polyadenylation sites are derived from the P2 promoter in 
human and contain exons 4 and 4b. The P2 derived splice variant with the leading exon 4 (but 
not exon 4b) is not available in the databases. Five transcripts derived from the P3 promoter 











CTCF-BS1:  GCGGCCGCGAGGCGGCAGTGCAGGCTCATGCATCA Bos taurus 
CTCF-BS1:  GCGGCCAAAAGGCGGCAGTGCAGGCTCATGCATCA Bos indicus 
 
CTCF-BS2:  GCGGCCGCGGGGCGGCAGTGTGGGCTCACACATCA Bos taurus 
CTCF-BS2:  GCGGCCGCGGGGCGGCAGTGTGGGCTCACACATCA Bos indicus 
 
CTCF-BS3:  GCGGCCGCGAGGCGGCAGTGCAGGCTCATGCATCA Bos taurus 
CTCF-BS3:  GCGGCCGCGAGGCGGCAGTGCAGGCTCACACATCA Bos indicus 
 
CTCF-BS4:  GCGGCCGCGGGGCGGCGGTGTGGGCTCACACATCA Bos taurus 
CTCF-BS4:  GCGGCCGCGGGGCGGCGGTGTGGGCTCACACATCA Bos indicus 
 
CTCF-BS5:  GCGGCCGCGAGGCGGCAGTGCAGGCTCACACATCA Bos taurus 
CTCF-BS5:  GCGGCCGCGAGGCGGCAGTGCAGGCTCACRCATCA Bos indicus 
 
CTCF-BS6:  GCGGCTGCGAGGTGGCAGTGCAGGCTCACACATCA Bos taurus 
CTCF-BS6:  GCGGCTGCGAGGTGGCAGTGCAGGCTCACACATCA Bos indicus 
 
CTCF-BS7:  GCGGCCGCGAGGCGGCGGTGCAGGCGCCAACATCA Bos taurus 
CTCF-BS7:  GCGGCCGCGAGGCGGCGGTGCAGGCGCCAACATCA Bos indicus 
 
Figure 2.11 Comparison of the sequences of seven CTCF binding sites (CTCF-BS1-7) between Bos taurus and 
Bos indicus. 
The boxed sequences depict the consensus sequences which are conserved across species. The single nucleotide 
polymorphisms are marked in red. Sequence similarity searches were performed using the Basic Local 
Alignment Search Tool (BLAST) with Bos indicus genome, in National Center for Biotechnology Information 





Despite the complex patterns of transcription, all IGF2 transcripts are translated into the 
same protein (Li et al., 1997; Curchoe et al., 2005). However, truncated forms of IGF2 
mRNA missing the major portion of exon 10 have been found in bovine tissues where full-
length transcripts are not present (Curchoe et al., 2005). Exon 10 translates the major part of 
E domain of the IGF2 precursor protein which is cleaved off to form the mature IGF2 protein 
(Curchoe et al., 2005). The truncated forms of mouse Igf2 transcripts missing exon 6 are 
present in Ensembl (Figure 2.3). It is speculated that truncation of IGF2 transcripts is a 
mechanism for control of IGF2 protein levels in tissues via translational regulation of IGF2 
protein and E-domain. This is supported by data in rat in which the level of E-domain peptide 
changes during development (Hylka and Straus, 1990). 
Variant forms of the IGF2 protein have been identified in human blood (Hampton et al., 
1989; Straczek et al., 1990; Vandenbrande et al., 1990) and placenta (De Ceuninck et al., 
1995). Furthermore, higher molecular weight forms of the IGF2 (unprocessed proIGF2s) have 
been found in human plasma (Zumstein et al., 1985; Gowan et al., 1987) and cerebrospinal 
fluid (Haselbacher and Humbel, 1982). Presence of variant forms of IGF2 in human tissues 
implies that regulatory mechanisms which are active at the translation level may be linked to 
the transcriptional regulation as the result of differential splicing, which influence IGF2 
bioavailability and binding affinity to its receptors and binding proteins. For example, a 
variant isoform of IGF2 has been shown to have a 2 to 3-fold lower affinity for IGF1R 
compared to the IGF1 and IGF2 (Hampton et al., 1989). Although, the biological role of 
IGF2 transcript variants is poorly understood, their tissue and developmental stage-specific 
regulation of transcription and association of these variants with the protein levels needs to be 
investigated. There are no reports of bovine proIGF2 protein variants, however, based on the 
information in human and rodents, they are also likely to be present in bovine. The 
identification of putative IGF2 protein variants in bovine tissues and their association with 
IGF2 transcript variants can be of particular interest. 
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In mouse, three distinct promoters, P1, P2 and P3, which are equivalent to human P2, P3 
and P4 promoters, respectively, regulate IGF2 expression in fetal tissues (Rotwein and Hall, 
1990). Furthermore, a unique promoter (P0) drives a transcript containing exons U1 and U2 
specifically in mouse placenta which is necessary for placental growth (Moore et al., 1997).  
A novel IGF2 transcript has been found in human that appears to be equivalent to the 
mouse placental-specific transcript derived from P0 transcript (Monk et al., 2006). The 
human exons 2 and 3 exhibit sequence similarity of 81% and 53% to the mouse exons U1 and 
U2 respectively (Rotwein and Hall, 1990). The promoter for the human P0 transcript is 
located within intron 1 which initiates transcription from a unique sequence 5’ to exon 2 
extending 256 bp towards upstream of intron 1 (Figure 2.1). The transcript is subsequently 
spliced onto exon 3 as well as the last three coding exons of the IGF2 gene (Monk et al., 
2006) (Figure 2.2). These results show an evolutionary shift in tissue specificity of P0 
promoter from placental-specific activity in rodents to fetal skeletal muscle-specific activity in 
other mammals. 
P1 transcripts containing exon 1 in human and bovine are not present in the databases. 
We found transcripts in human and mouse whose leader exon is exon 3 and U2, respectively, 
raising the possibility of a new as yet unknown promoter upstream of exons 3 in human and 
U2 in mouse. The sequence information on promoter-specific transcripts in human, bovine, 
mouse and porcine is not complete in NCBI. For example, human P4 and P1 sequence, mouse 
P0 sequence and porcine P2, P3 and P4 are not available in NCBI. In bovine, there is a 
transcript beginning from exon 2 splicing onto exon 3. This transcript appears to be P0 
transcript with an alternative transcription start site or P1 transcript whose exon 1 is missing 
in the database.  
Hybrid transcripts (INSIGF) which originating from the upstream insulin exonic regions 
and splice to the downstream IGF2 exons have been identified in human pancreas (Monk et 
al., 2006). Two long and short isoforms of INSIGF2 mRNA result from alternative splicing of 
the hybrid transcripts. The INSIGF short transcript is composed of INS exon1, IGF2 exons 2, 
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3 as well as a specific exonic region downstream of exon 3 (Figure 2.5). This region, which is 
also present in the human IGF2 antisense transcript, is highly conserved in bovine (data not 
shown), suggesting that hybrid INSIGF transcripts may exist in bovine. There is no evidence 
regarding the presence of the hybrid transcripts in mouse and other species. The INSIGF2 
transcript contains an open reading frame (ORF) which extends to IGF2 exon 3. Translation 
of this ORF results in a novel protein that includes the insulin leader sequence and B-chain 
peptide as well as an additional peptide at the C-terminal end (Monk et al., 2006). 
An IGF2 antisense transcript has been detected in human (Okutsu et al., 2000), mouse 
(Rivkin et al., 1993) and porcine (Braunschweig et al., 2004). Human IGF2AS lies within the 
IGF2 gene and shares some exonic regions (exons 2, 3, 4), exhibiting about 50% homology 
with the mouse Igf2as (Okutsu et al., 2000). In mouse, three Igf2as transcripts encompassing 
DMR0, which overlap P0- and P1- derived transcripts, have been detected (Moore et al., 
1997). Notwithstanding, there is no evidence of a link between Igf2as and Igf2 expression. 
Human IGF2AS is imprinted and exclusively expressed from the paternal allele. There is no 
information on the possible regulatory effects of IGF2AS on IGF2 expression and imprinting. 
IGF2 and IGF2AS are overexpressed in human Wilms’ tumors at levels over 10 and 100 
times higher than that in normal fetal tissues, indicating their expression is co-regulated 
(Okutsu et al., 2000). Human IGF2AS has an ORF encoding a putative peptide, while the 
corresponding mouse Igf2 does not have such an ORF. Although no relevant proteins for 
IGF2AS have been identified this gene can affect tumorogenesis by its protein products or 
acting as a non-coding RNA (Okutsu et al., 2000). Analysis of the expression pattern of IGF2 
and IGF2AS in human fetal tissues has revealed that IGF2AS is ubiquitously expressed in 
most tissues at levels similar to P2-derived transcripts, so it is possible that both transcripts 
are under control of the same regulatory elements (Vu et al., 2003). This can be explained by 
the locations of IGF2 and IGF2AS promoters which are adjacent to each other and may share 
the same regulatory mechanisms. Dissociation of imprinting of IGF2 and IGF2AS was 
inferred from the study of loss of imprinting (LOI) of IGF2AS in Wilms’ tumors (Vu et al., 
80 
2003). No IGF2 antisense transcripts were reported in bovine, but our current knowledge on 
IGF2AS in human, mouse and porcine can postulate a putative antisense transcript with the 
potential for a regulatory role in pre and postnatal development. Investigation of the bovine 
EST database revealed evidence for the existence of the putative IGF2AS. These ESTs 
matched the sequences in intron 3 of bovine IGF2 and show splicing patterns. Interestingly, 
the corresponding region in porcine harbours exons 2 and 3 of IGF2AS. 
Results from an early study of cross-hybridisation of bovine mRNA using human-
derived probes covering different IGF2 exons revealed seven transcripts of different size from 
P3 (5.2, 3.4, 2.8, 2.1 kb), P4 (4, 1.1 kb) and a liver-specific transcript of 4.4 kb (Boulle et al., 
1993). According to the known sequence lengths of bovine IGF2 exons/introns, sizes of the 
transcripts obtained in this study differ from the expected sizes of different transcripts (4 kb 
for P1 promoter; 4.4 kb for P3 promoter; 3.6 kb for P4 transcript). This raises the possibility 
of alternative functional polyadenylation signals located downstream to the distal 
polyadenylation signal of 3’UTR. An alternative explanation is that the measurement of 
transcript length based on size markers might not be accurate. 
Some IGF2 exons overlap exonic regions of the putative sense and antisense transcripts, 
including INSIGF2 and IGF2AS. Therefore, primers for amplification of IGF2 promoter-
specific transcripts must be designed considering the overlapping exons. Postnatal liver-
specific expression of P1 transcript in bovine was demonstrated by PCR-amplification of the 
transcript containing exon 1 (Goodall and Schmutz, 2007). Curchoe et al. (2005) used exon 3, 
which is shared between P0 and P1 transcripts, to analyse expression of P1 transcript and 
reported non-specific expression of transcripts containing exon 3 in bovine fetal and adult 
tissues, including liver, heart, lung, brain and kidney, although the developmental stage of 
fetuses was not clear in this work (Curchoe et al., 2005). The ubiquitous expression of P1 
transcript in adult tissues using primers within exon 3 (Curchoe et al., 2005) likely results 
from amplification of IGF2AS which entirely overlaps IGF2 exon 3 (Figure 2.6). 
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We investigated the bovine expressed sequence tag (EST) database for the putative 
AIRN transcript and found 12 ESTs corresponding to intron 2 of IGF2R, two of which show 
splicing patterns (Figure 2.11). These data support the existence of AIRN in bovine which 
originate from the CpG island within intron 2. Therefore, primers located within IGF2R 
intron 2 in a region close to the CpG island likely amplify all putative variants of AIRN. The 
putative AIRN transcript was previously amplified in bovine fetal tissues by placing primers 
in IGF2R intron 2 (Suteevun-Phermthai et al., 2009) and intron 1/exon 2 (Farmer et al., 
2013). 
Single nucleotide polymorphisms were identified in the consensus sequence of the first 
CTCF binding site, which is conserved across species (Young et al., 2003). These SNPs, 
which disrupted two CpG dinucleotides, are likely to affect regulation of imprinting and 
expression of IGF2 and H19. Several studies demonstrated that mutations in the CTCF 
binding sites and ICR influence epigenetic state and imprinted expression of H19 and IGF2 
with consequent effects on growth (Szabó et al., 2002; Engel et al., 2004; Pant et al., 2004; 
Han et al., 2008; Li et al., 2008b; Lee et al., 2010; Matsuzaki et al., 2010; Quenneville et al., 
2011; Singh et al., 2012) 
In conclusion, the bovine IGF2 expression pattern may be much more complicated than 
previously thought. A number of sense and antisense transcripts found in human, mouse and 
porcine IGF2 gene region have not been identified in bovine. These antisense transcripts share 
exonic regions with the IGF2 gene. The discrepancies in results of expression analyses of 
IGF2 promoter-specific transcripts in bovine likely result from amplification of different 
IGF2 exons which overlap exonic regions of other sense and/or antisense transcripts. Further 
studies are required to elucidate complete sequence and exon/intron structure of different 
IGF2 transcripts and their tissue-specific and developmental expression in bovine. The high 
sequence homology between human and bovine and the intron-exon structure demonstrate 
that the human IGF2 gene is closer to bovine than mouse. Thus, the bovine could provide a 
suitable model for studying the role of this gene in human prenatal development. 
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Chapter 3                                                   
Tissue and developmental stage-specific 
expression of the imprinted IGF2, IGF2R, 
H19 and AIRN genes in bovine
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3.1 Introduction 
The imprinted IGF2 and IGF2R genes play a key role in regulating prenatal growth and 
development (Dechiara et al., 1990; Lau et al., 1994; Wang et al., 1994; Ludwig et al., 1996). 
Furthermore, several lines of evidence showed that they are associated with postnatal growth 
(Jeon et al., 1999; Petry et al., 2005; Berkowicz et al., 2012). This requires that expression of 
these genes is controlled in a developmental stage-specific manner. The imprinted expression 
of IGF2 and IGF2R is regulated by the reciprocally imprinted H19 and AIRN long non-
coding RNA genes (Steenman et al., 1994; Ripoche et al., 1997; Sleutels et al., 2002). 
IGF2 is a potent growth promoter and essential for prenatal development. The IGF2 
gene is subject to genomic imprinting and paternally expressed in mouse (Mus musculuc 
domesticus), human, ovine (Ovis aries) and bovine (B. taurus/B. gaurus) (DeChiara et al., 
1991; Giannoukakis et al., 1993; McLaren and Montgomery, 1999; Dindot et al., 2004). 
Postnatally, IGF2 has a significant role in muscle growth and fat deposition in porcine (Jeon 
et al., 1999; Nezer et al., 1999; Van Laere et al., 2003) and bovine (Zhao et al., 2002; Goodall 
and Schmutz, 2003; Sherman et al., 2008; Zwierzchowski et al., 2010). In human, bovine, 
ovine and porcine, four promoters (P1-4) are involved in regulation of IGF2 transcription in a 
manner depending on tissue and developmental stage (Ohlsen et al., 1994; Amarger et al., 
2002; Curchoe et al., 2005; Goodall and Schmutz, 2007).  
The IGF2R is a cell surface receptor possessing multiple functions. It acts as a scavenger 
receptor which binds and internalises IGF2 for lysosomal degradation, thus, regulating its 
bioavailability to cells (Braulke, 1999). The IGF2R gene is imprinted and expressed from the 
maternal allele in Mus musculus/Mus spretus (Barlow et al., 1991), ovine (Ovis aries) (Young 
et al., 2003), bovine and porcine (Killian et al., 2001), whereas it is likely polymorphically 
imprinted in human (Xu et al., 1993; Xu et al., 1997; Buckberry et al., 2012). Associations of 
polymorphisms in IGF2R with postnatal growth-related traits in bovine also suggest a role for 
IGF2R in postnatal growth (Berkowicz et al., 2012). Imprinted expression of the IGF2R is 
controlled by the reciprocally imprinted long non-coding RNA gene, AIRN. While expression 
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of IGF2R was shown to be under developmental regulation, evidence of tissue-specific 
developmental expression of AIRN is lacking. 
The H19 gene is located downstream of IGF2 being part of an imprinted cluster. The 
gene encodes a long RNA which shows common features of RNA polymerase II derived 
mRNAs undergoing polyadenylation and splicing but lacks a conserved open reading frame 
(Brannan et al., 1990). The gene is imprinted on the paternal chromosome and expressed from 
the maternal allele in human (Rachmilewitz et al., 1992; Zhang and Tycko, 1992; Buckberry 
et al., 2012), mouse (Bartolomei et al., 1991), bovine (Zhang et al., 2004), porcine (Li et al., 
2008) and ovine (Ovis aries) (Young et al., 2003). The conserved structure and sequence of 
H19 across species suggests a functional role for the non coding RNA (Juan et al., 2000). H19 
is highly expressed during embryogenesis in mouse mesoderm and endoderm-derived tissues 
and its expression is fully suppressed in postnatal tissues, except skeletal muscle and heart 
(Poirier et al., 1991). 
Several lines of evidence in different species showed that expression patterns of the 
imprinted genes belonging to the IGF system are developmentally regulated (Brown et al., 
1986; Soares et al., 1986; Gray et al., 1987; Schofield and Tate, 1987; Sklar et al., 1989; 
Ballesteros et al., 1990; Senior et al., 1990; O'Mahoney et al., 1991 ; Sklar et al., 1992; 
Boulle et al., 1993; Delhanty and Han, 1993a; Moats-Staats et al., 1995; Pfuender et al., 
1995). However, quantitative tissue-specific expression of IGF2, IGF2R and their regulatory 
transcripts across key developmental time points has not been systematically examined in any 
species. 
The aim of the present study was (i) to investigate the distribution of transcript 
abundance of IGF2, IGF2R, H19 and AIRN genes in different tissues of bovine and (ii) to 
compare developmental changes in expression of these genes between Day-48 embryos, Day-
153 fetuses and 12-month old juvenile calves. 
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3.2 Materials and methods 
3.2.1 Animals and tissue 
All animal experiments and procedures described in this study were approved by the 
University of Adelaide Animal Ethics Committee (No. S-094-2005 and S-094-2005A). Dams 
and sires of the Angus and Brahman breeds were used to generate purebred and crossbred 
offspring at three developmental stages, Day-48 embryo, Day-153 fetus and 12-month-old 
juvenile. Angus and Brahman females, which had not given birth previously and were 
approximately 16–20 months of age received standard commercial estrous cycle 
synchronization (e.g. http://www.absglobal.com/aus/resources/beef-resources/synchronisation 
-programs---cue-mate-1/). Cidirol - Heat Detection & Timed Insemination (HTI) and Cidirol -
Timed Insemination (TI) was used. Briefly this consisted of an initial injection of 1 ml of 1 
mg/ml estradiol benzoate (Cidirol, Genetics Australia Co-operative Ltd., Bacchus Marsh, 
Australia) and insertion of a progesterone-releasing vaginal insert (Eazi-Breed CIDR, DEC 
International, Hamilton, New Zealand). The vaginal inserts were removed after 7–9 days and 
heifers injected with 2 ml of a prostaglandin analogue (0.26 mg of cloprostenol sodium/ml 
(Estrumate), Schering-Plough Animal Health, Baulkam Hills, Australia). Estrus detection 
devices (Kamar, Agrigene, Wangaratta, Australia) were placed on all animals. In HTI, 
animals that showed estrus two days later were inseminated, while animals not in estrus 
received an additional 0.5 ml injection of estradiol benzoate and were inseminated 24 h later. 
In TI, animals received 0.7 ml estradiol benzoate the day after removal of vaginal inserts and 
were inseminated 24 h later. Synchronization/insemination was repeated in HTI and TI with 
estradiol benzoate injection of all animals after removal of vaginal inserts, followed by a final 
round of insemination and natural breeding in HTI animals without further synchronization 
measures. Angus and Brahman paternal genetics were used in HTI and Ti. Animals were 
pregnancy tested by ultrasound scanning (Anand-Ivell et al., 2011).  
Embryos, fetuses and offspring were generated using at least two sires of each breed. 
Dams were pregnancy tested by ultrasound scanning, and embryos and fetuses recovered in 
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an abattoir. Embryos and fetuses were removed from the uterus, eviscerated, vacuum packed 
and stored frozen at -20C until further processing. 
Tissues were collected from 60 Day-48 embryos, 100 Day-153 fetuses (term ~ 283 
days), with both sexes represented, and 23 calves recovered by cesarian section (Day-278 of 
gestation) and 12-14-month old heifers and steers. At Day-48 of gestation, all organs have not 
yet formed and embryos still have a mesonephros, but some organs (heart, brain, liver) are 
clearly visible and could be sampled. The amount of tissue available was another criterion to 
opt for Day-48 rather than earlier stages that often require pooling of individual samples or 
amplification procedures that can impact on the quality of data obtained. Dissected tissues 
were immediately placed into RNA-later
®
 (Qiagen, Chadstone Centre, VIC, Australia) and 
stored at -80C after equilibration for 24 hours at 2–4C. Heart, brain, and liver samples were 
collected from Day-48 embryos. Heart, brain, liver, lung, kidney, skeletal muscle (M. 
semitendinosus) and testis were collected from Day-153 fetuses and the same tissues, with the 
exception of testis, were collected at 12 months of age. Cotyledon (placenta fetalis) was 
collected at Day-48, Day-153 and following delivery by caesarean section at Day-278 term. 
All tissue samples were provided by Prof. Stefan Hiendleder. 
 
3.2.2 RNA isolation and reverse transcription 
Tissue specimens (40-50 mg of each tissue) were homogenised by PRECELLYS
®
24 
lyser / homogeniser (Bertin Technologies, Saint Quentin en Yvelines Cedex, France). 
Homogenisation of samples was carried out in 1 ml of TRIzol reagent (Ambion, Life 
Technologies™, Inc., Carlsbad, CA, USA) in tubes containing 1.4 mm ceramic beads (Mo 
Bio Laboratories, Inc., Carlsbad, CA, USA) (for embryonic liver, fetal lung, liver, kidney and 
brain, and juvenile brain) or 2.8 mm ceramic beads (for fetal heart and cotyledon, juvenile 
muscle, kidney, heart, liver and lung, and term cotyledon). Homogenisation runs were 
performed at the speed of 6500 rpm in one (embryonic liver, fetal brain, kidney and lung, and 
juvenile liver, lung and brain) or two (fetal liver, heart and cotyledon, term cotyledon, and 
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juvenile muscle, kidney and heart) cycles, with a cycle duration of 7 seconds (fetal brain), 10 
seconds (fetal heart and cotyledon), 12 seconds (fetal kidney and lung, embryonic liver, near-
term cotyledon, juvenile muscle, kidney, heart and brain), or 15 seconds (fetal liver and 
juvenile liver and lung). In cases where tissue samples underwent two cycles of 
homogenisation, the waiting time between two cycles was 10 seconds (fetal heart and 
cotyledon) or 12 seconds (fetal liver, term cotyledon, and juvenile muscle, kidney and heart). 
Total RNA was extracted from fetal tissues using TRI Reagent
® 
(Ambion, Life 
Technologies™, Inc., Carlsbad, CA, USA). After removing insoluble materials from the 
homogenate by centrifugation at 12000 g for 10 minutes at 2 to 8 °C and incubation of the 
supernatant on ice for 5 minutes, 0.2 ml of chloroform was added, followed by incubation on 
ice for 3 minutes and centrifugation for 20 minutes at 12000 g (4°C). The aqueous phase was 
separated and mixed with 0.6ml of isopropyl alcohol and incubated for overnight at -20° C, 
followed by centrifugation at 13000 g (4°C). After removing the supernatant, the pellet was 
washed by adding 1.2 ml of 75% ethanol and re-pelleted by centrifugation at 12000 g for 5 
minutes (4°C). After removing the supernatant, the RNA pellet was dissolved in 50-100 µl of 
nuclease-free water (GIBCO UltraPure
TM
 Distilled Water, Invitrogen
TM
, Inc., Auckland, NZ). 
Due to small sample size, AllPrep™ DNA/RNA Micro (Qiagen GmbH, Inc., Hilden, 
Germany) was used for extraction of RNA from embryonic heart and brain tissues according 
to the manufacturer’s instructions (Appendix 1). 8-10 mg of embryonic heart and brain was 
used for DNA/RNA extraction. RNA quality and integrity was assessed by a NanoDrop ND-
1000 spectrophotometer (Thermo Scientific, Inc., Wilmington, DE, USA) and Agilent RNA 
6000 Nano Kit with Bioanalyzer 2100 (Agilent Technology, Inc., Santa Clara, CA, USA) and 
RIN (RNA Integrity Number) values averaged 7.16 and 8.21 for skeletal muscle in juvenile 
and fetus, 7.43 and 8.85 for lung in juvenile and fetus, 4.16 and 7.03 for kidney in juvenile 
and fetus, 7.66, 9.00 and 8.45 for heart in juvenile, embryo and fetus, 7.54, 8.93 and 8.05 for 
liver in juvenile, embryo and fetus, 6.74 and 8.38 for brain in juvenile and fetus, 5.49, 6.35 
and 7.16 for cotyledon in calf, embryo and fetus, and 5.85 for testis in fetus, respectively. The 
92 
integrity of RNA molecules is a major concern in gene expression studies, which can affect 
the results. RIN values are based on an algorithm which is a user-independent, automated and 
reliable procedure for standardisation of RNA quality control (Schroeder et al., 2006). RNA 
samples were provided by Ali Javadmanesh. 
Prior to RT-PCR, the extracted RNAs were treated by DNase (RQ1-DNase, Promega, 
Inc., Madison, WI, USA). Reactions were performed in a total volume of 10 l containing 
RNase-Free DNase 10X reaction buffer (1 l), RNase-Free DNase (1 U/g RNA), RNA 
solution and nuclease-free water incubated at 37C for 30 minutes. 1 l of DNase stop 
solution was added to the mixture, followed by incubation at 65 C for 10 minutes. 
Complementary DNA (cDNA) was synthesised from 500 ng of total RNA using 
SuperScript™ III First-Strand Synthesis System (Invitrogen, Life Technologies™, Inc., 
Carlsbad, CA, USA) and random hexamer oligonucleotides according to the manufacturer’s 
instructions. Briefly, 10 l of a mixture containing total RNA, 1 l of 50 ng/l random 
hexamers, 1 l of 10 mM dNTP mix and nuclease-free water was incubated at 65 C for 5 
minutes and placed on ice for 1 minute. The mixture was mixed with 10 l of a cDNA 
synthesis mix containing 2 l of 10X RT buffer, 4 l of 25 mM MgCl2, 2 l of 0.1 M DTT, 1 
l of 40 U/l RNaseOUT
TM
 and 1 l of 200 U/l SuperScript
TM
 III RT, and incubated at 25 
C for 10 minutes, followed by 50 C for 50 minutes. The reaction was terminated at 85 C 
for 5 minutes and then chilled on ice. The mixture was incubated at 37 C for 20 minutes after 
adding 1 l of RNase H. Equal quantities of 60 embryonic cDNA samples, 100 fetal cDNA 
samples and 23 juvenile cDNA samples were mixed to create a pooled representive cDNA 
sample for each tissue and developmental stage. The pooled cDNA samples were then used as 





3.2.3 Quantitative real time RT-PCR 
Relative abundance of the following transcripts was analysed: IGF2 global and 
promoter-specific transcripts, including P0, P1 (two transcripts, P1e2 and P1e3), P2 (two 
splice variants, P2e4 and P2e5), P3 and P4; IGF2R, H19 and AIRN. Details of primers used 
are summarised in Appendix 2. Schematic location of primers for amplification of IGF2 
promoter-specific transcripts is presented in Figure S1 (Appendix 8). We amplified two splice 
variants of P2 transcripts. The splice variant containing leader exon 4 was amplified by 
forward primer located at the junction of exons 4 and 8 and reverse primer within exon 8. The 
other splice variant with leader exons 4 and 5 was amplified by forward and reverse primers 
placed in exons 5 and 8, respectively. Forward and reverse primers for amplification of P3 
transcript were placed in exons 6 and 8, and for amplification of P4 transcript were located in 
exons 7 and 8, respectively. IGF2 global transcripts were amplified by placing primers in 
exons 8 and 9, which are found in all known IGF2 transcripts. Although all RNA samples 
were DNase I treated we designed most primers spanning an intron to avoid potential 
amplification of genomic DNA. 
Quantitative real time PCR reactions were performed using Fast Start Universal SYBR 
Green Master (Roche Diagnostics GmbH, Mannheim, Germany) in an Eppendorf 
Mastercycler
®
 pro S thermal cycler (Eppendorf, Inc., Hamburg, Germany). The pooled 
sample from each tissue and developmental stage was used as a cDNA template in the 
reactions in triplicate and the mean of the three CTs used to calculate the mean amount of 
target transcript and standard error for three technical replicates. Reactions were performed in 
a total volume of 12 µl containing 6 µl of SYBR master mix (2×), 4 µl of cDNA (40-time 
diluted from stock cDNA, equivalent to 12.5 ng of starting RNA), 0.8 µl of primers (5 
pmol/l) and 1.2 µl of double distilled nuclease-free water (ddH2O). A non-template control 
was included in all experiments to check for DNA contamination of reagents used for 
amplification. Thermocycling reactions were carried out with a 10-minute initial 
denaturation/activation step at 95C, followed by 40 cycles of 95C for 20 seconds 
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(denaturation), 57-62C for 30 seconds (annealing, depending on the primer pair) and 72C 
for 20 seconds (extension). Product specificity and integrity was confirmed via sequencing on 
a 3730xl DNA Analyzer (Applied Biosystems, Inc., Foster City, CA, USA), plots of the 
melting curve derived by Mastercycler
®
 ep Realplex software (Eppendorf, Inc., Hamburg, 
Germany), and electrophoresis on a 2% agarose gel (Agarose low EEO, AppliChem GmbH, 
Darmstadt, Germany) stained with GelRed™ Nucleic Acid Stain (Biotium, Inc., Hayward, 
CA, USA) and visualised under UV with Gel Doc
TM
 1000 Single Wavelength Mini-
Transilluminator, using Quantity One image analysing software (Bio-Rad Laboratories, Inc., 
Hercules, CA, USA). 
An equal proportion of cDNA from all tissues and developmental stages was pooled to 
generate a cDNA template for standard curve analysis. The standard curve included a 3-fold 
serial dilution of initial pooled cDNA template over eight data points. Three replicates were 
used for each dilution of the cDNA template. The CT (threshold cycle) values of the standards 
were used to derive a standard curve which shows the CT values as a linear function of 
natural logarithm of the specified arbitrary amounts of cDNA. The relative abundance of each 
target transcript was calculated by the relative standard curve method with determination of 
PCR amplification efficiency using the following equation: 
                                                    
            
     
  
where, “exp” indicates the exponential function, CT is threshold cycle for each sample, 
intercept is the point at which the standard curve intersects with the Y-axis and slope is the 
increase in standard curve. PCR amplification efficiencies (E) were calculated by the 
following equation: 
    
 
  
     
 
   
CT values and transformed quantities (relative transcript abundances, in terms of 
standard curve), as well as standard curve parameters, including amplification efficiency and 




Realplex software (Eppendorf, Inc., Hamburg, Germany). Amplification efficiency and 
coefficient of determination for the experiments are shown in Appendix 6. Since pooled 
cDNA was used in the quantitative real time RT-PCR reactions, there was no need to 
normalise the expression data using housekeeping gene expression. In addition, we deemed it 
not appropriate to perform statistical significance tests on technical replicates to compare the 
average transcript abundances between tissues and developmental stages. Rather, we 




3.3.1 IGF2, global transcript 
Transcript abundance of global IGF2 was lowest in brain at all developmental stages 
(Figure 3.1). In Day-48 bovine embryos, highest abundance of IGF2 transcript was in liver, 
with expression levels 330-fold higher than in brain. Expression of IGF2 in embryonic heart 
and cotyledon was 77- and 30-fold higher than in brain, respectively. In the fetus, highest 
IGF2 mRNA transcript abundance was observed in fetal lung, muscle and liver, followed by 
kidney. Despite a 4-fold decrease in global IGF2 transcript abundance in postnatal liver, when 
compared to mid gestation, liver displayed the highest expression of IGF2 compared with 
other postnatal tissues, i.e., approximately 13-fold higher than IGF2 expression in postnatal 
skeletal muscle. The expression level of IGF2 fell markedly after birth in all other tissues, 
with the highest fold decrease between pre and postnatal developmental periods being 
observed in lung (356-fold), kidney (122-fold) and muscle (60-fold). In general, expression 
levels of global IGF2 transcript are higher at the fetal stage in all examined tissues. In 
cotyledon, a slightly higher transcript abundance was observed in embryos compared with 
fetuses, and IGF2 expression was down-regulated 2-fold at term. 
 
3.3.2 IGF2R 
IGF2R expression was detected in all tissues studied at all three developmental stages 
(Figure 3.1). Expression of IGF2R in embryonic liver was (more than 2-fold) higher than in 
other embryonic tissues, whereas in the fetus, expression of IGF2R in heart, lung and kidney 
was comparable to liver. Fetal skeletal muscle, cotyledon and brain showed the lowest mRNA 
abundance of IGF2R compared to all other fetal tissues.  
Relative expression level in brain as compared to other tissues for IGF2R (around 10 
fold less than liver) was substantially higher than that for IGF2 (around 300-fold less than 
liver). Postnatal expression of IGF2R was highest in liver, followed by skeletal muscle. The 
transcript abundance of IGF2R was highest in the fetus and decreased dramatically after birth. 
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The highest fold change from fetal to postnatal developmental stage occurs in lung (67-fold 
decrease), heart (35-fold decrease) and kidney (25-fold decrease). 
 
 
Figure 3.1 Means for transcript abundances of IGF2, IGF2R, H19 and AIRN in tissues of three developmental 
stages, including embryo, fetus and juvenile. 
Standard errors of means for each tissue were calculated on three technical replicates of pooled cDNA made 
from 60 embryonic cDNA samples, 100 fetal cDNA samples and 23 juvenile cDNA samples. Cotyledon was 
taken from Day-48 embryo, Day-153 fetus and Day-278 calves. Transcript abundance was calculated by the 
standard curve method and expressed in arbitrary logarithmic units (ND: not determined). 
 
3.3.3 H19 
The abundance of H19 transcript was highest in liver and lowest in brain, with more than 
500-fold difference during prenatal development (Figure 3.1). In the current study, skeletal 
muscle displayed the highest expression of H19 at the postnatal developmental stage 
compared with other tissues. 
In all examined tissues, expression of H19 declined with advancing developmental age. 
The relative expression of H19 in cotyledon from C-section delivered calves was 2.5-fold 
lower compared to cotyledons sampled at Day-48 gestation. Transcript abundance of H19 
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decreases in all tissues after birth with highest and lowest postnatal fold change occurring in 
kidney (100-fold decrease) and skeletal muscle (9-fold decrease), respectively. 
 
3.3.4 AIRN 
We showed expression of AIRN in all tissues of each developmental stage (Figure 3.1). 
Liver displayed the highest mRNA abundance of AIRN at all developmental stages, which in 
embryos was at least 21-fold higher than other tissues. The transcript abundance of AIRN in 
liver of fetuses and juveniles was more than seven times higher than in other tissues at these 
developmental stages. 
Expression of AIRN was highest in tissues obtained at midgestation compared with the 
other developmental stages. Expression of AIRN increased from Day-48 to Day-153 in liver, 
brain and heart by 2, 3 and 7-fold, respectively. The level of AIRN mRNA in cotyledon was 
relatively constant across embryonic and fetal stages but decreased by 6-fold in late gestation. 
AIRN expression declined postnatally, with the postnatal fold decrease being highest in 
kidney (58-fold) and lowest in brain (3-fold).  
 
3.3.5 IGF2 P0 
By performing a sequence similarity search, we identified a region upstream of bovine 
IGF2 exon 2 that corresponded to the human P0 promoter with the upstream sequence highly 
conserved in bovine (data not shown). Therefore, we hypothesised the existence of a putative 
orthologous promoter in bovine and were able to amplify the corresponding transcript by 
specifically designed primers. We demonstrated P0-specific expression in skeletal muscle and 
testis during fetal development (Figure 3.2), with 30-fold lower expression in testis compared 
to muscle. We also demonstrated for the first time, a developmental shift in tissue specificity 
of IGF2 P0 activity. During the postnatal period, the promoter is turned off in bovine skeletal 
muscle and becomes active specifically in liver. The transcript is expressed in postnatal liver 
at levels resembling those observed in fetal muscle.  
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Figure 3.2 Means for transcript abundances of transcript abundances of IGF2 promoters, P0 and P1, and splice 
variants, P1 exon 2 and P2 exon 3, in tissues of three developmental stages, including embryo, fetus and 
juvenile. 
Standard errors of means for each tissue were calculated on three technical replicates of pooled cDNA made 
from 60 embryonic cDNA samples, 100 fetal cDNA samples and 23 juvenile cDNA samples. Cotyledon was 
taken from Day-48 embryo, Day-153 fetus and Day-278 calves. Transcript abundance was calculated by the 
standard curve method and expressed in arbitrary logarithmic units (ND: not determined). 
 
3.3.6 IGF2 P1 
We used two pairs of primers located in exons 3 and 8 (P1e3) and also exon 2 (P1e2) of 
the bovine IGF2 gene as specific amplification of P1 transcript failed using primers located in 
exon 1. As exons 2 and 3 are found in P0 and P1 transcripts, the P1e3 and P1e2 amplicons 
could potentially belong to both P0 and P1 transcripts depending on tissue and developmental 
stage. In the fetus, expression level for IGF2 transcripts containing exon 3 (P1e3) and exon 2 
(P1e2) was highest in skeletal muscle (Figure 3.2). Both P1e3 and P1e2 are expressed in fetal 
liver, while only P1e3 transcript is present in embryonic liver. Expression of P1 transcripts 
amplified by P1e3 and P1e2 primers is substantially elevated in postnatal liver, which was 
more than 200 times the transcript abundance in fetal liver. 
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3.3.7 IGF2 P2 
Two splice variants are derived from P2 promoters which comprise exon 4 (IGF2 P2e4) 
and exons 4 and 5 (IGF2 P2e5) as well as protein coding exons of 8, 9 and 10. The transcript 
that includes exons 4 and 5 was amplified by placing forward and reverse primers within 
exons 5 and 8, respectively. The forward primer for specific amplification of the splice variant 
that includes only exon 4 was located at the junction of exons 4 and 8 with the reverse primer 
placed within exon 8. 
The IGF2 P2e5 is expressed in liver, cotyledon and heart at Day-48 of gestation but was 
not detected in embryonic brain (Figure 3.3). The transcript was also expressed in all fetal 
tissues studied, with lowest expression in brain. Highest expression of the IGF2 P2e5 
transcript was in liver, with expression in embryos, fetuses and juveniles being at least 13, 3 
and 8-fold higher than in other tissues, respectively. Decreased activity of P2 promoter was 
observed after birth in all studied tissues with the highest fold decrease in lung (177-fold), 
muscle (34-fold) and liver (11-fold). No expression was detected in juvenile brain, heart and 
kidney. 
Transcript abundance of IGF2 P2e4 in liver of embryos, fetuses and juveniles was at 
least 75, 10 and 5-fold higher than other tissues, respectively. The transcript is completely 
absent in brain, is repressed in postnatal heart, lung and kidney, and is dramatically 
downregulated in postnatal liver (70-fold decrease) and muscle (32-fold decrease).  
 
3.3.8 IGF2 P3 
Expression of IGF2 P3 transcripts was present in all embryonic tissues studied, with 
highest expression in liver and heart and lowest expression in brain (Figure 3.3). In the fetus, 
P3 transcript was also expressed in all studied tissues, with the highest activity in lung and 
lowest in brain. Expression of P3 transcripts in cotyledon displayed a progressive decline with 
gestational age, with transcript abundance in embryos being 3 and 76-fold higher than in 
fetuses and at term, respectively. Postnatally, P3 transcripts were detected only in muscle, 
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heart and liver, with abundance declining sharply by 225, 140 and 90-fold, respectively. 
Expression of P3 transcript in liver, heart and cotyledon was highest in the embryo compared 
with other developmental stages. 
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Figure 3.3 Means for transcript abundances of IGF2 promoters, P2, P3 and P4, and splice variants, P2 exon 4 
and P2 exon 5, in tissues of three developmental stages, including embryo, fetus and juvenile. 
Standard errors of means for each tissue were calculated on three technical replicates of pooled cDNA made 
from 60 embryonic cDNA samples, 100 fetal cDNA samples and 23 juvenile cDNA samples. Cotyledon was 
taken from Day-48 embryo, Day-153 fetus and Day-278 calves. Transcript abundance was calculated by the 
standard curve method and expressed in arbitrary logarithmic units (ND: not determined). 
 
3.3.9 IGF2 P4 
The transcript derived from P4 promoter was expressed in all studied tissues of all three 
developmental stages (Figure 3.3). In the fetus, expression of P4 transcript was highest in 
liver and skeletal muscle, and lowest in brain. In embryonic tissues, P4 transcript abundance 
in liver was 8, 23 and 300-fold higher than heart, cotyledon and brain, respectively, and in 
juvenile, expression level in liver was at least 4-fold higher than in other tissues, and lowest 
expression was observed in brain. Expression from P4 was highest in fetal tissues compared 
with embryonic tissues, except cotyledon, and decreased dramatically in postnatal tissues. The 
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fold decrease was highest in lung (195-fold), muscle (95-fold) and kidney (70-fold). The 
developmental expression pattern of P4 in cotyledon was similar to that of global IGF2 
transcripts. 
 
3.3.10 Expression ratio of IGF2/H19, IGF2R/AIRN and IGF2/IGF2R 
Since imprinted expression of IGF2 and IGF2R is known to be controlled by H19 and 
AIRN, we examined relative transcript abundance of IGF2 to H19 and IGF2R to AIRN and 
showed that these parameters change in a manner depending on the tissue and developmental 
stage (Figure 3.4). 
 
 
Figure 3.4 Means for ratio of IGF2/H19, IGF2R/AIRN and IGF2/IGF2R transcript abundance in tissues of three 
developmental stages, including embryo, fetus and juvenile. 
Cotyledon was taken from Day-48 embryo, Day-153 fetus and Day-278 calves. Transcript abundance was 
calculated by the standard curve method and expressed in arbitrary logarithmic units (ND: not determined). 
 
Relative expression of IGF2 to H19 was higher in tissues of Day-153 compared with 
Day-48 of gestation. The IGF2/H19 ratio was highest in postnatal liver and heart but declined 
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in brain, lung and skeletal muscle of juveniles. Liver and brain displayed the lowest ratio of 
IGF2R/AIRN at all developmental stages. The relative transcript abundance of IGF2R to AIRN 
was highest in embryonic heart. The ratio of IGF2/IGF2R was lowest in brain at all 
developmental stages and was higher in embryos compared with fetuses. The IGF2/IGF2R 
ratio was highest in fetal skeletal muscle and substantially declined in postnatal lung, kidney 
and skeletal muscle, whereas it did not change markedly in liver and heart of the juvenile 




In the present study, the use of pooled cDNA revealed drastic differences in transcript 
abundances between tissues and developmental stages. The magnitude of differences in 
transcript abundances between genetic groups and sexes, analysed by individual cDNAs, was 
much smaller (see chapter 4) compared with the differences in expression levels between 
tissues and developmental stages, analysed by pooled cDNA. 
The five studied IGF2 promoters showed differential expression patterns depending on 
tissue and developmental stage. Global IGF2 expression in bovine fetal tissues was consistent 
with relative abundance of IGF2 in rat fetal tissues (Brown et al., 1986). Overall, expression 
of total IGF2 transcripts in juvenile liver and other tissues decreased compared with those in 
prenatal developmental stages. A postnatal decrease in IGF2 expression level has been 
previously reported in tissues of bovine (Boulle et al., 1993), ovine and human (Schofield and 
Tate, 1987; O'Mahoney et al., 1991; Delhanty and Han, 1993b), and rat (Brown et al., 1986; 
Soares et al., 1986; Gray et al., 1987). 
In cotyledon, abundance of IGF2 transcript was relatively constant across embryonic 
and fetal developmental stages, followed by a slight decrease at term. IGF2 expression level 
in placenta was higher at term compared with midgestation in human (Gray et al., 1987), 
whereas did not change after midgestation in ovine (O'Mahoney et al., 1991; Reynolds et al., 
1997) and rhesus monkey (Coulter and Han, 1996). 
Specific expression of IGF2 P0 in bovine fetal skeletal muscle is in agreement with 
results obtained in human (Monk et al., 2006), whereas specific expression of P0 in fetal testis 
has not been previously reported in bovine or any other species. Whether expression of P0 in 
testis is developmentally controlled or whether it plays a role in testis development and 
function remains to be elucidated. In contrast to specific expression of P0 in bovine postnatal 
liver, ubiquitous expression of P0 in adult human (20-46 years old) tissues has been observed 
(Monk et al., 2006). The discrepancy between the postnatal expression pattern of IGF2 P0 in 
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human and bovine may relate to the different developmental ages, with bovine offspring 
studied as juveniles.  
Since transcripts derived from P0 are expressed in fetal muscle, and exons 2 and 3 are 
present in both P0 and P1 derived transcripts, the P1e3 and P1e2 amplicons detected in 
skeletal muscle could be derived from both P0 and P1 promoters. The amplicons containing 
exons 2 and 3 in fetal liver most likely belong to P1 splice variants, as P0 is not active in 
prenatal liver. These results demonstrate that the P1 promoter is active throughout the prenatal 
stage in liver and is upregulated postnatally, which is in agreement with the observations in 
porcine (Amarger et al., 2002). A postnatal developmental switch in IGF2 promoter usage has 
been reported in human (Depagterholthuizen et al., 1987; Monk et al., 2006), porcine 
(Amarger et al., 2002), ovine (O'Mahoney et al., 1991; Ohlsen et al., 1994) and bovine 
(Boulle et al., 1993), when P2-4 transcription drops sharply and P1 transcription becomes 
predominant in liver. Our results provide further evidence for a developmental shift in 
promoter usage in the IGF2 gene in bovine. 
The two splice variants derived from the IGF2 P2 promoter showed similar patterns of 
expression, with the exception that relative transcript abundance in liver compared with other 
tissues was higher for P2e4 compared with P2e5. Furthermore, they exhibited different 
expression patterns in embryonic and fetal cotyledon. Both P2 derived splice variants were 
previously detected in tissues of bovine and porcine fetuses (Amarger et al., 2002; Curchoe et 
al., 2005). The transcript that includes exons 4 and 5 has also been identified in ovine fetal 
and adult liver (Ohlsen et al., 1994) and in human liver and placenta (Ikejiri et al., 1991; 
Mineo et al., 2000). Expression of P2 derived splice variants in postnatal tissues has been 
analysed in bovine (Curchoe et al., 2005; Goodall and Schmutz, 2007), porcine (Amarger et 
al., 2002), human (Li et al., 1996) and ovine (Ohlsen et al., 1994). 
The high expression level of total IGF2 transcripts in fetal lung was consistent with 
highest transcript abundance of IGF2 P3 in fetal lung, suggesting that P3 is the most active 
promoter in fetal lung. Expression of IGF2 P3 transcripts was reported in a range of tissues 
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from bovine, porcine and human fetal and postnatal tissues (Li et al., 1996; Amarger et al., 
2002; Curchoe et al., 2005). Results of tissue-specific expression of IGF2 P3 in postnatal 
tissues were not consistent in different studies (Curchoe et al., 2005; Goodall and Schmutz, 
2007). Amplification of low abundant transcripts in postnatal tissues is highly variable 
depending on the experimental conditions and may lead to inconsistent results in different 
studies. Transcript abundance of IGF2 P3 was highest in embryonic tissues, except brain, 
compared with other studied developmental stages, whereas expression of the IGF2 P2 and 
P4 promoters was highest in fetal tissues. P3 was shown to be the most active promoter in 
tissues during human prenatal development (Holthuizen et al., 1993; Ohlsson et al., 1994). 
In agreement with our results, a postnatal decrease in IGF2 P4 transcript was reported in 
human liver (Li et al., 1996). The transcript was shown to be expressed in bovine and porcine 
fetal tissues (Amarger et al., 2002; Curchoe et al., 2005) but was not found in juvenile bovine 
lung and heart (Goodall and Schmutz, 2007). 
Consistent with the results presented here, a high level of IGF2R expression in fetal 
heart has been shown in rat (Sklar et al., 1989; Ballesteros et al., 1990; Senior et al., 1990; 
Sklar et al., 1992), human (Funk et al., 1992) and bovine fetuses (Pfuender et al., 1995), 
whereas in another study, expression of IGF2R in fetal heart was lower than other tissues 
(Suteevun-Phermthai et al., 2009). We demonstrated that IGF2R expression changes across 
pre and postnatal developmental stages. Developmental regulation of IGF2R has been shown 
in rat with highest expression in fetal tissues (Sklar et al., 1989; Ballesteros et al., 1990; 
Senior et al., 1990; Sklar et al., 1992; Moats-Staats et al., 1995). 
In the bovine fetus, liver exhibited a higher level of H19 expression compared with other 
tissues. Studies on tissue-specific expression of H19 during bovine development are limited. 
In bovine fetuses, the highest expression of H19 was detected in amnion, chorion, and 
allantois, and the lowest expression was in brain (Khatib and Schutzkus, 2006). In the current 
study, transcript abundance of H19 was highest in skeletal muscle of juveniles compared with 
other postnatal tissues, which agrees with previous data from bovine (Khatib and Schutzkus, 
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2006) and mouse (Gabory et al., 2009). These observations suggest that H19 may be 
important in postnatal growth of skeletal muscle. H19 expression in cotyledon decreased from 
Day-48 to Day-153 of gestation and did not change significantly until term. H19 is expressed 
at a constant level throughout prenatal development in human placenta (Goshen et al., 1993). 
Expression of the H19 gene is dramatically downregulated in the investigated postnatal 
tissues and is fully repressed in brain, which is consistent with the observation in human adult 
brain (Pham et al., 1998). A postnatal decrease in H19 expression has previously been 
reported in bovine (Khatib and Schutzkus, 2006) ovine (Lee et al., 2002) and mouse (Pachnis 
et al., 1984; Poirier et al., 1991) tissues. The higher expression level of H19 in embryonic 
tissues, compared with fetal tissues, implies that H19 may be more important in regulation of 
earlier stages of prenatal development. 
We demonstrated for the first time that expression of AIRN is developmentally 
controlled and is highest in fetal tissues. Transcripts of AIRN were previously detected in 
brain, cotyledon, kidney, liver and lung of bovine Day-75 fetuses (Suteevun-Phermthai et al., 
2009), and fetal liver at Day-35-55 and 70 of gestation (Farmer et al., 2013). Higher relative 
transcript abundance of IGF2R and AIRN in brain, compared with the relative expression 
level of IGF2 and H19 in brain, suggests that the IGF2R/AIRN system may play an important 
role in brain development and/or function. 
We demonstrated that relative expression of IGF2 to H19, IGF2R to AIRN and IGF2 to 
IGF2R is controlled in a tissue and developmental stage-specific manner. Highest relative 
transcript abundance of IGF2 to H19 in postnatal liver is attributed to the upregulation of the 
IGF2 P1 promoter transcript, which is biallelically transcribed with dissociated expression 
from H19 (Vu and Hoffman, 1994; Ekstrom et al., 1995; McLaren and Montgomery, 1999; 
Goodall and Schmutz, 2007). The highest expression ratio of IGF2R/AIRN in embryonic heart 
suggests that specific co-regulation of IGF2R and AIRN expression in heart may be important 
at the embryonic stage. The importance of IGF2R in heart development was shown in IGF2R-
deficient mice which showed abnormal heart growth and perinatal death, due to heart failure 
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secondary to cardiac hyperplasia (Lau et al., 1994; Wang et al., 1994; Ludwig et al., 1996). 
Relative expression of IGF2 to IGF2R, which is interpreted as an indicator of free IGF2 
available to the tissues, was highest in fetal skeletal muscle, suggesting that IGF2 is important 
in prenatal muscle development. This is supported by several lines of evidence that show 
importance of IGF2 in skeletal muscle differentiation and development (Florini et al., 1996; 
Stewart and Rotwein, 1996; Coolican et al., 1997; Morali et al., 2000; Prelle et al., 2000; 
Wilson et al., 2003; Wilson and Rotwein, 2006; Alzhanov et al., 2010). 
In conclusion, our findings provide further evidence that developmentally important 
imprinted genes are subject to significant spatial and temporal regulation of gene expression. 
We used quantitative real time PCR to examine expression patterns of the imprinted genes 
across bovine development. Most studies in bovine and other species have exploited northern 
blot or semi-quantitative RT-PCR techniques for studying expression patterns of imprinted 
genes which may produce conflicting results depending on experimental conditions. The 
results of the present study enhance our understanding of how expression patterns of 
functionally linked imprinted genes and their regulatory non-coding RNAs change during pre- 
and postnatal development. Further studies are required to elucidate the imprinting status of 
the studied genes at different developmental stages and association of alterations in imprinting 
with changes in overall expression of the genes and phenotype during pre and postnatal 
development.   
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Chapter 4                                                 
Genetic effects on transcript abundances of 
the imprinted IGF2, IGF2R, H19 and AIRN 




Fetal growth is a complex process governed by the interplay of genetic, epigenetic and 
environmental factors. Any changes in environment, including maternal factors and fetal 
nutrition, result in developmental adaptations which have a permanent impact on postnatal 
growth and development, a process termed “fetal programming” (Barker and Clark, 1997). 
Although the concept of fetal programming has the most implications in the context of human 
disease there is growing evidence that animal postnatal performance has its origin in prenatal 
development and is affected by maternal environmental conditions (Young et al., 1998; Bell, 
2006; Foxcroft et al., 2006; Wu et al., 2006; Gardner et al., 2007; Funston et al., 2010; Hill et 
al., 2010). Changes in genetic and epigenetic mechanisms and effects as caused by intra-
species hybridisation are likely to be significant contributors to postnatal phenotype, including 
heterosis. 
Heterosis is defined as superiority of hybrids in a trait compared to the average of their 
parental purebreds (Veitia and Vaiman, 2011). A number of agricultural systems, including 
the beef industry, benefit from heterosis. There are two subspecies of domesticated cattle, Bos 
taurus and Bos indicus (Hiendleder et al., 2008; Elsik et al., 2009), which have been widely 
used in crossbreeding programs to improve performance via heterosis (Franke, 1980; Koger, 
1980; Huffman et al., 1990; Johnson et al., 1990; Brown et al., 1993). 
Classical genetic models, including dominance (Davenport, 1908; Bruce, 1910; Keeble, 
1910; Jones, 1917), overdominance (Shull, 1908; Crow, 1948) and more recently epistasis 
(Powers, 1944; Hochholdinger and Hoecker, 2007), have been proposed to explain heterosis, 
but molecular mechanisms underlying this phenomenon remain enigmatic and the role of the 
genes conferring non-Mendelian (epi)genetic effects is largely unexplored. 
Several lines of evidence suggested epigenetic parent-of-origin effects as part of 
molecular mechanisms that explain phenotypic variation of complex traits and heterosis 
(Cubas et al., 1999; Manning et al., 2006; Shindo et al., 2006; Ni et al., 2009; He et al., 2010; 
Groszmann et al., 2011). Alteration in gene expression as a result of changes in methylation 
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of differentially methylated regions may play a role in heterosis (Shen et al., 2012). Imprinted 
genes, whose expression is regulated by epigenetic mechanisms in a parent-of-origin 
dependent manner (Reik and Walter, 2001), significantly contribute to phenotypic variation of 
complex traits (de Koning et al., 2000; Mantey et al., 2005; Wolf et al., 2008b) and are likely 
to be candidate genes underlying heterosis and differences between reciprocal hybrids. 
However, the significance of parent-of-origin dependent gene expression associated with 
genomic imprinting in heterosis has not been studied. Genomic imprinting can mimic the 
effects that arise from hybrid vigor (Chakraborty, 1989). Loss of imprinting of imprinted 
genes under genetic influence has been shown in mouse interspecific hybrids of Mus 
musculus domesticus/Mus musculus castaneus and Peromyscus polionotus/Peromyscus 
maniculatus (Jiang et al., 1998; Vrana et al., 1998). Parent-dependent loss of gene silencing 
has also been documented in Arabidopsis interspecies hybrids (Josefsson et al., 2006).  
It is evident that the imprinted IGF2, IGF2R and their regulatory noncoding genes have 
an indispensable function in prenatal development and are subject to epigenetic regulation in 
response to changes in prenatal environment, suggesting involvement in fetal programming 
(Dean et al., 1998; Sinclair et al., 2000; Khosla et al., 2001; Young et al., 2001; Holt, 2002; 
Igwebuike, 2010; Micke et al., 2011b; Micke et al., 2011a). However, genetic effects on 
tissue-specific expression patterns of imprinted genes and their contribution to prenatal 
phenotypic variation and programming of postnatal performance and heterosis are largely 
unexplored. 
We hypothesised a major role for IGF2/H19 and IGF2R/AIRN in prenatal programming 
of heterosis. The objective of this study was to explore non-additive expression of the 
imprinted genes in tissues of hybrid fetuses and its link to heterosis in phenotype. Therefore, 
we sought to examine genetic and heterotic effects on tissue-specific expression patterns of 
these imprinted genes at Day-153 of gestation in a bovine model of two genetically and 
phenotypically distinct subspecies, Bos taurus (Angus, A), Bos indicus (Brahman, B) and 
their reciprocal cross hybrids (BA and AB, sire indicated first). 
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4.2 Materials and methods 
4.2.1 Animal model, fetuses and tissues 
All animal experiments and procedures described in this study were approved by the 
University of Adelaide Animal Ethics Committee (No. S-094-2005 and S-094-2005A). Angus 
(A) and Brahman (B) breeds were used to study differential expression of imprinted genes at 
midgestation. These two breeds represent two subspecies of domesticated cattle, Bos taurus 
(Bt) and Bos indicus (Bi) (Elsik et al., 2009), which have also been classified as Bos 
primigenius taurus and Bos p. indicus based on ancestral wild subspecies (Hiendleder et al., 
2008). Forty-five Angus and 28 Brahman females which had not given birth previously and 
were approximately 16–20 months of age received standard commercial estrous cycle 
synchronization (e.g. http://www.absglobal.com/aus/resources/beef-resources/synchronization 
-programs---cue-mate-1/). Cidirol - Heat Detection & Timed Insemination (HTI) was used. 
Briefly this consisted of an initial injection of 1 ml of 1 mg/ml estradiol benzoate (Cidirol, 
Genetics Australia Co-operative Ltd., Bacchus Marsh, Australia) and insertion of a 
progesterone-releasing vaginal insert (Eazi-Breed CIDR, DEC International, Hamilton, New 
Zealand). The vaginal inserts were removed after 7–9 days and heifers injected with 2 ml of a 
prostaglandin analogue (0.26 mg of cloprostenol sodium/ml (Estrumate), Schering-Plough 
Animal Health, Baulkam Hills, Australia). Estrus detection devices (Kamar, Agrigene, 
Wangaratta, Australia) were placed on all animals. Animals that showed estrus two days later 
were inseminated, while animals not in estrus received an additional 0.5 ml injection of 
estradiol benzoate and were inseminated 24 h later. Synchronization/insemination was 
repeated with estradiol benzoate injection of all animals after removal of vaginal inserts, 
followed by a final round of insemination and natural breeding without further 
synchronization measures. Angus (n = 3) and Brahman (n = 2) paternal genetics of average 
breeding value for birth weight were used to generate fetuses. Animals were pregnancy tested 
by ultrasound scanning (Anand-Ivell et al., 2011; Xiang et al., 2013). 
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Fetuses were sired by three Angus and two Brahman bulls. Dams were pregnancy tested 
by ultrasound scanning, and fetuses were recovered at Day-153 ± 1 in a commercial abattoir. 
Fetuses were removed from the uterus, eviscerated, vacuum packed and stored frozen at -
20C until further processing. A total of 73 fetuses, including 23 Bt×Bt (11 males and 12 
females), 22 Bi×Bt (5 males and 17 females), 13 Bt×Bi (7 males and 6 females) and 15 Bi×Bi 
(4 males and 11 females) genetics (sire breed indicated first), were used in this study. 
Therefore, 45 and 28 fetuses were representative of Bt and Bi maternal genetics, respectively, 
and 36 and 37 fetuses were representative of Bt and Bi paternal genetics, respectively 
(Appendix 7). 
Fetal phenotype, including fetal weight and weights of individual fetal tissues (liver, 
heart, brain, kidney, lung), was recorded immediately after collection and fetal placenta 
weight was recorded as weight of the fetal membranes. Musculus supraspinatus, M. 
longissimus dorsi, M. quadriceps femoris (consisting of M. rectus femoris, M. vastus medialis, 
M. vastus intermedius and M. vastus lateralis) and M. semimembranosus were dissected from 
both sides of the fetus. M. longissimus dorsi was defined from the 7th rib to the natural caudal 
end of the muscle, at the apophysis of the lumbosacral. Dissected muscles from both sides of 
the fetus were weighed, and absolute muscle weight was recorded as the mean weight for 
each muscle. Combined muscle weights were calculated as the sum of mean weight of each 
dissected muscle. Relative muscle weights, reflecting fetal muscle proportions, were 
calculated as muscle weight divided by the fetal body weight. Samples of fetal tissues, 
including brain, cotyledon (placenta fetalis), heart, kidney, liver, lung and skeletal muscle (M. 
semitendinosus), were collected in RNA-later
®
 (Qiagen, Chadstone Centre, VIC, Australia) 
immediately after recovery of fetuses in the abattoir and stored at -80C after equilibration in 
RNA-later
®
 for 24 hours at 2–4C. All fetal samples and phenotypes were provided by 




4.2.2 RNA extraction and cDNA synthesis 
Tissue specimens (40-50 mg of each tissue) were homogenised by PRECELLYS
®
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lyser / homogeniser (Bertin Technologies, Saint Quentin en Yvelines Cedex, France). 
Homogenisation of samples was carried out in 1 ml of TRIzol reagent (Ambion, Life 
Technologies™, Inc., Carlsbad, CA, USA) in tubes containing 1.4 mm ceramic beads (Mo 
Bio Laboratories, Inc., Carlsbad, CA, USA) (for lung, liver, kidney and brain) or 2.8 mm 
ceramic beads (for heart and cotyledon). Homogenisation runs were performed at the speed of 
6500 rpm in one (brain, kidney and lung) or two (liver, heart and cotyledon) cycles with cycle 
duration of 7 seconds (brain), 10 seconds (heart and cotyledon), 12 seconds (kidney and lung) 
and 15 seconds (liver). In cases where tissue samples underwent two cycles of 
homogenisation, the waiting time between two cycles was 10 seconds (heart and cotyledon) 
or 12 seconds (liver). Total RNA was extracted from fetal tissues using TRI Reagent
® 
(Ambion, Life Technologies™, Inc., Carlsbad, CA, USA). After removing insoluble materials 
from the homogenate by centrifugation at 12000 g for 10 minutes at 2 to 8 °C and incubation 
of the supernatant on ice for 5 minutes, 0.2 ml of chloroform was added, followed by 
incubation on ice for 3 minutes and centrifugation for 20 minutes at 12000 g (4°C). The 
aqueous phase was separated and mixed with 0.6ml of isopropyl alcohol and incubated for 
overnight at -20° C, followed by centrifugation at 13000 g (4°C). After removing the 
supernatant, the pellet was washed by adding 1.2 ml of 75% ethanol and re-pelleted by 
centrifugation at 12000 g for 5 minutes (4°C). After removing the supernatant, the RNA pellet 
was dissolved in 50-100 µl of nuclease-free water (GIBCO UltraPure
TM
 Distilled Water, 
Invitrogen
TM
, Inc., Auckland, NZ). RNA quality and integrity was assessed by a NanoDrop 
ND-1000 spectrophotometer (Thermo Scientific, Inc., Wilmington, DE, USA) and Agilent 
RNA 6000 Nano Kit with Bioanalyzer 2100 (Agilent Technology, Inc., Santa Clara, CA, 
USA) and RIN (RNA Integrity Number) values averaged 8.21 for skeletal muscle, 8.85 for 
lung, 7.03 for kidney, 8.45 for heart, 8.05 for liver, 8.38 for brain and 7.16 for cotyledon. 
RNA samples were provided by Ali Javadmanesh. 
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Prior to RT-PCR, the extracted RNAs were treated by DNase (RQ1-DNase, Promega, 
Inc., Madison, WI, USA). Reactions were performed in a total volume of 10 l, containing 
RNase-Free DNase 10X reaction buffer (1 l), RNase-Free DNase (1 U/g RNA), RNA 
solution and nuclease-free water incubated at 37C for 30 minutes. 1 l of DNase stop 
solution was added to the mixture, followed by incubation at 65 C for 10 minutes. 
Five hundred ng of total RNA was reverse transcribed to cDNA using SuperScript™ III 
First-Strand Synthesis System (Invitrogen, Life Technologies™, Inc., Carlsbad, CA, USA) 
and random hexamer oligonucleotides according to the manufacturer’s manual. Briefly, 10 l 
of a mixture containing total RNA, 1 l of 50 ng/l random hexamers, 1 l of 10 mM dNTP 
mix and nuclease-free water was incubated at 65 C for 5 minutes and placed on ice for 1 
minute. The mixture was mixed with 10 l of a cDNA synthesis mix containing 2 l of 10X 
RT buffer, 4 l of 25 mM MgCl2, 2 l of 0.1 M DTT, 1 l of 40 U/l RNaseOUT
TM
 and 1 l 
of 200 U/l SuperScript
TM
 III RT and incubated at 25 C for 10 minutes, followed by 50 C 
for 50 minutes. The reaction was terminated at 85 C for 5 minutes and then chilled on ice. 
The mixture was incubated at 37 C for 20 minutes after adding 1 l of RNase H. For each 
tissue, equal quantities of all individual cDNAs were then combined to generate a pooled 
representative cDNA sample. 
 
4.2.3 Quantitative real time RT-PCR 
Expression of IGF2R, AIRN, IGF2, H19 as well as IGF2 promoter-specific transcripts 
(P0, P1, P2, P3, P4) and two splice variants derived from IGF2 P2 promoter (P2e4 and P2e5) 
were analysed in fetal tissues by quantitative real time PCR using gene-specific primers. 
Sequences, locations and annealing temperatures of the primers are listed in Appendix 2. 
Schematic exon/intron structure of the bovine IGF2 gene and locations of the primers 
designed for amplification of the IGF2 promoter-specific transcripts and splice variants are 
shown in Figure S1 (Appendix 8). We amplified two splice variants of P2 transcripts. The 
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splice variant containing leader exon 4 was amplified by forward primer located at the 
junction of exons 4 and 8 and reverse primer within exon 8. The other splice variant with 
leader exons 4 and 5 was amplified by forward and reverse primers placed in exons 5 and 8, 
respectively. Forward and reverse primers for amplification of P3 transcript were placed in 
exons 6 and 8, and for amplification of P4 transcript were located in exons 7 and 8, 
respectively. IGF2 global transcripts were amplified by placing primers in exons 8 and 9 that 
are found in all known IGF2 transcripts. We designed most primers spanning an intron to 
avoid amplification of genomic DNA. 
Quantitative real time PCR reactions were performed using Fast Start Universal SYBR 
Green Master (Roche Diagnostics GmbH, Mannheim, Germany) in an Eppendorf 
Mastercycler
®
 pro S thermal cycler (Eppendorf, Inc., Hamburg, Germany) using 4µl of cDNA 
(40-time diluted from stock cDNA, equivalent to 12.5 ng of starting RNA), 0.8 µl of primers 
(5 pmol/l) and 1.2 µl of double distilled nuclease-free water (ddH2O) in a final volume of 12 
µl. A non-template control was included in all experiments to check for DNA contamination 
of reagents used for amplification. Thermocycling reactions were carried out with a 10-minute 
initial denaturation/activation step at 95C, followed by 40 cycles of 95C for 20 seconds 
(denaturation), 57-62C for 30 seconds (annealing, depending on the primer pair) and 72C 
for 20 seconds (extension). Product specificity and integrity was confirmed via sequencing on 
a 3730xl DNA Analyzer (Applied Biosystems, Inc., Foster City, CA, USA), plots of melting 
curve derived by Mastercycler
®
 ep Realplex software (Eppendorf, Inc., Hamburg, Germany), 
and electrophoresis on a 2% agarose gel (Agarose low EEO, AppliChem GmbH, Darmstadt, 
Germany) stained with GelRed™ Nucleic Acid Stain (Biotium, Inc., Hayward, CA, USA) and 
visualized under UV with Gel Doc
TM
 1000 Single Wavelength Mini-Transilluminator using 
Quantity One image analysing software (Bio-Rad Laboratories, Inc., Hercules, CA, USA). 
Each qPCR experiment was performed in duplicate and the mean of both CTs used to 
calculate the amount of target transcript. 
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An equal proportion of cDNA from all fetuses in each tissue was pooled to generate a 
cDNA template for standard curve analysis. The standard curve included a 2-fold serial 
dilution of initial pooled cDNA template over eight data points. Three replicates were used 
for each dilution of the cDNA template. The CT (threshold cycle) values of the standards 
were used to derive a standard curve which shows the CT values as a linear function of 
natural logarithm of the specified arbitrary amounts of cDNA. The relative abundance of each 
target transcript was calculated by the relative standard curve method with determination of 
PCR amplification efficiency using the following equation: 
                               
                  
     
  
where, TBSample is relative transcript abundance of the gene of interest in each sample, 
“exp” indicates the exponential function, CTSample is threshold cycle for each sample, intercept 
is the point at which the standard curve intersects with the Y-axis, and slope is the increase in 
standard curve. PCR amplification efficiencies (E) were calculated by the following equation: 
    
 
  
     
 
   
CT values and transformed quantities (relative transcript abundances, in terms of 
standard curve), as well as standard curve parameters, including amplification efficiency and 
coefficient of determination (R-squared), were automatically calculated by Mastercycler
®
 ep 
Realplex software (Eppendorf, Inc., Hamburg, Germany). Amplification efficiency and 
coefficient of determination for transcripts of target and housekeeping genes are shown in 
Appendix 4 and 5. 
We determined expression levels of seven putative housekeeping genes, including actin 
beta (ACTB), ribosomal protein S9 (RPS9), ubiquitin B (UBB), H3 histone family 3A 
(H3F3A), TATA box binding protein (TBP), vacuolar protein sorting 4 homolog A (VPS4A) 
and cyclin G associated kinase (GAK) (Appendix 3), in each fetal tissue. In cotyledon, 
expression level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was determined 
instead of H3F3A. The geNorm program version 3.5 (Vandesompele et al., 2002) was used to 
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identify RPS9 and VPS4A in brain and cotyledon, and GAK and VPS4A in heart, kidney, liver, 
lung and skeletal muscle as the most stable genes for normalisation of the target genes. 
Expression levels of the genes in each tissue were normalised to the geometric mean of the 
expression levels of the selected housekeeping genes (TBHK), referred to as “normalisation 
factor” (Vandesompele et al., 2002): 
                    
        
                          
 
The qPCR reactions and data analysis for the housekeeping genes in fetal liver, brain, 
heart, muscle and cotyledon, and also data analysis for housekeeping genes in lung and 
kidney, were performed by Ali Javadmanesh. 
 
4.2.4 Statistical analysis 
The normalised expression data were checked for normality. Logarithmic transformation 
was performed on the data which were not normally distributed. When transformation was 
needed, the results for least square means and standard errors of means were presented after 
back-transformation. Gene expression data and fetal phenotype, including fetal weight and 
tissue weights, were analysed by Univariate Analysis of Variance (ANOVA) using the 
general linear model procedure of SPSS 19 (SPSS Inc, an IBM Company). Data were fitted 
into the following linear model to analyse the effects of fetal genetics and sex: 
yijk = Gi + Sj + eijk 
where yijk is the normalised relative gene expression level or fetal phenotype, Gi is fetal 
genetic effect (i = AA, BA, AB, BB), Sj is fetal sex effect (j = male, female) and eijk is the 
residual effect. 
The following model was used to analyse heterotic effects on gene expression and fetal 
phenotype: 
yijkl = Hi + Gj(Hi) + Sk + eijkl 
where yijkl is the normalised relative gene expression level or fetal phenotype, Hi is 
heterotic effect (i = purebred, crossbred), Gj(Hi) is fetal genetic effect nested within heterotic 
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effect (j = AA, BB nested within purebred, j = BA, AB nested within crossbred), Sk is fetal 
sex (k = male, female) and eijkl is the residual effect.  
Coordinate expression of genes in each tissue was analysed using Pearson’s correlation 
coefficients with the two-tailed tests of significance. Associations between fetal phenotypic 
traits and relative gene expression levels were analysed using simple linear regression models. 
Dependent and/or independent variables were subjected to logarithmic transformation in order 
to meet assumptions of regression analysis, including linearity, normality and 
homoscedasticity. 
The following linear models were used to estimate relative contribution of each 
promoter-specific transcript (P0, P2, P3 and P4) to the total IGF2 expression in each tissue: 
 
IGF2 (skeletal muscle) = IGF2 P0 + IGF2 P2e4 + IGF2 P2e5 + IGF2 P3 + IGF2 P4 
IGF2 (liver) = IGF2 P2e4 + IGF2 P2e5 + IGF2 P3 + IGF2 P4 
IGF2 (cotyledon, heart, lung, kidney) = IGF2 P2e5 + IGF2 P3 + IGF2 P4 
 
Where IGF2 is the relative expression (normalised to the housekeepers) of global IGF2 
and IGF2 P2e4 (transcript with untranslated leader exon 4) IGF2 P2e5 (transcript with 
untranslated leader exons 4 and 5) are relative expression of the splice variants derived from 
P2 promoter. IGF2 P0, IGF2 P3 and IGF2 P4 are relative expression of the transcripts 
derived from P0, P3 and P4 promoters, respectively. The contribution of each promoter-
specific transcript to total IGF2 variation was calculated from the type III sums of squares 
(SSIII) of relative transcript abundance for the promoter divided by total SSIII for all 




We analysed the effects of fetal genetics and estimated heterosis effects on body weight 
as well as absolute and relative organ weights in Day-153 fetuses of Angus (AA), Brahman 
(BB), and reciprocal cross hybrids (BA and AB, sire given first) (Figure 4.1). Moreover, we 
examined heterotic and fetal genetic effects on tissue-specific transcript abundances of the 
IGF2 promoters, IGF2R, H19, AIRN and expression ratios of IGF2 promoters to H19, IGF2R 
to AIRN and IGF2 to IGF2R, and their correlations with weights of the relevant tissues in 
Day-153 fetuses. 
 
4.3.1 Genetic effects on fetal body weight, relative and absolute weights of 
fetal tissues 
Fetal weight and absolute weights of all the examined fetal tissues, except brain, were 
significantly affected by fetal genetics, (P<0.001) with higher fetal weight observed in AA 
compared with BB fetuses. Significant differences were observed between reciprocal hybrids 
in fetal body and organ weights, which were higher in the BA compared with AB fetuses. 
Absolute lung and fetal placental weight displayed significant heterosis (P<0.05). Fetal 
weight and absolute weights of fetal tissues, except placenta, were significantly higher in 
male fetuses compared with females (Figure 4.1.a). 
Relative weights of liver, skeletal muscle, heart and brain were significantly influenced 
by fetal genetics. Relative liver and brain weight was higher in BB compared with AA 
fetuses, whereas relative muscle and heart weight was higher in AA compared with BB fetal 
groups. A significant fetal genetic effect (P<0.001) was observed on placental efficiency 





Relative skeletal muscle, heart and brain weight was higher in female fetuses compared 
with males, whereas placental efficiency was significantly (P<0.05) higher in male fetuses 
compared with females. Relative weights of liver and skeletal muscle were significantly 
(P<0.05) affected by negative and positive heterosis, respectively (Figure 4.1.b). 
 
4.3.2 Genetic effects on expression of IGF2, H19 and IGF2/H19 in fetal 
tissues and associations with fetal tissue weights 
Fetal genetics, sex and heterosis did not impact on transcript abundance of IGF2 global 
transcript in the examined fetal tissues, with the exception of lung. Expression of IGF2 in 
lung was significantly (P<0.001) affected by fetal genetics and negative heterosis and was 
lower in BA compared with the other genetic groups (Figure 4.2). 
Transcript abundance of H19 in the examined tissues, with the exception of brain, was 
significantly (P<0.001) influenced by fetal genetics and was higher in BB compared with AA 
fetuses. Expression of H19 in liver and lung showed a significant difference between 
reciprocals and was higher in AB compared with BA fetuses, whereas in the other tissues, 
H19 expression was not different between reciprocals. A negative heterotic effect (P<0.05) 
was observed on transcript abundance of H19 in fetal lung and skeletal muscle (Figure 4.2). 
H19 expression was negatively correlated with fetal tissue weight in all examined tissues 
(P<0.01), except cotyledon and brain (Figure 4.3). Independent regression analyses in 
purebred (AA and BB) and hybrid (BA and AB) fetal groups showed that H19 transcript 
abundance was significantly correlated with lung, muscle mass, heart, kidney and fetal 
placental weight in purebreds only. H19 expression was negatively correlated with absolute 
and relative liver weight in hybrids (P<0.01) and also with absolute liver weight in purebred 






Figure 4.2 Effect of heterosis, fetal genetics and sex on transcript abundance of IGF2 and H19, and the ratio of 
IGF2 to H19 transcript abundance in fetal tissues. 
Least square means and standard errors of means for relative transcript abundance of (calculated by standard 
curve method, normalised to the housekeeper genes and expressed in arbitrary units) IGF2 and H19, and the 
ratio of IGF2 to H19 transcript abundance in liver, lung, skeletal muscle (M. semitendinosus), heart, kidney, 
brain and cotyledon of Day-153 fetuses with Angus (AA), Brahman (BB) and reciprocal crossbred genetics (BA 
and AB, sire given first), as well as purebred (P, consisting of AA and BB) and crossbred (F1, consisting of BA 
and AB) genetics. The means were also shown for male (M) and female (F) fetal groups. Effects of genetics, 
heterosis, and sex were shown where significant (F-test). Statistical tests were considered significant at the levels 
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Figure 4.3 Regression of absolute weight of fetal liver, lung, heart, kidney and placenta, and relative weight of 
liver and skeletal muscle on H19 transcript abundance in overall (including fetuses with purebred and hybrid 
genetics), purebred and hybrid genetic groups. 
P-values and correlation coefficients are shown above each graph. Logarithmic transformations (ln) were 
performed for dependent and/or independent variable where necessary to meet assumptions of regression 
analyses. 
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The relative expression level of IGF2 to H19 was affected by fetal genetics (P<0.01) in 
all studied tissues, except brain, and was higher in AA compared with BB fetuses. The 
IGF2/H19 expression ratio in liver was significantly higher in fetuses from the BA compared 
with AB group. The IGF2/H19 expression ratio was significantly influenced by positive 
heterosis (P<0.05) in heart and by fetal sex (P<0.05) in kidney (Figure 4.2). The IGF2/H19 
ratio in heart was positively correlated with heart weight (P<0.01) in all fetuses combined, 
and in the purebred genetic groups (Figure 4.10). IGF2/H19 was significantly positively 
correlated with weights of fetal tissues, except cotyledon (data not shown). 
 
4.3.3. Genetic effects on expression of IGF2 promoter-specific transcripts, 
their ratio to H19 expression, and associations with fetal tissue weights 
We analysed tissue-specific expression of the IGF2 promoter-specific transcripts, 
including P0, P1 (two transcripts P1e2 and P1e3 which may derive from putative P0 and/or 
P1 promoters), P2 (two splice variants P2e4 and P2e5), P3 and P4. We also analysed relative 
expression of IGF2 promoters to H19. Analysis of regression of global IGF2 transcript 
abundance on expression levels of promoter-specific transcripts revealed that P4 is the most 
abundant transcript in most tissues accounting for 66 % (in skeletal muscle), 84 % (in heart), 
92 % (in cotyledon), 82 % (in lung), 88 % (in kidney), and 42 % (in liver) of global IGF2 
transcripts. P2 is the most abundant transcript in liver which accounts for 53 % of global 
IGF2 transcripts and the second most abundant transcript in heart (14 %), lung (17 %), and 
kidney (10 %) (Figure S2, Appendix 8). Transcript abundances of P2 (P2e5) and P4 in lung 
and P3 in liver were significantly affected by fetal genetics (P<0.01) being higher in AB 
compared with BA reciprocal fetuses. P4 transcript abundance in cotyledon and P2e4 
transcript abundance in liver were significantly affected by fetal genetics (P<0.01) and were 
higher in fetuses with paternal Brahman genetics (BA and BB) compared to those with 
paternal Angus genetics (Figures 4.4 and 4.6). Significant negative heterosis affected P4 
transcript abundance in liver (P<0.05), lung (P<0.01) and kidney (P<0.05). P3 transcript 
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abundance in kidney was higher (P<0.05) in male fetuses compared with females (Figure 
4.4). 
Fetal genetics affected the expression ratios of IGF2 promoter-specific transcripts to 
H19 in all examined tissues (except for IGF2 P3/H19 in liver), with the expression ratios 
being higher in AA compared with BB fetuses (with the exception of IGF2 P2e4/H19 in liver, 
which did not differ significantly between purebred fetal groups). A substantial difference 
between BA and AB reciprocals was observed for IGF2 P2/H19 in heart and cotyledon, IGF2 
P3/H19 in muscle and heart, IGF2 P4/H19 in liver and heart (Figure 4.5) and IGF2 P2e4/H19 
in liver (Figure 4.6). The IGF2 P2/H19 in kidney (Figure 4.5), and IGF2 P0/H19 (Figure 4.6) 
and IGF2 P1e3/H19 (Figure 4.6) in muscle were significantly higher in females compared 
with males (P<0.05). Furthermore, positive heterotic effects were significant on IGF2 
P2e4/H19 in muscle (P<0.01), IGF2 P3/H19 in kidney (P<0.05), IGF2 P4/H19 in muscle 
(P<0.05) and also the expression ratio of skeletal muscle-specific transcripts (P0, P1e2 and 
P1e3) to H19 (P<0.01) (Figures 4.5 and 4.6). The ratio of expression of IGF2 skeletal muscle-
specific promoter to H19 was positively correlated (P<0.001) with relative muscle mass. 
Analysis within genetic subgroups revealed that the correlation was significant (P<0.01) only 
for purebred fetuses (Figure 4.10). 
 
4.3.4. Genetic effects on expression of IGF2R, AIRN, IGF2R/AIRN and 
IGF2/IGF2R, and associations with fetal tissue weights 
Expression of IGF2R in lung was significantly influenced by fetal genetics and negative 
heterosis (P<0.001) with the lowest transcript abundance observed in BA group. Furthermore, 
relative transcript abundance of IGF2R to AIRN in lung was subject to significant fetal genetic 
and negative heterotic effects (P<0.01). IGF2R and AIRN in cotyledon showed similar 
patterns of expression with transcript abundances being higher (P<0.001) in BA compared 
with the other three genetic groups (Figure 4.7). AIRN expression in cotyledon was positively 
related to placental weight and was negatively related to placental efficiency (P<0.01). 
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Regression analysis within the genetic subgroups showed that these correlations were only 
significant in hybrid fetuses (P<0.05). IGF2R expression in cotyledon displayed a positive 
correlation (P<0.05) with fetal placental weight only in the hybrid fetal group (Figure 4.9). 
Relative expression of IGF2 to IGF2R in cotyledon was affected by fetal genetics 
(P<0.05) and was lower in BA fetuses compared with the other fetal groups (Figure 4.8). The 
IGF2/IGF2R expression ratio in cotyledon was negatively correlated with fetal placental 
weight (P<0.05) and positively correlated with placental efficiency (P<0.01) in overall 
(including fetuses with purebred and hybrid genetics), and hybrid genetic groups (Figure 4.9). 
Expression of AIRN in liver was significantly impacted by fetal genetics (P<0.05) and 
was higher in fetal groups with maternal Brahman genetics (AB and BB) compared to those 
with maternal Angus genetics. AIRN transcript abundance in brain was higher in BA 
compared with the other three genetic groups (P<0.001) and was subject to heterosis (P<0.05) 
(Figure 4.7). Expression of AIRN was positively correlated with relative brain weight in 
hybrid fetuses (P<0.05) (Figure 4.10). Fetal genetics and negative heterosis had significant 
effects on IGF2R/AIRN expression ratio in brain (P<0.001), which was lower in BA 
compared with the other fetal groups (Figure 4.7). Significant positive heterosis was also 
observed (P<0.05) for IGF2/IGF2R expression ratio in brain (Figure 4.8). 
The relative expression of IGF2R to AIRN in heart was influenced by fetal genetics 
(P<0.01) and sex (P<0.05) and was higher in fetuses with maternal Brahman genetics 
compared to those with maternal Angus genetics (Figure 4.7). Regression analysis showed a 
negative correlation of IGF2R/AIRN expression in heart, with heart weight (P<0.05) in 
overall, and also purebred genetic groups (Figure 4.10). 
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Figure 4.4 Effect of heterosis, fetal genetics and sex on transcript abundance of IGF2 promoter-specific 
transcripts, P2, P3 and P4 in fetal tissues. 
Least square means and standard errors of means for relative transcript abundance (calculated by standard curve 
method, normalised to the housekeeper genes and expressed in arbitrary units) of IGF2 transcripts derived from 
promoters P2, P3 and P4 in liver, lung, skeletal muscle (M. semitendinosus), heart, kidney and cotyledon of 
Day-153 fetuses with Angus (AA), Brahman (BB) and reciprocal crossbred genetics (BA and AB, sire given 
first), as well as purebred (P, consisting of AA and BB) and crossbred (F1, consisting of BA and AB) genetics. 
The means were also shown for male (M) and female (F) fetal groups. Effects of genetics, heterosis, and sex 
were shown where significant (F-test). Statistical tests were considered significant at the levels of P<0.05 (*), 
P<0.01 (**) and P<0.001 (***). The IGF2 P2 transcript (IGF2 P2e5) is the splice variant consisting of non 
protein coding exons 4 and 5 plus protein coding exons 8, 9 and 10. 
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Figure 4.5 Effect of heterosis, fetal genetics and sex on the ratio of transcript abundance of IGF2 promoter-
specific transcripts, P2, P3 and P4, to H19 in fetal tissues. 
Least square means and standard errors of means for the ratio of IGF2 P2 (P2e5), P3 and P4 to H19 transcript 
abundance (calculated by standard curve method, normalised to the housekeeper genes and expressed in arbitrary 
units) in liver, lung, skeletal muscle (M. semitendinosus), heart, kidney and cotyledon of Day-153 fetuses with 
Angus (AA), Brahman (BB) and reciprocal crossbred genetics (BA and AB, sire given first), as well as purebred 
(P, consisting of AA and BB) and crossbred (F1, consisting of BA and AB) genetics. The means were also shown 
for male (M) and female (F) fetal groups. Effects of genetics, heterosis, and sex were shown where significant 
(F-test). Statistical tests were considered significant at the levels of P<0.05 (*), P<0.01 (**) and P<0.001 (***). 
The IGF2 P2 transcript (IGF2 P2e5) is the splice variant consisting of non protein coding exons 4 and 5 plus 
protein coding exons 8, 9 and 10. 
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Figure 4.6 Effect of heterosis, fetal genetics and sex on transcript abundance of IGF2 promoter-specific 
transcripts, P0, P1e2, P1e3, and P2e4, and their ratio to H19 transcript abundance in fetal muscle and liver. 
Least square means and standard errors of means for relative transcript abundance (calculated by standard curve 
method, normalised to the housekeeper genes and expressed in arbitrary units) of IGF2 promoter-specific 
transcripts, including (a) P0, P1e2, P1e3 in skeletal muscle (M. semitendinosus), and (b) P2e4 in skeletal muscle 
(M. semitendinosus) and liver of Day-153 fetuses with Angus (AA), Brahman (BB) and reciprocal crossbred 
genetics (BA and AB, sire given first), as well as purebred (P, consisting of AA and BB) and crossbred (F1, 
consisting of BA and AB) genetics. The ratios of transcript abundances of IGF2 promoters to H19 were also 
shown. The means were also shown for male (M) and female (F) fetal groups. Effects of genetics, heterosis, and 
sex were shown where significant (F-test). Statistical tests were considered significant at the levels of P<0.05 
(*), P<0.01 (**) and P<0.001 (***). Expression of the splice variant (IGF2 P2e4) comprising exon 4 plus exons 


































































































































































































































































































































































Figure 4.7 Effect of heterosis, fetal genetics and sex on transcript abundance of IGF2R and AIRN, and the ratio 
of IGF2R to AIRN transcript abundance in fetal tissues. 
Least square means and standard errors of means for relative transcript abundance (calculated by standard curve 
method, normalised to the housekeeper genes and expressed in arbitrary units) of IGF2R and AIRN, and the ratio 
of IGF2R to AIRN transcript abundance in liver, lung, skeletal muscle (M. semitendinosus), heart, kidney, brain 
and cotyledon of Day-153 fetuses with Angus (AA), Brahman (BB) and reciprocal crossbred genetics (BA and 
AB, sire given first), as well as purebred (P, consisting of AA and BB) and crossbred (F1, consisting of BA and 
AB) genetics. The means were also shown for male (M) and female (F) fetal groups. Effects of genetics, 
heterosis, and sex were shown where significant (F-test). Statistical tests were considered significant at the levels 


















































































































Figure 4.8 Effect of heterosis, fetal genetics and sex on the ratio of IGF2 to IGF2R transcript abundance in fetal 
tissues. 
Least square means and standard errors of means for the ratio of IGF2 to IGF2R transcript abundance (calculated 
by standard curve method, normalised to the housekeeper genes and expressed in arbitrary units) in liver, lung, 
skeletal muscle (M. semitendinosus), heart, kidney, brain and cotyledon of Day-153 fetuses with Angus (AA), 
Brahman (BB) and reciprocal crossbred genetics (BA and AB, sire given first), as well as purebred (P, consisting 
of AA and BB) and crossbred (F1, consisting of BA and AB) genetics. The means were also shown for male (M) 
and female (F) fetal groups. Effects of genetics, heterosis, and sex were shown where significant (F-test). 
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Figure 4.9 Regression of (a) fetal placental weight and (b) placental efficiency on transcript abundance of 
IGF2R, AIRN and the ratio of IGF2/IGF2R expression in cotyledon. 
Placental efficiency was defined as the ratio of fetal body weight to fetal placental weight. The regressions were 
analysed in overall (including fetuses with purebred and hybrid genetics), purebred and hybrid genetic groups. P-
values and correlation coefficients are shown above each graph. Logarithmic transformations (ln) were 
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Figure 4.10 Regression of absolute/relative weight of fetal tissues on transcript abundance/expression ratio of 
imprinted genes significantly affected by genetics, in overall (including fetuses with purebred and hybrid 
genetics), purebred and hybrid genetic groups. 
P-values and correlation coefficients are shown above each graph. Logarithmic transformations (ln) were 






Fetal body weight, absolute weights of fetal tissues, with the exception of brain, and 
relative brain weight showed phenotypic patterns with parent-of-origin (maternal) genetic 
effects. Genomic imprinting is a plausible mechanism that may explain phenotypic 
manifestation of the difference between two reciprocals (Wolf et al., 2008b). However, 
parent-of-origin phenotypic patterns caused by maternal effects may be confounded by 
genomic imprinting (Hager et al., 2008). A genome-wide analysis of the imprinted QTLs 
revealed a complex phenotypic pattern of genomic imprinting, including dominance 
imprinting (Wolf et al., 2008a). A phenotype-based approach has been exploited in this study 
to describe the phenotypic patterns associated with genomic imprinting according to the 
difference between two reciprocals. Although the underlying molecular mechanisms that lead 
to a specific expression pattern, e.g. miRNA interference, are disregarded, this approach can 
also be applied to quantitative data on transcript abundances to characterise imprinting 
patterns of gene expression and their link to manifestation of parent-of-origin dependent 
phenotypes and heterosis. 
Analysis of phenotypic data at Day-153 of gestation revealed positive heterosis for fetal 
lung and placental weight and relative muscle mass, and negative heterosis in relative liver 
weight. Heterosis in fetal placenta, with the highest placental weight in BA fetuses, is in 
agreement with heterosis reported on birth weight, which was higher in the BA hybrid 
(Brown et al., 1993). This is consistent with the significant role of the placenta in 
programming pre and postnatal growth (Godfrey, 2002; Jansson and Powell, 2007; Fowden et 
al., 2008). 
Expression of H19 in cotyledon was significantly affected by fetal genetics with 
differential B. taurus and B. Indicus-specific expression. Spatial expression of a splice variant 
of H19 in human placenta was shown to be associated with genetic polymorphism and was 
affected by fetal genetics (Lin et al., 1999). A negative relationship was found between fetal 
placental weight and H19 expression in only purebreds. A negative role of H19 in placental 
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growth has been documented in mice with targeted disruption of the H19 gene, which showed 
increased fetal and placental weight (Leighton et al., 1995; Ripoche et al., 1997; Esquiliano et 
al., 2009; Angiolini et al., 2011; Keniry et al., 2012). Transcript abundance of H19 in 
cotyledon was not significantly different between the two reciprocals and was not subject to 
heterotic effects. Lack of significant correlation between H19 expression and placental weight 
in hybrids implies that H19 could not explain the heterotic phenotypic pattern of fetal 
placenta. 
The expression level of IGF2R in cotyledon was higher in the BA group, which could 
account for the higher placental weight observed in this fetal group. This is supported by the 
observation that transcript abundance of IGF2R in hybrid genetics was positively correlated 
with fetal placental weight, raising the possibility that IGF2R may be implicated in cellular 
pathways that lead to increased placental weight. The traditional role of IGF2R in suppressing 
placental growth has been documented in mouse gene knockout experiments (Wylie et al., 
2003). However, several lines of evidence have suggested that IGF2R is involved in 
signalling pathways mediating IGF2 function in stimulation of trophoblast cell migration, 
mitogenesis and survival of trophoblast (McKinnon et al., 2001; El-Shewy et al., 2006; El-
Shewy et al., 2007; Harris et al., 2011).  
Expression of AIRN was higher in the BA group and was positively correlated with fetal 
placental weight in hybrids. The role of AIRN in placental growth remains to be explored. 
Airn in mouse (Mus musculus domesticus) placenta is engaged in regulation of imprinted 
expression of Igf2r and transporter genes within an imprinted domain (Sleutels et al., 2002; 
Nagano et al., 2008).  
Placental efficiency, which is indicative of placental capacity to provide nutrients to the 
growing fetus and is defined as the ratio of fetal weight to placental weight (Wilson and Ford, 
2001), fell sharply in the BA group. Our data showed that expression of IGF2R and AIRN, 
which is affected by fetal genetics, is negatively correlated with placental efficiency in the 
hybrid fetuses. 
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Relative transcript abundance of IGF2/IGF2R, which may be interpreted as an indicator 
of the relative level of free IGF2 protein available to the tissue, was lowest in the BA group. 
The IGF2/IGF2R ratio was positively correlated with placental efficiency and negatively 
correlated with placental weight. The negative correlation of IGF2/IGF2R with placental 
weight is not consistent with the generally accepted function of IGF2R in growth suppression 
by reducing cellular bioavailability of IGF2 raising the possibility that IGF2R in placenta may 
also be involved in mediating growth stimulatory pathways. This speculation is in agreement 
with previous findings on the potential signalling role of IGF2R in placenta (Harris et al., 
2011). However, a positive correlation between the molar ratio of cord blood IGF2 to soluble 
IGF2R, and placental and birth weight, has been observed in human (Ong et al., 2000). 
The positive correlation of IGF2/IGF2R with efficiency of fetal placenta could be 
indicative of increased placental efficiency as a consequence of elevated bioavailability of 
IGF2. Gene ablation studies in mouse demonstrated that Igf2 is involved in regulation of 
expression of glucose and amino acid transporter genes (Matthews et al., 1999; Constancia et 
al., 2005). Disruption of Igf2 and Igf1r similarly altered expression patterns of amino acid 
transporters in mouse placenta (Matthews et al., 1999). However, null mutation of mouse Igf2 
resulted in decreased placental weight, while null mutation of Igf1r did not display such an 
effect, suggesting that IGF2 function in placental growth is mediated by receptors other than 
the Igf1r (Baker et al., 1993). In guinea pig, Leu
27
-IGF2, an IGF2 analogue which can bind 
IGF2R but not IGF1R influenced placental efficiency and fetal weight, suggesting that the 
role of IGF2 in enhancing placental functional development and nutrient transfer is also 
mediated in part by IGF2R (Sferruzzi-Perri et al., 2008). 
According to imprinting patterns described previously (Wolf et al., 2008a), absolute and 
relative muscle mass showed partial imprinting (with difference between reciprocals) and 
dominance non-imprinting (with no difference between reciprocals) phenotypic patterns, 
respectively. The significant negative correlation of H19 transcript abundance with muscle 
mass phenotypes in purebreds suggests that H19 could be a major determinant of skeletal 
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muscle phenotype. The importance of H19 in prenatal growth has been shown by the 
associations of the genetic polymorphisms within the human H19 gene with birth weight 
(Petry et al., 2005; Petry et al., 2011). 
Positive heterosis on relative muscle mass could be attributed to a negative heterotic 
effect on H19 transcript abundance in skeletal muscle, although the correlation between H19 
expression and muscle mass was not significant in the hybrid group. The relative expression 
of the skeletal muscle-specific promoter, IGF2 P0 to H19 exhibited positive heterosis, which 
was consistent with the heterotic phenotypic pattern of relative muscle mass with respect to 
positive relationship between IGF2 P0/H19 ratio and relative muscle mass. Relative 
expression of IGF2 P4 and IGF2 P2e4 to H19 was also subject to positive heterotic effects. 
This suggests that fetal genetics differentially impacts on relative expression of IGF2 
promoter-specific transcripts to H19. 
Absolute liver weight showed a phenotypic pattern of maternal expression, as described 
previously (Wolf et al., 2008a). The negative correlation of H19 expression with absolute 
liver weight in both purebred and hybrid fetal groups suggests that H19 could be a driver of 
the parent-of-origin effect on absolute liver weight. Relative liver weight was higher in 
fetuses with BB genetics compared with AA genetics, which could not be explained by the 
molecular data produced in this study. The significant negative correlation of H19 expression 
with relative liver weight in only hybrids suggests that the negative heterosis on relative liver 
weight, which was lowest in the AB group, could be driven by H19 with highest transcript 
abundance in the AB group. Furthermore, the negative heterosis on relative liver weight was 
consistent with the negative heterotic effects on IGF2 P4 expression in liver, which was 
lowest in the AB group, but this was not supported by the regression data. Although global 
IGF2 expression in liver was highly stable and was not affected by fetal genetics, sex or 
heterosis, the abundance of IGF2 P3 and P2e4 transcripts was influenced by fetal genetics, 
suggesting that genetics differentially drives expression of IGF2 promoters. Expression of 
AIRN in liver was affected by fetal genetics and was higher in fetuses with maternal Brahman 
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genetics, which is against the accepted imprinting status of a maternally imprinted gene. 
Further studies are required to elucidate imprinting status of AIRN in liver. 
Considering the negative relationship between H19 expression and lung weight, positive 
heterosis in lung weight could be explained by the negative heterotic effect on H19 
expression. However, no significant correlation was observed between H19 expression and 
lung weight in hybrids and the phenotypic difference between reciprocals may not be caused 
by H19. Despite a genetic and negative heterotic effect on IGF2 and IGF2R expression in 
fetal lung, which showed a significant difference between reciprocals, correlation of lung 
weight with IGF2 and IGF2R expression was not significant. This could be explained by the 
indication that relative expression of IGF2 to IGF2R in lung did not significantly change 
across genetic groups.  
Heart weight showed a phenotypic pattern of maternal expression associated with partial 
imprinting, as described previously (Wolf et al., 2008a). H19 expression in heart did not 
exhibit a significant difference between reciprocals and was negatively related to heart weight 
in purebred fetuses. Heterotic effect on expression ratio of IGF2 to H19 is not related to the 
phenotypic pattern of heart in hybrids, and IGF2/H19 had a positive relationship with heart 
weight only in purebreds. This could indicate that phenotypic manifestation of the altered 
expression ratio of IGF2/H19 in favour of heterosis in heart does not occur at mid-gestation 
developmental stage. Relative expression of IGF2R to AIRN was under the influence of fetal 
genetics and was negatively correlated with heart weight in purebreds. These observations 
suggest that both IGF2/H19 and IGF2R/AIRN imprinted gene systems could be implicated in 
differential manifestation of heart weight in Angus and Brahman. A critical role of Igf2r in 
heart development has been postulated in mice (Mus musculus domesticus) carrying a 
disrupted maternal allele of Igf2r which show phenotypes of heart enlargement and heart 
failure (Lau et al., 1994). The molecular systems studied here do not explain the phenotypic 
appearance of heart in hybrids.  
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According to the imprinting patterns classified previously (Wolf et al., 2008a), kidney 
weight showed a phenotypic pattern of maternal expression associated with partial imprinting. 
Differential expression of H19 in Angus and Brahman and negative correlation of H19 
expression with kidney weight in purebreds could explain breed (genetic) effect on kidney 
weight. 
Although absolute brain weight did not change significantly across genetic groups 
relative brain weight was significantly under fetal and parent-of-origin genetic effects. 
Significance of parent-of-origin effects on brain development has been previously postulated 
(Keverne et al., 1996; Gregg et al., 2010). In brain, AIRN displayed a polar overdominance 
imprinting pattern of expression with elevated transcript abundance in the BA group and 
consequently a heterotic effect. Despite a negative correlation between AIRN transcript 
abundance and relative brain weight in hybrids, a negative heterosis on IGF2R/AIRN in fetal 
brain, and a positive heterosis on IGF2/IGF2R in fetal brain, heterotic effects at molecular 
level in brain are not phenotypically manifested at Day-153 of gestation raising the possibility 
that such effects on imprinted gene expression may manifest in brain phenotype at subsequent 
stages of prenatal development or after birth. Our molecular data, including H19 expression, 
are not consistent with the phenotypic pattern of relative brain weight in purebreds. Further 
studies are required to elucidate imprinting status of imprinted genes and their role in 
programming brain development. 
In the present study, we showed that transcript abundance of H19 was consistently 
influenced by fetal genetics in all examined tissues, except brain. These observations along 
with the demonstration of negative correlations between H19 expression and weights of fetal 
tissues, except brain, in the purebred genetic group suggest that H19 is associated with the 
differential prenatal phenotypes in B. indicus and B. taurus and could be involved in 
developmental programming. H19 is a master regulator involved in downregulation of the 
genes in the newly described imprinted gene network (IGN), including Igf2 and Igf2r in 
mouse skeletal muscle (Gabory et al., 2009). Regression analysis revealed that correlation of 
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H19 expression with tissue weight was highest in skeletal muscle compared with other 
tissues, suggesting that a similar regulatory role for H19 exists in bovine skeletal muscle. 
To our knowledge, this is the first study to examine genetic effects on tissue-specific 
expression of imprinted genes and their relationship with growth-related phenotypes in 
prenatal development. We demonstrated that fetal genetics affects fetal weight, weights of 
fetal tissues and tissue-specific expression of imprinted genes. Furthermore, we showed that 
transcript abundances of imprinted genes are correlated with weight of the corresponding 
tissues in a manner depending on fetal tissue and genetic background. This is the first 
demonstration that imprinted genes are subject to non-additive heterotic expression and could 





Anand-Ivell, R., Hiendleder, S., et al. (2011). INSL3 in the ruminant: A powerful indicator of gender- and 
genetic-specific feto-maternal dialogue. PLoS One 6(5): e19821. 
Angiolini, E., Coan, P. M., et al. (2011). Developmental adaptations to increased fetal nutrient demand in mouse 
genetic models of Igf2-mediated overgrowth. The FASEB Journal 25(5): 1737-1745. 
Baker, J., Liu, J.-P., et al. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 
75(1): 73-82. 
Barker, D. and Clark, P. (1997). Fetal undernutrition and disease in later life. Reviews of Reproduction 2(2): 105-
112. 
Bell, A. W. (2006). Prenatal programming of postnatal productivity and health of livestock: A brief review. 
Australian Journal of Experimental Agriculture 46(7): 725-732. 
Brown, M. A., Tharel, L. M., et al. (1993). Genotype x environment interactions in preweaning traits of purebred 
and reciprocal cross Angus and Brahman calves on common bermudagrass and endophyte-infected tall 
fescue pastures. Journal of Animal Science 71(2): 326-333. 
Bruce, A. B. (1910). The Mendelian theory of heredity and the augmentation of vigor. Science New York N S 32. 
Chakraborty, R. (1989). Can molecular imprinting explain heterozygote deficiency and hybrid vigor? Genetics 
122(3): 713-717. 
Constancia, M., Angiolini, E., et al. (2005). Adaptation of nutrient supply to fetal demand in the mouse involves 
interaction between the Igf2 gene and placental transporter systems. Proceedings of the National 
Academy of Sciences of the United States of America 102(52): 19219-19224. 
Crow, J. F. (1948). Alternative hypotheses of hybrid vigor. Genetics 33(5): 477-487. 
Cubas, P., Vincent, C., et al. (1999). An epigenetic mutation responsible for natural variation in floral symmetry. 
Nature 401(6749): 157-161. 
Davenport, C. B. (1908). Degeneration, albinism and inbreeding. Science 28: 454-455. 
De Koning, D.-J., Rattink, A. P., et al. (2000). Genome-wide scan for body composition in pigs reveals 
important role of imprinting. Proceedings of the National Academy of Sciences 97(14): 7947-7950. 
Dean, W., Bowden, L., et al. (1998). Altered imprinted gene methylation and expression in completely ES cell-
derived mouse fetuses: Association with aberrant phenotypes. Development 125(12): 2273-2282. 
El-Shewy, H. M., Johnson, K. R., et al. (2006). Insulin-like growth factors mediate heterotrimeric G protein-
dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. Journal of 
Biological Chemistry 281(42): 31399-31407. 
El-Shewy, H. M., Lee, M.-H., et al. (2007). The insulin-like growth factor type 1 and insulin-like growth factor 
type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. 
Journal of Biological Chemistry 282(36): 26150-26157. 
Elsik, C. G., Tellam, R. L., et al. (2009). The genome sequence of Taurine cattle: A window to ruminant biology 
and evolution. Science 324(5926): 522-528. 
Esquiliano, D. R., Guo, W., et al. (2009). Placental glycogen stores are increased in mice with H19 null 
mutations but not in those with insulin or IGF Type 1 receptor mutations. Placenta 30(8): 693-699. 
Fowden, A. L., Forhead, A. J., et al. (2008). The placenta and intrauterine programming. Journal of 
Neuroendocrinology 20(4): 439-450. 
Foxcroft, G. R., Dixon, W. T., et al. (2006). The biological basis for prenatal programming of postnatal 
performance in pigs. Journal of Animal Science 84(13 suppl): E105-E112. 
Franke, D. E. (1980). Breed and heterosis effects of american Zebu cattle. Journal of Animal Science 50(6): 
1206-1214. 
Funston, R. N., Larson, D. M., et al. (2010). Effects of maternal nutrition on conceptus growth and offspring 
performance: Implications for beef cattle production. Journal of Animal Science 88(13 electronic 
suppl): E205-E215. 
Gabory, A., Ripoche, M.-A., et al. (2009). H19 acts as a trans regulator of the imprinted gene network 
controlling growth in mice. Development 136(20): 3413-3421. 
Gardner, D. S., Buttery, P. J., et al. (2007). Factors affecting birth weight in sheep: Maternal environment. 
Reproduction 133(1): 297-307. 
147 
Godfrey, K. M. (2002). The role of the placenta in fetal programming—A review. Placenta 23, Supplement 
A(0): S20-S27. 
Gregg, C., Zhang, J., et al. (2010). High-resolution analysis of parent-of-origin allelic expression in the mouse 
brain. Science 329(5992): 643-648. 
Groszmann, M., Greaves, I. K., et al. (2011). Changes in 24-nt siRNA levels in Arabidopsis hybrids suggest an 
epigenetic contribution to hybrid vigor. Proceedings of the National Academy of Sciences 108(6): 2617-
2622. 
Hager, R., Cheverud, J. M., et al. (2008). Maternal effects as the cause of parent-of-origin effects that mimic 
genomic imprinting. Genetics 178(3): 1755-1762. 
Harris, L. K., Crocker, I. P., et al. (2011). IGF2 actions on trophoblast in human placenta are regulated by the 
insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. 
Biology of Reproduction 84(3): 440-446. 
He, G., Zhu, X., et al. (2010). Global epigenetic and transcriptional trends among two rice subspecies and their 
reciprocal hybrids. The Plant Cell Online 22(1): 17-33. 
Hiendleder, S., Lewalski, H., et al. (2008). Complete mitochondrial genomes of Bos taurus and Bos indicus 
provide new insights into intraspecies variation, taxonomy and domestication. Cytogenetic and Genome 
Research 120(1-2): 150-156. 
Hill, R. A., Connor, E. E., et al. (2010). Growth and development symposium: Fetal programming in animal 
agriculture. Journal of Animal Science 88(13 electronic suppl): E38-E39. 
Hochholdinger, F. and Hoecker, N. (2007). Towards the molecular basis of heterosis. Trends in Plant Science 
12(9): 427-432. 
Holt, R. I. G. (2002). Fetal programming of the growth hormone–insulin-like growth factor axis. Trends in 
Endocrinology and Metabolism 13(9): 392-397. 
Huffman, R. D., Williams, S. E., et al. (1990). Effects of percentage Brahman and Angus breeding, age-season 
of feeding and slaughter end point on feedlot performance and carcass characteristics. Journal of 
Animal Science 68(8): 2243-2252. 
Igwebuike, U. M. (2010). Impact of maternal nutrition on ovine foetoplacental development: A review of the 
role of insulin-like growth factors. Animal Reproduction Science 121(3-4): 189-196. 
Jansson, T. and Powell, T. L. (2007). Role of the placenta in fetal programming: Underlying mechanisms and 
potential interventional approaches. Clinical Science 113(1): 1-13. 
Jiang, S., Hemann, M. A., et al. (1998). Strain-dependent developmental relaxation of imprinting of an 
endogenous mouse gene, Kvlqt1. Genomics 53(3): 395-399. 
Johnson, D. D., Huffman, R. D., et al. (1990). Effects of percentage Brahman and Angus breeding, age-season of 
feeding and slaughter end point on meat palatability and muscle characteristics. Journal of Animal 
Science 68(7): 1980-1986. 
Jones, D. F. (1917). Dominance of linked factors as a means of accounting for heterosis. Genetics 2(5): 466-479. 
Josefsson, C., Dilkes, B., et al. (2006). Parent-dependent loss of gene silencing during interspecies hybridization. 
Current Biology 16(13): 1322-1328. 
Keeble, F. (1910). The mode of inheritance of stature and of time of flowering in peas (Pisum sativum). Journal 
of Genetics 1(1): 47-56. 
Keniry, A., Oxley, D., et al. (2012). The H19 lincRNA is a developmental reservoir of miR-675 that suppresses 
growth and Igf1r. Nature Cell Biology 14(7): 659-665. 
Keverne, E. B., Fundele, R., et al. (1996). Genomic imprinting and the differential roles of parental genomes in 
brain development. Developmental Brain Research 92(1): 91-100. 
Khosla, S., Dean, W., et al. (2001). Culture of preimplantation mouse embryos affects fetal development and the 
expression of imprinted genes. Biology of Reproduction 64(3): 918-926. 
Koger, M. (1980). Efective crossbreeding systems utilizing Zebu cattle. Journal of Animal Science 50(6): 1215-
1220. 
Lau, M. M. H., Stewart, C. E. H., et al. (1994). Loss of the imprinted IGF2/cation-independent mannose 6-
phosphate receptor results in fetal overgrowth and perinatal lethality. Genes and Development 8(24): 
2953-2963. 
Leighton, P. A., Ingram, R. S., et al. (1995). Disruption of imprinting caused by deletion of the H19 gene region 
in mice. Nature 375(6526): 34-39. 
148 
Lin, W.-L., He, X.-B., et al. (1999). The genotype and epigenotype synergize to diversify the spatial pattern of 
expression of the imprinted H19 gene. Mechanisms of Development 82(1-2): 195-197. 
Manning, K., Tor, M., et al. (2006). A naturally occurring epigenetic mutation in a gene encoding an SBP-box 
transcription factor inhibits tomato fruit ripening. Nature Genetics 38(8): 948-952. 
Mantey, C., Brockmann, G. A., et al. (2005). Mapping and exclusion mapping of genomic imprinting effects in 
mouse F-2 families. Journal of Heredity 96(4): 329-338. 
Matthews, J. C., Beveridge, M. J., et al. (1999). Placental anionic and cationic amino acid transporter expression 
in growth hormone overexpressing and null IGF-II or null IGF-I receptor mice. Placenta 20(8): 639-
650. 
Mckinnon, T., Chakraborty, C., et al. (2001). Stimulation of human extravillous trophoblast migration by IGF-II 
Is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. 
Journal of Clinical Endocrinology and Metabolism 86(8): 3665-3674. 
Micke, G. C., Sullivan, T. M., et al. (2011a). Heifer nutrient intake during early- and mid-gestation programs 
adult offspring adiposity and mRNA expression of growth-related genes in adipose depots. 
Reproduction 141(5): 697-706. 
Micke, G. C., Sullivan, T. M., et al. (2011b). Protein intake during gestation affects postnatal bovine skeletal 
muscle growth and relative expression of IGF1, IGF1R, IGF2 and IGF2R. Molecular and Cellular 
Endocrinology 332(1-2): 234-241. 
Nagano, T., Mitchell, J. A., et al. (2008). The air noncoding RNA epigenetically silences transcription by 
targeting G9a to chromatin. Science 322(5908): 1717-1720. 
Ni, Z., Kim, E.-D., et al. (2009). Altered circadian rhythms regulate growth vigour in hybrids and allopolyploids. 
Nature 457(7227): 327-331. 
Ong, K., Kratzsch, J., et al. (2000). Size at birth and cord blood levels of insulin, insulin-like growth factor I 
(IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-
phosphate receptor in term human infants. Journal of Clinical Endocrinology and Metabolism 85(11): 
4266-4269. 
Petry, C., Ong, K., et al. (2005). Common polymorphism in H19 associated with birthweight and cord blood 
IGF-II levels in humans. BMC Genetics 6(1): 22. 
Petry, C., Seear, R., et al. (2011). Maternally transmitted foetal H19 variants and associations with birth weight. 
Human Genetics 130(5): 663-670. 
Powers, L. (1944). An expansion of Jones's theory for the explanation of heterosis. American Naturalist 78: 275-
280. 
Reik, W. and Walter, J. (2001). Genomic imprinting: Parental influence on the genome. Nature Reviews 
Genetics 2(1): 21-32. 
Ripoche, M. A., Kress, C., et al. (1997). Deletion of the H19 transcription unit reveals the existence of a putative 
imprinting control element. Genes and Development 11(12): 1596-1604. 
Sferruzzi-Perri, A. N., Owens, J. A., et al. (2008). Maternal insulin-like growth factor-II promotes placental 
functional development via the type 2 IGF receptor in the guinea pig. Placenta 29(4): 347-355. 
Shen, H., He, H., et al. (2012). Genome-wide analysis of DNA methylation and gene expression changes in two 
Arabidopsis ecotypes and their reciprocal hybrids. The Plant Cell Online 24(3): 875-892. 
Shindo, C., Lister, C., et al. (2006). Variation in the epigenetic silencing of FLC contributes to natural variation 
in Arabidopsis vernalization response. Genes & Development 20(22): 3079-3083. 
Shull, G. H. (1908). The Composition of a field of maize. Journal of Heredity os-4(1): 296-301. 
Sinclair, K. D., Young, L. E., et al. (2000). In-utero overgrowth in ruminants following embryo culture: lessons 
from mice and a warning to men. Human Reproduction 15(suppl 5): 68-86. 
Sleutels, F., Zwart, R., et al. (2002). The non-coding Air RNA is required for silencing autosomal imprinted 
genes. Nature 415(6873): 810-813. 
Vandesompele, J., De Preter, K., et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by 
geometric averaging of multiple internal control genes. Genome Biology 3(7): research0034.0031 - 
research0034.0011. 
Veitia, R. A. and Vaiman, D. (2011). Exploring the mechanistic bases of heterosis from the perspective of 
macromolecular complexes. The FASEB Journal 25(2): 476-482. 
149 
Vrana, P. B., Guan, X.-J., et al. (1998). Genomic imprinting is disrupted in interspecific Peromyscus hybrids. 
Nature Genetics 20(4): 362. 
Wilson, M. E. and Ford, S. P. (2001). Comparative aspects of placental efficiency. Reproduction (Cambridge, 
England) Supplement 58: 223-232. 
Wolf, J. B., Cheverud, J. M., et al. (2008a). Genome-wide analysis reveals a complex pattern of genomic 
imprinting in mice. PLOS Genetics 4(6). 
Wolf, J. B., Hager, R., et al. (2008b). Genomic imprinting effects on complex traits A phenotype-based 
perspective. Epigenetics 3(6): 295-299. 
Wu, G., Bazer, F. W., et al. (2006). Board-invited review: Intrauterine growth retardation: Implications for the 
animal sciences. Journal of Animal Science 84(9): 2316-2337. 
Wylie, A. A., Pulford, D. J., et al. (2003). Tissue-specific inactivation of murine M6P/IGF2R. American Journal 
of Pathology 162(1): 321-328. 
Xiang, R., Ghanipoor-Samami, M., et al. (2013). Maternal and paternal genomes differentially affect myofibre 
characteristics and muscle weights of bovine fetuses at midgestation. PLoS One 8(1): e53402. 
Young, L., Sinclair, K., et al. (1998). Large offspring syndrome in cattle and sheep. Reviews of Reproduction 
3(3): 155-163. 
Young, L. E., Fernandes, K., et al. (2001). Epigenetic change in IGF2R is associated with fetal overgrowth after 











Chapter 5                                              
Maternal and paternal genomes differentially 
affect myofibre characteristics and muscle 
weights of bovine fetuses at midgestation
151 
Maternal and paternal genomes differentially affect myofibre characteristics and muscle 










, David L. 
Rutley
1
, Zbigniew A. Kruk
1,a
, Carolyn J. Fitzsimmons
1,b







, Brian M. Burns
5
, Gail I. Anderson
1







 J.S. Davies Non-Mendelian Genetics Group, School of Animal and Veterinary Sciences, Roseworthy Campus, 
The University of Adelaide, South Australia, Australia. 
2
 Robinson Institute, The University of Adelaide, South Australia, Australia. 
3
 NSW Department of Primary Industries, Beef Industry Centre, Trevenna Rd, University of New England, 
Armidale, New South Wales, Australia. 
4
 School of Paediatrics and Reproductive Health, The University of Adelaide, South Australia, Australia. 
5
 The University of Queensland, Centre for Animal Science, Queensland Alliance for Agriculture and Food 
Innovation, Rockhampton, Queensland, Australia. 
a
 current address: Department of Animal Science and Biotechnology, Chungnam National University, Daejeon 
305-764, Korea. 
b
 current address: Agriculture and Agri-Food Canada, Edmonton, Canada 
 
Citation: Xiang R, Ghanipoor-Samami M, Johns WH, Eindorf T, Rutley DL, et al. (2013) Maternal and Paternal 
Genomes Differentially Affect Myofibre Characteristics and Muscle Weights of Bovine Fetuses at Midgestation. 
PLoS ONE 8(1): e53402. doi:10.1371/journal.pone.0053402 
Editor: Alejandro Lucia, Universidad Europea de Madrid, Spain 
Received May 16, 2012; Accepted November 30, 2012; Published January 14, 2013 
Copyright: © 2013 Xiang et al. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited. 
Funding: This work was funded by the JS Davies Bequest with support from the Queensland Government 
through the Department of Agriculture, Fisheries and Forestry’s Reinvestment Fund. The funders had no role in 
study design, data collection and analysis, decision to publish, or preparation of the manuscript. 
Competing Interests: The authors have declared that no competing interests exist. 







Postnatal myofibre characteristics and muscle mass are largely determined during fetal 
development and may be significantly affected by epigenetic parent-of-origin effects. 
However, data on such effects in prenatal muscle development that could help understand 
unexplained variation in postnatal muscle traits are lacking. In a bovine model we studied 
effects of distinct maternal and paternal genomes, fetal sex, and non-genetic maternal effects 
on fetal myofibre characteristics and muscle mass. Data from 73 fetuses (Day-153, 54% term) 
of four genetic groups with purebred and reciprocal cross Angus and Brahman genetics were 
analysed using general linear models. Parental genomes explained the greatest proportion of 
variation in myofibre size of Musculus semitendinosus (80-96%) and in absolute and relative 
weights of M. supraspinatus, M. longissimus dorsi, M. quadriceps femoris and M. 
semimembranosus (82-89% and 56-93%, respectively). Paternal genome in interaction with 
maternal genome (P<0.05) explained most genetic variation in cross sectional area (CSA) of 
fast myotubes (68%), while maternal genome alone explained most genetic variation in CSA 
of fast myofibres (93%, P<0.01). Furthermore, maternal genome independently (M. 
semimembranosus, 88%, P<0.0001) or in combination (M. supraspinatus, 82%; M. 
longissimus dorsi, 93%; M. quadriceps femoris, 86%) with nested maternal weight effect (5-
6%, P<0.05), was the predominant source of variation for absolute muscle weights. Effects of 
paternal genome on muscle mass decreased from thoracic to pelvic limb and accounted for all 
(M. supraspinatus, 97%, P<0.0001) or most (M. longissimus dorsi, 69%, P<0.0001; M. 
quadriceps femoris, 54%, P<0.001) genetic variation in relative weights. An interaction 
between maternal and paternal genomes (P<0.01) and effects of maternal weight (P<0.05) on 
expression of H19, a master regulator of an imprinted gene network, and negative correlations 
between H19 expression and fetal muscle mass (P<0.001), suggested imprinted genes and 
miRNA interference as mechanisms for differential effects of maternal and paternal genomes 




Skeletal muscle accounts for up to half of mammalian body mass (Du et al., 2010b) and 
has important functions in metabolic homeostasis (Daniel et al., 1977; Wolfe, 2006). It is a 
major source of endocrine factors, including insulin-like growth factors -I (IGF1) and -II 
(IGF2), key components of the insulin-like growth factor (IGF) system and growth hormone – 
IGF axis, which are major regulators of pre- and postnatal muscle development and growth 
(Adams, 2002; Chang, 2007; Pedersen and Febbraio, 2008; Sawitzky et al., 2012). Skeletal 
muscle is composed of two major fibre types, type I (slow oxidative) fibres and type II (fast) 
fibres (Daniel et al., 1977). Myofibres originate from mesenchymal stem cells which 
differentiate into myoblasts during embryonic development (Relaix, 2006). Myoblasts fuse to 
form myotubes which develop into myofibres at the fetal stage (Picard et al., 2002). In 
ruminants, myofibres differentiate during late fetal development into type I, type IIA (fast 
oxidative-glycolytic) and type IIX (fast glycolytic) myofibres (Scott et al., 2001; Greenwood 
et al., 2009). Thus, myofibre number is established during fetal development and postnatal 
skeletal muscle mass is largely determined prenatally (Picard et al., 2002; Du et al., 2010a) by 
the interplay of a complex network of genetic and epigenetic factors (Brand-Saberi, 2005; 
Baar, 2010; Ge and Chen, 2011; Bentzinger et al., 2012). 
Studies on postnatal muscle tissue of human, porcine and bovine revealed that genetics 
explained up to 45% of variation in slow myofibre percentage (Simoneau and Bouchard, 
1995), up to 58% of variation in myofibre number (Larzul et al., 1997) and 74% of variation 
in myofibre size (Rehfeldt et al., 1999), respectively. Similarly, using proxies such as lean 
body mass and lean tissue percentage, studies in human (Seeman et al., 1996; Arden and 
Spector, 1997) and porcine (Larzul et al., 1997) demonstrated that genetics accounted for 
approximately 50-80% of variation in postnatal muscle mass. Apart from genetic factors that 
follow Mendelian rules of inheritance, prenatal muscle development and postnatal muscle 
phenotype may be affected by genetic and epigenetic factors with Non-Mendelian modes of 
inheritance. This includes effects of mitochondrial genome (Mannen et al., 1998), X- and Y-
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chromosomes (Engellandt and Tier, 2002; Amen et al., 2007a), non-random X-inactivation 
(Amen et al., 2007b), microRNA (miRNA) interference (Clop et al., 2006) and genomic 
imprinting (Engellandt and Tier, 2002; Boysen et al., 2010; Neugebauer et al., 2010a; 
Neugebauer et al., 2010b). Genomic imprinting, i.e., parent-of-origin dependent allele-
specific gene expression (Reik and Walter, 2001), has been described for genes with pivotal 
roles in myogenesis, including IGF2 and its receptor IGF2R (Nezer et al., 1999; Young et al., 
2001). In porcine, mapping and gene expression studies demonstrated that IGF2 alleles 
explained up to 30% of variation in postnatal muscle mass (Van Laere et al., 2003). The ovine 
callipyge (CLPG) mutation has provided an example of complex genetic and epigenetic 
effects on postnatal muscle phenotype. The CLPG mutation causes postnatal muscle 
hypertrophy only in heterozygous offspring and only when inherited through the paternal 
germline (Cockett et al., 1996). This polar overdominance changes imprinted gene 
expression, presumably by miRNA interference (Caiment et al., 2010), and affects absolute 
and relative weights of specific muscles and muscle groups of the torso (e.g. M. longissimus 
lumborum) and pelvic limb (e.g. M. semimembranosus, M. quadriceps femoris), but not of the 
thoracic limb (e.g. M. supraspinatus) (Koohmaraie et al., 1995; Jackson et al., 1997). The 
increased muscle mass of CLPG sheep is due to fast myofibre hypertrophy and results in 
higher glycolytic metabolism of affected muscles (Carpenter et al., 1996; Jason et al., 2008). 
A similar paternal polar overdominance effect on postnatal myofibre characteristics, muscle 
mass and growth has been described in porcine (Kim et al., 2004). Furthermore, the ovine 
Carwell locus, which exerts paternal effects on weight of M. longissimus dorsi and a shift 
from type IIA to type IIX myofibres, was mapped to the same chromosome region as the 
CLPG mutation (Nicoll et al., 1998; Cockett et al., 2005; Greenwood et al., 2006). More 
recently, statistical modelling revealed significant parent-of-origin effects attributed to 
genomic imprinting on postnatal absolute and relative weights of specific muscles in porcine 
(Neugebauer et al., 2010a) and bovine (Neugebauer et al., 2010b). 
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Nutritional effects on prenatal myogenesis are well documented (Dwyer et al., 1994; 
Greenwood et al., 1999; Zhu et al., 2004; Du et al., 2010a), but data on parental genetic and 
epigenetic effects are lacking. To our knowledge, only one previous study investigated 
genetic effects on mammalian prenatal muscle. This report described significant individual 
sire effects on bovine fetal biceps weight in the last trimester of gestation (Anthony et al., 
1986). However, the study was designed to test only for effects of different sires and did not 
address differential effects of maternal and paternal genomes. In the present study, we 
generated the largest fetal resource to date for the study of (epi)genetic effects on mammalian 
prenatal muscle development. This collection of defined bovine fetuses consists of both 
purebreds and reciprocal hybrids with Angus and Brahman genetics. The taurine (Angus) and 
indicine (Brahman) breeds are subspecies of the domestic cattle, currently named Bos taurus 
taurus and Bos taurus indicus, respectively (Sequencing et al., 2009). Both subspecies 
originated from the wild aurochs (Bos primigenius) and are commonly referred to as Bos 
taurus and Bos indicus (Linnaeus, 1758; Bojanus, 1827; loc. cit. http://www.itis.gov) 
(Hiendleder et al., 2008). This unique intra-species model with well defined divergent 
parental genomes allowed us to dissect maternal and paternal genome effects on fetal 
myofibre characteristics and absolute and relative muscle weights at midgestation (Day-153, 
54% term). We show, for the first time, significant differential effects of parental genomes, 
independently or in combination with non-genetic maternal effects, on specific fetal muscles. 
Furthermore, we correlated expression of the imprinted non-coding RNA H19, which harbors 
miRNAs and is involved in regulation of IGF2 and IGF1R, with fetal muscle mass, 
demonstrating that imprinted genes and miRNA interference provide plausible mechanisms 
for observed differential effects of parental genomes on fetal muscle phenotype. 
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5.2 Materials and Methods 
5.2.1 Cattle and fetuses 
All animal experiments and procedures described in this study were approved by The 
University of Adelaide Animal Ethics Committee (No. S-094-2005 and S-094-2005A). We 
used animals and semen of the Angus and Brahman breeds to study differential parental 
genome effects on fetal muscle phenotype at midgestation. The two breeds are subspecies of 
domestic cattle, commonly referred to as Bos taurus and Bos indicus, respectively 
(Hiendleder et al., 2008; Sequencing et al., 2009). Nulliparous Angus and Brahman dams 
which were approximately 16–20 months of age were purchased from farms in South 
Australia and Queensland and transferred to, and maintained at, Struan Agricultural Centre, 
South Australia. Animals were on pasture supplemented by silage. After an adjustment period 
of 3-4 weeks the animals received standard commercial estrous cycle synchronization as 
described previously (Anand-Ivell et al., 2011). All fetuses were sired by two Brahman and 
three Angus bulls. Dams were pregnancy tested by ultrasound scanning and fetuses recovered 
in an abattoir at Day-153±1 of gestation. Fetuses were removed from the uterus, eviscerated, 
vacuum packed and stored frozen at ‒20ºC until further processing. Final maternal weight 
(FMW) was recorded and average maternal daily weight gain (MDG) was calculated as FMW 
minus weight at conception divided by gestation length (Figure S6, Appendix 8). We 
analysed 73 fetuses in total, including 23 Bt × Bt, 22 Bi × Bt, 13 Bt × Bi and 15 Bi × Bi 
(paternal genetics listed first) with both sexes represented in each genetic group. The 
distribution of Bt and Bi maternal and paternal genomes, and of females and males, are shown 
in Appendix 7. 
 
5.2.2 Muscle dissection and weights 
Fetuses were thawed and the head removed by disarticulation between the Os occipitale 
and first cervical vertebra atlas. Musculus supraspinatus, M. longissimus dorsi, M. 
semimembranosus and M. quadriceps femoris (consisting of M. rectus femoris, M. vastus 
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medialis, M. vastus intermedius and M. vastus lateralis) were dissected from both sides of the 
fetus. M. longissimus dorsi was defined from the 7
th 
rib to the natural caudal end of the 
muscle, at the apophysis of the lumbosacral. The dissection protocol was based on Budras and 
Habel (Budras and Habel, 2003) and muscle nomenclature according to Tucker (Tucker, 
1952). M. semimembranosus was obtained from 61 fetuses due to damage to some specimens 
from sampling adjacent M. semitendinosus for immunohistochemistry, described below. 
Dissected muscles from both sides of the fetus were weighed and absolute muscle weight was 
recorded as the mean weight for each muscle. Combined muscle weights were calculated as 
the sum of mean weight of each dissected muscle. Relative muscle weights, reflecting fetal 
muscle proportions, were calculated as muscle weight divided by the weight of the 
decapitated eviscerated fetus (see Figure S4, Appendix 8). 
 
5.2.3 Muscle immunohistochemistry 
At the time of fetus collection, a section of M. semitendinosus was cut from the centre of 
the muscle and mounted using gum tragacanth (Sigma Chemical Company, St. Louis, MO; 
prepared 5% wt/vol in distilled, deionized H2O) onto a cork block, with muscle fibres running 
perpendicular to the cork block. Samples were frozen by immersion in iso-pentane cooled to 
approximately −160°C in liquid nitrogen, before storage at −80°C. Muscle tissue preparation 
and immunohistochemical staining followed the protocol by Greenwood et al. (Greenwood et 
al., 2009). Briefly, 10-µm-thick, serial cross-sections were cut from each frozen sample using 
a cryostat microtome (ThermoShandon AS 620 Cryostat SME, Thermotrace Ltd., Noble Park, 
Victoria, Australia). After air-drying, cross-sections were stained against type I (slow) (clone 
WBMHC, Novocastra, Newcastle upon Tyne, UK; diluted 1:100 in PBS) and type II (fast) 
(clone MY-32, Sigma; diluted 1:400 in PBS) myosin heavy chain isoforms. Staining using 
these antibodies was previously shown to discern these myofibre types in ruminant fetal 
muscle (Greenwood et al., 1999). They were revalidated in bovine fetal muscle using 
myofibrillar ATPase staining for the present experiment. The stained sections were 
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dehydrated and cleared using graded ethanols and xylenes to produce slides using a xylene-
based mounting medium. 
 
5.2.4 Myofibre classification and morphometry 
Microscopic image analysis was used to classify and measure myofibres on stained 
slides. A Zeiss AxioPlan2 microscope fitted with Plan-Neofluar objectives (Carl Zeiss Pty. 
Ltd., Goettingen, Germany) and a Fujix colour digital camera (FUJIFILM Australia Pty. Ltd.) 
were used to produce images. Images were generated using a 40 × objective, and were 
captured using Analysis FIVE software (Soft Imaging System Corp. 12596 W. Bayaud Ave. 
Suite 300 Lakewood CO 80228, USA) and analysed using Image Pro Plus 6.0 software 
(Media Cybernetics, Inc. 4340 East-West Hwy, Suite 400 Bethesda, MD 20814-4411 USA). 
Fibre type was identified based on staining characteristics (Picard et al., 1998). Myotubes 
were defined as cells that appeared hollow in cross-section, the remainder were considered 
myofibres (Picard et al., 1994; Picard et al., 2002). Myofibres and myotubes were classified 
as type I (slow) myofibre, type I (slow) myotube, type II (fast) myofibre and type II (fast) 
myotube (Figure S3, Appendix 8).  
Morphological measurements were conducted by manually tracing anti-laminin-stained 
(rabbit anti-laminin, affinity isolated antibody: Sigma; diluted 1:500 in PBS) margins of cells 
using the draw/merge object function of Image Pro Plus 6.0. For each fetus, the serial slow or 
fast stained myosin heavy chain slide with highest contrast was chosen to measure myofibre 
characteristics. Three fields (40 × objective) of each chosen slide were analysed. For each 
field, cross-sectional area (CSA) and number of type I (slow) myotubes and myofibres, type II 
(fast) myotubes and myofibres were measured. Furthermore, number and CSA were measured 
irrespective of cell type. All counted cells in the field comprised total cell number, and CSA 
of counted cells in the field was total cell CSA. For each myofibre characteristic an average 
was calculated of the three fields measured. For each fetus the average number of cells 
measured was 369, ranging from 152 to 705 cells. The average standard deviation between 
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replicated fields for myofibre number was 1.3 for slow myotubes, 0.9 for slow myofibres, 5.1 
for fast myotubes and 16.9 for fast myofibres. The average standard deviation between 
replicated fields for CSA was 43.3µm
2
 for slow myotubes, 38.3µm
2
 for slow myofibres, 
19.7µm
2
 for fast myotubes and 10.7µm
2
 for fast myofibres.  
 
5.2.5 Expression of H19 in skeletal muscle 
Samples from M. semitendinosus were collected into RNA later (Qiagen, Chadstone 
Centre, VIC, Australia) immediately after recovery of fetuses in the abattoir and stored at 
−80°C after equilibration for 24 hours at 2-4°C. Total RNA was extracted from M. 
semitendinosus of all fetuses by TRI Reagent
® 
Solution (Ambion, Life Technologies™ Inc., 
Carlsbad, CA, USA) according to the manufacturer’s instructions and RQ1-DNase treated 
(Promega, Madison, WI, USA). Reverse transcription was carried out using SuperScript™ III 
First-Strand synthesis system for RT-PCR (Invitrogen, Life Technologies™ Inc., Carlsbad, 
CA, USA) on 500 ng of total RNA with random hexamer oligonucleotides according to the 
manufacturer’s instructions. Amplification of H19 from cDNA was performed using a 
forward primer located at the junction of exons 3 and 4, and a reverse primer located within 
exon 5 (Appendix 2). Total length of this amplicon was 171 bp. Real time quantitative PCR 
(qPCR) reactions were performed using Fast Start Universal SYBR Green Master (Roche 
Diagnostics GmbH, Mannheim, Germany) in an Eppendorf Mastercycler
®
 pro S thermal 
cycler (Eppendorf Inc., Hamburg, Germany) on 4µl of 40-fold diluted cDNA in a final 
volume of 12 µl with 6 µl of SYBR master mix (2×) at an annealing temperature of 60 ºC. 
Product specificity and integrity were confirmed using plots of melting curve and 
electrophoresis on a 2% agarose gel stained with GelRed™ Nucleic Acid Stain (Biotium Inc., 
Hayward, CA, USA). All qPCR experiments were performed in duplicate and the mean of 
both Cts used to calculate the amount of target transcript. We used the standard curve method 
with determination of PCR amplification efficiency. A two-fold serial dilution over eight data 
points was produced on a mixture of pooled cDNAs from all fetuses with equal proportions. 
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Three replicates were used for each dilution of the cDNA template. Non-template control was 
included in all experiments. We determined relative expression levels of seven putative 
housekeeping genes including actin beta (ACTB), ribosomal protein S9 (RPS9), ubiquitin B 
(UBB), H3 histone family 3A (H3F3A), TATA box binding protein (TBP), vacuolar protein 
sorting 4 homolog A (VPS4A) and cyclin G associated kinase (GAK) and used geNorm 
program version 3.5 (Vandesompele et al., 2002) to identify GAK and VPS4A (see Appendix 
3) as the most stable genes for normalisation of the target gene. Expression levels of H19 
were normalised to the geometric mean of the expression levels of the selected housekeeping 
genes. As the normalised expression data were not normally distributed, we performed 
statistical analysis after logarithmic transformation of the data. The results for least square 
means and standard errors of means were presented after back -transformation. 
 
5.2.6 Statistical estimation of effects and means 
All data were analysed by Univariate Analysis of Variance (ANOVA) using the general 
linear model (GLM) procedure of SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Initially, data 
were fitted to the following full linear model: 
       









where yijk were myofibre characteristics, muscle weights and transcript abundance, Mi 
was maternal genome effect (j = Angus, Brahman), Pj was paternal genome effect (i = Angus, 
Brahman), Sk was fetal sex effect (k = male, female), gain was post-conception daily weight 
gain and weight was final maternal weight. Mi, Pj and Sk were fitted as fixed factors (F) and 
gain and weight were fitted as covariates (C). The covariates fitted in the model were nested 
within maternal genome (Mi) in order to adjust for effects of gain and weight within each of 
the two dam breeds. Interactions between factors and covariates were tested as follows: F×F 
was 2-way interaction between factors, Mi ×Pj, Mi×Sk and Pj×Sk, F×F×F was the 3-way 
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interaction between factors, Mi×Pj×Sk; C×C(Mi) was the 2-way interaction of covariates 
nested within maternal genome, gain×weight(Mi); C
2
(Mi) was the quadratic term of covariates 




(Mi); F×C(Mi) was the 2-way 
interaction between factors and covariates nested within maternal genetics, Pj×gain(Mi) and 
Sk×gain(Mi), Pj×weight(Mi) and Sk×weight(Mi); F×C×C(Mi) was the 3-way interaction 
between factors and the two covariates nested within maternal genetics, Pj×gain×weight(Mi) 
and Sk×weight×gain(Mi); F×C
2
 was the interaction between factors and quadratic terms of 












Backward stepwise elimination was used to reduce the model for each measured 
parameter based on type III sums of squares (SSIII) at significance level (P) of 0.05. Type III 
sums of squares are independent of the order that effects are fitted in the model (Shaw and 
Mitchell-Olds, 1993). Specifically, elimination started with the least significant (largest P-
value) interaction or effect. Insignificant variables were removed stepwise according to 
marginality rules (Nelder, 1994) i.e. independent variables cannot be eliminated until after the 
interaction is eliminated due to insignificance, and lower order interactions cannot be 
eliminated until after the corresponding higher order interaction is eliminated. Main effects 
were also considered to be marginalized by corresponding nested effects of covariates. 
Elimination continued until only significant effects and interactions remained, or had to be 
retained to maintain the marginality requirements. Main effects of Mi, Pj and Sk were retained 
in the final model, irrespective of the significance levels. This approach retained factors of the 





values, model significance levels and significance levels of factors and nested 
covariates in the final model for each measured parameter are shown in Table 5.1. Means for 
effects of factors and interactions (with P-values from t-tests of the contrast, Figures 5.3, 5.4, 
5.6, 5.7) and regression slopes for nested effects of covariates (Figure 5.5, 5.7 and Figure S5, 
Appendix 8) were plotted according to marginal means and estimated parameters obtained 
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from the final model. P-values of maternal and/or paternal genome effects on fast myotube 
CSA, absolute weights of M. supraspinatus, M. longissimus dorsi and M. quadriceps femoris, 
and H19 transcript abundance were not determined. The significant effects of final maternal 
weight nested within maternal genetics and/or significant interaction effects of maternal and 
paternal genome, would have biased P-values for corresponding main effects estimated with 
type III sums of squares (Table 5.1., Figure 5.3, 5.4, 5.7). 
Only one nested quadratic effect was significant when tested; weight
2
(Mi) explained a 
significant (P = 0.007) amount of variation in absolute M.quadriceps femoris weight. 
However, examination of plotted curves with individual data points revealed that this effect 
was dependent upon two heavy dams with high leverage. Therefore, this quadratic effect was 
removed from the model and the linear effect retained. The graph for the initial quadratic 
effect is presented in Figure S5, Appendix 8. 
The contribution of maternal genome (Mi), paternal genome (Pj), fetal sex (Sk) and 
significant interaction and nested effects (P<0.05) to explained variation in myofibre 
characteristics, muscle weights and H19 transcript abundance, was calculated from type I 
sums of squares (SSI). Type I sums of squares are dependent on the order in which effects are 
fitted in the model and sum to the total model SS (Shaw and Mitchell-Olds, 1993; Nelder, 
1994) (Figures 5.1, 5.2). 
Final maternal weight (FMW) may contain both genetic and non-genetic effects as a 
function of breed and permanent environmental effect from origin of dam. Dams were 
sourced from different properties and had, therefore, been subject to different environments 
prior to recruitment for the experiment. By using SSI and fitting the maternal genome effect 
before weight in the model, we apportioned all the maternal genetic effect to maternal breed 
(Mi) and left only environmental effects attributable to weight. Specifically, variables and/or 
interactions were fitted into the final SSI model in the following order: 
 










The SSI values of Pj and Mi were averaged from both models, assuming equal 
importance of maternal and paternal genomes. SSI values of other variables and interactions 
were identical for models 1 and 2. The SSI contribution of an interaction was apportioned 
equally to each component of the interaction. The contributions of maternal genetics (Mi), 
paternal genetics (Pj), fetal sex (Sk) and final maternal weight (weight) to myofibre 
characteristics, muscle weights and transcript abundance were calculated from the SSI of Mi, 
Pj, Sk and weight as a percentage of total SSI, respectively (Figure 5.1). The contribution of 
weight was defined as the non-genetic maternal effect, since the estimation of SSI values of 
weight were independent of maternal genome. The relative proportions of maternal and 
paternal genomes to total genetic variation in myofibre characteristics, muscle weights and 
transcript abundance were calculated by totalling respective contributions (Figure 5.2). 
The regressions and Pearson correlation coefficients (r) for absolute and relative 
combined muscle weights and H19 transcript abundance were estimated in SPSS 17.0 (SPSS 




5.3.1 Proportion of variation explained by parental genomes, fetal sex and 
non-genetic effects  
Myofibre characteristics determined in M. semitendinosus samples included number and 
cross-sectional area (CSA) of type I (slow) and type II (fast) myotubes and myofibres and 
total cell number and total cell CSA (Figure S3, Appendix 8). Wet weights were determined 
for M. supraspinatus, M. longissimus dorsi, M. quadriceps femoris and M. semimembranosus. 
Since the four fetal groups with specific combinations of Bos taurus taurus (Bt) and Bos 
taurus indicus (Bi) genomes showed significant differences in carcass weights (Figure S4, 
Appendix 8), relative muscle weights were analyzed in addition to absolute muscle weights to 
identify effects of parental genomes on muscle mass independent of fetal size. 
Significant final statistical models for studied muscle parameters with adjusted R
2
 values 
and significance levels of retained variables are presented in Table 5.1. Parental genomes, 
fetal sex, and effects of maternal weight, caused by non-genetic variation and nested within 
maternal genomes (see methods), each contributed differentially to muscle parameters (Figure 
5.1). Parental genome was the most important source of variation for all studied traits with 
significant final statistical models. Maternal and paternal genomes together explained most of 
the variation in myofibre size (80-96%), absolute muscle weights (82-89%) and relative 
muscle weights (56-93%). Fetal sex contributed less to variation in myofibre characteristics 
(4-20%) and absolute (2-13%) and relative muscle weights (7-44%). Non-genetic maternal 
effects of final maternal weight accounted for some variation in absolute weights of M. 
supraspinatus, M. longissimus dorsi and M. quadriceps femoris (5-6%). Combined absolute 
and relative muscle weight showed parental genome contributions of 94% and 72%, 
respectively (Figure 5.1). 
The relative contributions of maternal and paternal genomes to total explained 
(epi)genetic variation in myofibre size and muscle weights are shown in Figure 5.2 Maternal 
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genome explained most of the (epi)genetic variation in fast myofibre CSA (93%) whereas the 
 
Table 5.1 Summary of the final general models (type III sums of squares) for myofibre 
characteristics, muscle weight parameters and H19 gene expression with adjusted R2 values 
and significance levels (P-values) of models and variables. 



















Fast myotube CSAa 0.152 0.0043 ND ND 0.4337 0.0129 
 
Fast myofibre CSAa 0.111 0.0117 0.0031 0.7345 0 1390 
  





      
M. supraspinatus 0.689 8.7E-17 ND 2.3E-07 7.0E-04 
 
0.0112 
M. longissimus dorsi 0.649 1.2E-15 ND 6.9E-08 0 2828 
 
0.0420 
M. quadriceps femoris 0.666 1.0E-14 ND 2.1E-05 0.0457 
 
0.0256 
M. semimenbranosus 0.595 7.2E-12 5.1E-12 0.04974 0.0026 
  
Combined muscles  0.667 2.9E-14 5.0E-13 3.3E-05 0.0095 
  
Relative muscle weights  
      
M. supraspinatus 0.210 3.3E-04 0.5294 2.7E-05 0 2327 
  
M. longissimus dorsi 0.441 4.8E-09 0.0014 9.8E-08 1.6E-04 
  
M. quadriceps femoris 0.332 1.6E-06 0.0048 1.2E-04 1.4E-04 
  
M. semimenbranosus 0.136 0.0115 0.0176 0.4209 0.0637 
  
Combined muscles 0.517 2.1E-09 2.3E-04 2.2E-06 5 9E-06 
  
H19 expression 0.350 4.0E-06 ND ND 0 1288 0.0051 0.0296 
aTotal cell CSA: Average cross-sectional area of muscle cells irrespective of cell type. 
bMaternal × paternal genome: Effect of maternal and paternal genome interaction. 
cFinal maternal weight (maternal genome): Effect of final maternal weight nested in maternal genome. ND: Not 
determined because of significant interaction and/or nested effect of final maternal weight. 
 
paternal genome accounted for most of the variation in fast myotube CSA (68%). Maternal 
genome again explained most of the variation in total cell CSA (82%). Maternal genome also 
explained most of the genetic variation (59-88%) in all absolute muscle weights. Paternal 
genome, in contrast, explained most of the genetic variation (54-97%) in relative weights of 
M. supraspinatus, M. longissimus dorsi and M. quadriceps femoris. However, maternal 
genome accounted for 82% of genetic variation in relative weight of M. semimembranosus. 
Combined absolute muscle weight was predominantly affected by maternal genome (73%) 
while combined relative muscle weight showed a stronger effect of paternal genome (63%). 
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Overall, the data clearly showed a distinct pattern of effects of maternal and paternal genomes 
with an increase of maternal genome contributions (or conversely, a decrease of paternal 
genome contributions) to variation in absolute and relative weights of muscles from the 
thoracic limb (M. supraspinatus) to muscles from the torso (M. longissimus dorsi) and pelvic 
limb (M. quadriceps femoris and M. semimembranosus) (Figure 5.2). 
 
 
Figure 5.1 Relative contributions of parental genomes, fetal sex and non-genetic maternal effects to explained 
variation in fetal myofibre characteristics, absolute and relative muscle weights, and H19 transcript abundance. 
Myofibre characteristics were determined in M. semitendinosus. Maternal and paternal genome, fetal sex and 
other significant effects were retained in the final general linear models as presented in Table 5.1. Non-genetic 
maternal effect: Final maternal weight at mid-gestation. CSA: Cross-sectional area. Total cell: All myofibres 
measured regardless of cell type. Combined muscle weights: Sum of M. supraspinatus, M. longissimus dorsi, M. 
semimembranosus and M. quadriceps femoris weight. Relative muscle weight: Absolute muscle weight divided 







Figure 5.2 Relative contributions of maternal and paternal genome to genetic variation in fetal myofibre 
characteristics, absolute and relative muscle weights, and H19 transcript abundance. 
bre characteristics were determined in M. semitendinosus. CSA: Cross-sectional area. Total cell: All myofibres 
measured regardless of cell type. Combined muscle weights: Sum of M. supraspinatus, M. longissimus dorsi, M. 
semimembranosus and M. quadriceps femoris weight. Relative muscle weight: Absolute muscle weight divided 
by decapitated and eviscerated fetal carcass weight. 
 
5.3.2 Specific effects of Bt and Bi genomes, fetal sex and maternal weight 
Least square means for specific effects of Bos taurus taurus (Bt, Angus) and B. taurus 
indicus (Bi, Brahman) maternal and paternal genomes, fetal sex and non-genetic maternal 
effects of final maternal weight, as detailed in statistical models for myofibre characteristics 
and muscle weights (Table 5.1.), are presented in Figure 5.3-5.6 Fast myotube CSA was 
affected by a significant interaction between maternal and paternal genomes (P<0.05). 
Fetuses with Bt × Bt genomes had larger CSA (P<0.05 – 0.01) than fetuses of other genetic 
combinations (Figure 5.3 A). Maternal genome significantly affected fast myofibre CSA and 




Figure 5.3 Specific effects of maternal genomes, paternal genomes and fetal sex on fetal myofibre 
characteristics of M. semitendinosus at midgestation. 
Least square means with standard errors of means are shown and P-values for significant differences (t-test) 
between means for fast myotube CSA (A), fast myofibre CSA (B) and total cell CSA (C) are indicated. CSA: 
Cross-sectional area. Total cell: All myofibres measured regardless of cell type. Bt: Bos taurus taurus, Angus. 
Bi: Bos taurus indicus, Brahman. 
 
Maternal genome significantly affected absolute weights of all muscles (Figure 5.4 A-
D), but M. supraspinatus, M. longissimus dorsi and M. quadriceps femoris also showed 
significant non-genetic effects of final maternal weight nested within maternal genome (all 
P<0.05, see below). Maternal genome effects, independent of maternal weight, were detected 
for M. semimembranosus (P<0.0001). Paternal genome, in contrast, independently and 
strongly affected absolute weights of M. supraspinatus, M. longissimus dorsi and M. 
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quadriceps femoris (all P<0.0001), but not M. semimembranosus, a muscle strongly affected 
by maternal genome (see above). 
 
 
Figure 5.4 Specific effects of maternal genomes, paternal genomes and fetal sex on fetal absolute muscle 
weights at midgestation. 
Least square means with standard errors of means are shown and P-values for significant differences (t-test) 
between means for M. supraspinatus (A), M. longissimus dorsi (B), M. quadriceps femoris (C), M. 
semimembranosus (D) and combined muscle weight (sum of weights of dissected muscles) (E) are indicated. 
ND: Not determined because of significant nested effect of final maternal weight (see Figure 5.5). Bt: Bos taurus 
taurus, Angus. Bi: Bos taurus indicus, Brahman. 
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Combined muscle weights showed significant effects of maternal and paternal genome 
that were stronger for the maternal genome. Irrespective of maternal or paternal origin Bt 
genome always increased, and Bi genome always decreased, absolute muscle weights. Fetal 
sex significantly affected absolute weights of M. supraspinatus (P<0.001), M. quadriceps 
femoris (P<0.05) and M. semimembranosus (P<0.01) with heavier muscles in males than in 
females (Figure 5.4 A,C,D). Non-genetic effects of final maternal weight, nested within 
maternal genome, on absolute weights of M. supraspinatus, M. longissimus dorsi and M. 
quadriceps femoris (P<0.05) indicated positive linear relationships for Bi and Bt, but with a 
higher intercept and less slope in Bt (Figure 5.5 A-C). Only one of the quadratic maternal 
weight effects tested yielded a significant result (M. quadriceps femoris, P<0.01). 
Examination of plotted curves with individual data points revealed that this was dependent 
upon two heavy dams with high leverage (see methods and Figure S5, Appendix 8). 
Therefore, we fitted linear effects throughout. Nested effects of post conception maternal 
daily weight gain were not significant for any of the investigated muscle parameters. 
Maternal genome had moderate effects on relative weights of M. longissimus dorsi 
(P<0.01), M. quadriceps femoris (P<0.01) and M. semimembranosus (P<0.05), but not M. 
supraspinatus. Paternal genome showed strong effects on M. supraspinatus (P<0.0001), M. 
longissimus dorsi (P<0.0001) and M. quadriceps femoris (P<0.001), but not M. 
semimembranosus. Combined relative muscle weight showed stronger effects of the paternal 
genome. Again, as for absolute muscle weights, Bt genome increased relative muscle weights 
irrespective of parental origin (Figure 5.6 A-D). Strong fetal sex effects were present for 
relative weights of M. longissimus dorsi (P<0.001) and M. quadriceps femoris (P<0.001), 
with greater weights in females than in males (Figure 5.6 B,C). 
 
5.3.3 Expression of the H19 lincRNA 
Expression of the H19 large intergenic non-coding RNA (lincRNA) was measured by 
real-time quantitative PCR in M. semitendinosus samples. Transcript abundance was 
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significantly affected by an interaction between maternal and paternal genomes (P<0.01) 
(Table 5.1.). Fetuses with Bi × Bi genome showed higher levels of H19 transcript (P<0.01) 
than fetuses of other genetic combinations (Figure 5.7 A). Transcript abundance was also 
affected by final maternal weight (P<0.05) nested within maternal genome (Figure 5.7 B). 
Subsequent regression analyses revealed significant negative relationships (P<0.001) between 




Figure 5.5 Effects of final maternal weight nested within maternal genomes on fetal absolute muscle weights at 
midgestation. 
P-values (ANOVA) of significant linear regressions within Bt and Bi maternal genetics on absolute weights of 
M. supraspinatus (A), M. longissimus dorsi (B) and M. quadriceps femoris (C) are indicated. Bt: Bos taurus 




Figure 5.6 Specific effects of maternal genomes, paternal genomes and fetal sex on fetal relative muscle weights 
at midgestation. 
Relative muscle weights were calculated as absolute muscle weight divided by fetal carcass weight. Least square 
means with standard errors of means and P-values for significant differences (t-test) between means for M. 
supraspinatus (A), M. longissimus dorsi (B), M. quadriceps femoris (C) and M. semimembranosus (D) are 
indicated. Combined relative muscle weight is the sum of relative weights of dissected muscles. Bt: Bos taurus 




Figure 5.7 Effects of interaction of maternal and paternal genomes, fetal sex and final maternal weight nested 
within maternal genetics on H19 transcript abundance in fetal M. semitendinosus at midgestation. 
Least square means with standard error of means and P-values for significant differences (t-test) between means 
(A) and significant regressions of final maternal weight nested within Bt and Bi maternal genomes (B) are 
shown. Bt: Bos taurus taurus, Angus. Bi: Bos taurus indicus, Brahman. 
 
 
Figure 5.8 Regressions of fetal muscle mass at midgestation on H19 transcript abundance. (A) Absolute muscle 
mass and (B) relative muscle mass. 
Muscle mass is combined absolute and relative weights of M. supraspinatus, M. longissimus dorsi, M. 




To our knowledge, this is the first study to examine effects of maternal and paternal 
genome on fetal myofibre characteristics and muscle mass. Our results showed that 
differential effects of parental genomes were the most important determinants of fetal muscle 
phenotype at midgestation. Fetal sex and non-genetic effects of final maternal weight had a 
significant but lesser impact on some investigated muscle parameters (Figure 5.1). 
Considering the fetal programming of skeletal muscle development (Picard et al., 2002; Du et 
al., 2010a), these findings are consistent with generally medium to high heritabilities reported 
for postnatal myofibre size and muscle mass in mammals, including bovine (Larzul et al., 
1997; Rehfeldt et al., 1999; Engellandt and Tier, 2002; Smith et al., 2007; Mansan Gordo et 
al., 2012). Since myotubes are immature myofibres that decrease in size as myogenesis 
progresses (Martyn et al., 2004), both the predominant contribution of the paternal genome to 
variation in fast myotube cross sectional area (CSA), and the predominant contribution of the 
maternal genome to variation in fast myofibre CSA (Figure 5.2), indicate specific roles of 
maternal and paternal genomes in myofibre differentiation and maturation. 
The observed differences between Bos taurus taurus (Bt) and Bos taurus indicus (Bi) 
genomes likely result from allelic differences in genes with parent-of-origin effects 
controlling myofibre development. Evidence for subspecies differences in postnatal fibre type 
ratios and size, and in absolute postnatal muscle weights of Bt and Bi breeds has been 
reported previously (Whipple et al., 1990; Ferrell, 1991; Strydom and Smith, 2010). 
Differential parental effects were masked in total cell CSA, which was predominantly affected 
by maternal genome (Figure 5.2). Muscle specific differences in fibre type composition and 
size (Totland and Kryvi, 1991) could explain some of the varying contributions of maternal 
and paternal genomes to different muscles. The present data suggest that maternal genes are 
important determinants of myofibre development and muscle mass. 
Variation in the maternally inherited mitochondrial genome has been associated with 
effects on postnatal muscle mass (Mannen et al., 1998), but specific effects of maternal genes 
178 
in myogenesis remain, to our knowledge, unexplored. The present results are in agreement 
with recent data obtained by statistical modelling and imprinted quantitative trait loci (QTL) 
analyses which suggested significant maternal parent-of-origin effects for postnatal muscle 
traits (Boysen et al., 2010; Neugebauer et al., 2010a; Neugebauer et al., 2010b). In contrast, 
paternally expressed genes with effects on myogenesis have been identified previously and 
were studied in detail. This includes the imprinted Delta-like 1 homolog (DLK1), which has 
been implicated in the commitment and/or proliferation of fetal myoblasts (Jason et al., 2008) 
and in increased postnatal myofibre diameter and muscle mass (Davis et al., 2004; Jason et 
al., 2008). Further examples of gene-specific genetic and epigenetic regulatory mechanisms 
that could explain effects of maternal and paternal genomes on fetal muscle phenotype 
observed in the present study are found in the IGF1-AKT/PKB pathway (Schiaffino and 
Mammucari, 2011). In the mouse embryo, paternally expressed IGF2 is required for fibre type 
specification (Merrick et al., 2007). This imprinted gene has been identified as a QTL for 
postnatal muscle mass (Jin-Tae Jeon, 1999; Nezer et al., 1999) and encodes a miRNA in 
intron 2 that targets transcripts of the non-imprinted IGF1 gene (Wang, 2008). Several other 
genes in this pathway, including PTEN, a gatekeeper for the accretion of muscle mass 
(Sawitzky et al., 2012), are also targeted by miRNAs (Crist and Buckingham, 2009; Ge and 
Chen, 2011). The significance of allelic differences in miRNA target sequences for regulation 
of muscle mass by epistatic miRNA interference has been demonstrated with myostatin 
alleles in the ovine model (Clop et al., 2006). Genome sequences of Bos taurus taurus and 
Bos taurus indicus revealed genomic variation (Sequencing et al., 2009; Canavez et al., 2012) 
that provides a basis for maternal and paternal (epi)genetic effects on myogenesis described in 
the present study. 
The imprinted long intergenic non-coding (linc) RNA H19 is maternally expressed at 
high levels in embryonic and fetal tissues, including skeletal muscle (Lee et al., 2002; Gabory 
et al., 2006). The H19 gene is located immediately downstream of IGF2 and involved in 
regulation of IGF2 expression. More recently, H19 has been identified as the master regulator 
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of an imprinted gene network with important roles in growth and development (Gabory et al., 
2010). The H19 transcript was further shown to harbor a miRNA that suppresses IGF1R 
expression and prenatal growth (Cai and Cullen, 2007; Keniry et al., 2012). Gene expression 
data generated in the present study demonstrated significant differences in H19 transcript 
abundance of M. semitendinosus from fetuses with different parental combinations of Bt and 
Bi genomes (Figure 5.7). In human, H19 expression is also affected by genetic background 
(Lin et al., 1999). Furthermore, H19 expression was significantly negatively correlated with 
absolute and relative fetal muscle mass (Figure 5.8). This is consistent with the previously 
reported role of H19 as a negative regulator of prenatal growth and development (Keniry et 
al., 2012). Thus, imprinted gene expression and miRNA interference are plausible 
mechanisms for differential effects of maternal and paternal genomes observed in the present 
study. 
Our data indicated predominant contributions of the maternal genome to variation in 
absolute fetal muscle weights and predominant contributions of the paternal genome to 
variation in relative fetal muscle weights (Figure 5.2). With respect to maternal genome, these 
results are in agreement with data available from an analysis of parent-of-origin effects on 
postnatal bovine muscle, where absolute muscle weights were predominantly affected by 
imprinted maternal genetic factors (Neugebauer et al., 2010b). The genetic conflict hypothesis 
of genomic imprinting states that paternally expressed genes promote, and maternally 
expressed genes limit, fetal growth (Moore and Haig, 1991). Accordingly, maternal genes are 
expected to control fetal size to avoid detrimental effects for the mother that are associated 
with higher nutrient transfer to the fetus and increased birthweight (Moore and Haig, 1991). 
In the present study, fetuses with different maternal and paternal combinations of Bt and Bi 
genomes showed significant differences in carcass weight (Figure S4, Appendix 8) that are 
consistent with a phenotypic pattern of genomic imprinting for maternally expressed genes 
(see Figure 1 in (Wolf et al., 2008)) affecting fetal size. Correlations between absolute muscle 
weights and fetal carcass weight ranged from r = 0.88 (M. longissimus dorsi, P<0.0001) to 
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r = 0.95 (M. quadriceps femoris, P<0.0001). Effects of the maternal genome on absolute 
muscle weights are, therefore, likely to be primarily correlated effects of maternal 
(epi)genetics on fetal size, presumably via imprinted genes (Moore and Haig, 1991; Wolf et 
al., 2008) and/or epistatic interaction of miRNAs and their target sites (see above). However, 
mitochondrial DNA (Mannen et al., 1998; Hiendleder et al., 2004b), or X-chromosome 
effects (Amen et al., 2007a; Amen et al., 2007b) could also contribute to Bt and Bi maternal 
(epi)genetic effects on muscle phenotype (Figure 5.3, 5.4). 
Predominance of parental genomic contributions to muscle weights varied from maternal 
for absolute weights to paternal for relative weights. An exception was M. semimembranosus, 
which showed only a weak maternal (P<0.05) and no paternal genome effect (Figure 5.2, 5.4, 
5.6). Considering the genetic conflict hypothesis (Moore and Haig, 1991), it appears that the 
full extent of paternal genome effects on muscle mass and shape should manifest postnatally, 
without causing detrimental effects to mother or fetus at parturition. Such effects could 
nevertheless be expected to be programmed prenatally (Picard et al., 2002; Du et al., 2010a) 
and to be independent of absolute fetal muscle weights. This interpretation is consistent with 
the imprinting status of major regulators of fetal muscle development and growth in bovine 
e.g. paternally expressed growth promoting IGF2 and maternally expressed growth inhibiting 
IGF2R (Dindot et al., 2004; Hiendleder et al., 2004a). Imprinted gene effects with paternal 
mode of expression responsible for increased muscle mass in ovine (DLK1) and porcine 
(IGF2) manifest postnatally (Jin-Tae Jeon, 1999; Nezer et al., 1999; Davis et al., 2004; 
Cockett et al., 2005). 
Analyses of the proportion of parental contributions to muscle traits revealed that 
contributions of the maternal genome to absolute and relative fetal muscle mass increased (or 
conversely, contributions of the paternal genome decreased) from thoracic limb to torso and 
pelvic limb. This novel spatial effect of the maternal genome mirrored paternal effects on 
muscle mass observed in sheep with the polar overdominant callipyge mutation (Koohmaraie 
et al., 1995; Cockett et al., 1996; Jackson et al., 1997). Consistent with our findings, a recent 
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study in porcine identified a quantitative trait locus (QTL) with maternal polar overdominance 
that affected postnatal pelvic limb muscle mass (Boysen et al., 2010). Moreover, statistical 
modelling of parent-of-origin effects on postnatal muscle mass in porcine and bovine also 
showed a preponderance of maternal effects attributed to genomic imprinting (Neugebauer et 
al., 2010a; Neugebauer et al., 2010b). The significant switch in gene expression, including 
imprinted transcripts from the DLK1-DIO3 region, in ovine M. longissimus dorsi from fetus 
to neonate (Byrne et al., 2010), could indicate developmental stage specific roles of maternal 
and paternal genomes in myogenesis. Interestingly, the imprinting status of genes can change 
from monoallelic to non-imprinted biallelic expression during development (Davies, 1994; 
McLaren and Montgomery, 1999; Goodall and Schmutz, 2007). Statistical analyses of 
experimental data for postnatal growth and development in mouse identified multiple 
imprinted QTL with complex temporal patterns of parent-of-origin effects (Wolf et al., 2008). 
It is tempting to speculate that such effects could also be spatial. 
Significant effects of sex on postnatal muscle mass of mammals, including bovine, have 
been reported (Seideman and Crouse, 1986; Fortin et al., 1987; Uttaro et al., 1993; Larzul et 
al., 1997), but the present study is the first to examine sex effects in prenatal myogenesis. In 
agreement with fetal programming of postnatal muscle mass discussed above (see maternal 
and paternal genomes), sex explained greater proportions of variation in relative fetal muscle 
weights than in absolute muscle weights (Figure 5.1). Male fetuses had higher absolute 
muscle weights but lower relative muscle weights than females (Figure 5.4, 5.6). The latter 
findings are in agreement with results for postnatal muscle weights in porcine (Fortin et al., 
1987) and ovine (Santos et al., 2007). In the present study, fetal sex had no effect on relative 
weight of M. supraspinatus, a shoulder muscle, but significantly affected the relative weights 
of M. longissimus dorsi (loin) and M. quadriceps femoris (pelvic limb) (Figure 5.6). This is 
again similar to results obtained for postnatal muscle mass in ovine (Santos et al., 2007), 
where sex had no effect on shoulder muscle percentage but significantly affected loin muscle 
percentage, with greater muscle percentage in females than in males. An explanation for these 
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results could be that fetal shoulder muscle mass is under strong selection because of its 
relevance for birthing difficulties and thus survival. The loin and pelvic limb region of 
females may require a higher relative muscle weight to maintain sex-specific postnatal 
proportions and reproductive functions, which may be programmed during fetal development. 
Our analyses identified significant contributions of final maternal weight (FMW) to 
variation in absolute fetal muscle weights and H19 expression at midgestation (Figure 5.1). 
These non-genetic maternal effects were estimated as nested effects within maternal genetics 
using type I sums of squares in the final linear models, allowing the removal of maternal 
genetic contributions from effects of FMW (see methods). Non-genetic maternal components 
can be explained by differences in environmental factors acting on dams before they were 
recruited for the experiment. These environmental effects could not be erased during several 
weeks of adjustment under a controlled environment prior to the start of the experiment. To 
our knowledge, pre-conception non-genetic maternal contributions to variation in fetal muscle 
mass have not been reported previously. The estimated regression coefficients suggested that 
the same mechanisms affect fetal muscle mass in dams with Bt and Bi genomes (Figure 5.5, 
5.7). 
In conclusion, we have shown for the first time, that fetal muscle development is 
differentially affected by maternal and paternal genome, independently, or in combination 
with non-genetic maternal effects. Our statistical analyses of effects of parental genomes, and 
molecular data for the imprinted maternally expressed lincRNA H19, suggested that 
imprinted gene networks (Gabory et al., 2010) and epistatic miRNA interference (Clop et al., 
2006) could be major drivers of the observed parental effects on fetal muscle traits. Our 
conclusions are supported by results from statistical modelling of postnatal muscle traits 
(Engellandt and Tier, 2002; Neugebauer et al., 2010a; Neugebauer et al., 2010b) which 
identified parent-of-origin effects attributed to imprinted genes as a major source of variation. 
Detailed molecular profiles are now required to elucidate genetic, epigenetic and non-genetic 
components and interactions that control variation in prenatal muscle traits. Our data further 
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suggest that specific combinations of (epi)genetic and non-genetic factors can be used to 
optimise fetal, and therefore, postnatal muscle development and phenotype. Non-Mendelian 
(epi)genetic and non-genetic maternal effects can help understand unexplained variation in 
postnatal muscle traits. These traits may be highly variable within populations, even when 
genetics and environment are well controlled (Reverter et al., 2003; Greenwood et al., 2007). 
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Chapter 6                                                
General discussion
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6.1 Developmental changes in transcript abundance of imprinted 
genes in bovine tissues 
In the present study, we have characterised tissue-specific quantitative changes in 
expression of the imprinted genes IGF2, IGF2R, and their regulatory lincRNA genes, H19 
and AIRN, in key stages of bovine prenatal development and postnatal life. We also analysed 
tissue and developmental stage-specific expression patterns of alternative IGF2 promoters. To 
our knowledge, this is the first comprehensive study to examine developmental changes in 
transcript abundance of these imprinted genes using a quantitative method, real time qPCR. 
We confirmed that the studied genes are highly active during bovine prenatal development 
and are downregulated after birth. The genes studied here belong to the IGF system, which is 
essential in prenatal development (Heyner et al., 1989; Rappolee et al., 1992; Adamson, 
1993; Baker et al., 1993; Heyner et al., 1993; Schultz et al., 1993; Oksbjerg et al., 2004; 
Randhawa and Cohen, 2005). The IGF2 global transcripts displayed a similar tissue-specific 
pattern of expression as IGF2R, with the exception of brain and cotyledon. The highest level 
of IGF2 transcription in cotyledon was observed in the embryo and persisted to the fetal 
stage, and expression of IGF2R in cotyledon peaked in midgestation. The relative expression 
level of IGF2/IGF2R in the studied fetal tissues, which can be interpreted as an indicator of 
the relative level of free IGF2 protein available to the tissues, was subject to developmental 
change and was lower in tissues from midgestation fetuses compared with the embryonic 
stage. This could indicate that more free IGF2 is required by fetal tissues at the earlier stage of 
prenatal development compared with midgestation. Differential relative expression of IGF2 
and IGF2R at embryonic and fetal stages could be linked to their functions at different stages 
of prenatal development. Accumulating evidence suggests that IGF2 plays a key role in 
placental development and function particularly at earlier stages of gestation (Kanai-Azuma et 
al., 1993; Kniss et al., 1994; Irving and Lala, 1995; Hamilton et al., 1998; McKinnon et al., 
2001; Hills et al., 2004). It has been shown that IGF2 affects placental growth via interaction 
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with IGF2R, which activates signal transduction pathways (McKinnon et al., 2001; Sferruzzi-
Perri et al., 2008; Harris et al., 2011). 
Relative IGF2R transcript abundance in brain, compared with other tissues, was higher 
than that for IGF2, which is compatible with a widespread distribution of Igf2r 
transcript/protein observed in rat brain (Hawkes and Kar, 2004). Several lines of evidence 
demonstrated that IGF2 can promote growth, proliferation and differentiation of a variety of 
neuronal cell types (Lenoir and Honegger, 1983; Lim et al., 1985; Recio-Pinto et al., 1986; 
Knusel et al., 1990; Liu and Lauder, 1992; Neff et al., 1993; Konishi et al., 1994; Sondell et 
al., 1997; Pu et al., 1999; Silva et al., 2000). Our results revealed the lowest ratio of 
IGF2/IGF2R transcript abundance in brain compared with other tissues. The significance of 
the relatively high level of IGF2R transcripts and specific functions of IGF2R in brain 
remains unclear. Several studies suggest different functions for IGF2R in brain. For example, 
IGF2R is involved in internalisation and degradation of LIF (leukemia inhibitory factor) 
(Blanchard et al., 1999), activation of TGF-β precursor form (Dennis and Rifkin, 1991; 
Ghahary et al., 1999; Villevalois-Cam et al., 2003) and mediating the growth-inhibitory effect 
of retinoic acid (Kang et al., 1997; Kang et al., 1998; Kang et al., 1999) all of which are 
known to modulate the functions of the nervous system (Murphy et al., 1997; Zetterström et 
al., 1999; Böttner et al., 2000; Malik et al., 2000; Turnley and Bartlett, 2000; Krieglstein et 
al., 2002; Thompson Haskell et al., 2002; Bauer et al., 2003; Maden and Hind, 2003; 
McCaffery et al., 2003; Luo et al., 2004; Haskell and LaMantia, 2005; Lane and Bailey, 
2005; Clagett-Dame et al., 2006; McCaffery et al., 2006; Aoto et al., 2008). However, the 
importance of the Igf2/Igf2r system in brain development has been challenged by the 
observations that mutant mice carrying disrupted Igf2 or Igf2r, and also transgenic mice 
overexpressing Igf2 show normal brain size and morphology (Rogler et al., 1994; Wolf et al., 
1994; van Buul-Offers et al., 1995; D'Ercole et al., 2002). One interpretation for such a result 
is that activity of these genes may be compensated by the action of other gene systems. In 
addition, ontogenetic changes may occur in growth of specific cell types in brain. 
191 
The ratio of IGF2/IGF2R decreased considerably in postnatal lung, kidney and muscle, 
which coincides with reduced growth rate. Nevertheless, the ratio of IGF2/IGF2R did not 
change significantly in heart, brain and liver at the postnatal compared with fetal stage. The 
significance of IGF2/IGF2R transcript ratio remaining at high levels in some tissues during 
postnatal development is unclear. 
In this thesis, we investigated developmental and tissue-specific changes in IGF2 
expression from alternative promoters. IGF2 is a complex gene which is expressed from 
distinct promoters overlapping a number of sense and antisense transcription units (Moore et 
al., 1997). The bovine orthologues for some human and mouse IGF2 promoters and 
overlapping transcripts are unknown. Expression analysis of IGF2 promoter-specific 
transcripts, without prior knowledge of their exon/intron structure, can yield misleading 
results. Therefore, we performed in silico comparative sequence analysis of IGF2 promoter-
specific transcripts in bovine, human, mouse and porcine to identify evolutionarily conserved 
regions which may belong to putative, as yet unknown, transcripts in bovine. A sequence 
similarity search showed that the promoter and first exon of the human P0 transcript is 
conserved in bovine. In agreement with the observation in human (Monk et al., 2006b), we 
found that bovine IGF2 P0 promoter is specifically active in skeletal muscle during prenatal 
development. In contrast, the equivalent P0 promoter in mouse is only active in placenta 
(Moore et al., 1997). Our finding gives further evidence for an evolutionary shift in tissue-
specific activity of P0 promoter from placenta in mouse to skeletal muscle in human and 
bovine prenatal development and indicates that the bovine IGF2 transcription unit is 
evolutionarily closer to its human orthologue compared with mouse. Thus, the bovine 
provides a suitable model for studying the role of IGF2 in prenatal development. 
The significance of the P0 promoter in skeletal muscle development remains enigmatic. 
Since we could not obtain skeletal muscle tissue from the embryo, further research is required 
to elucidate dynamic changes in P0 expression across prenatal development and role of P0 
expression in skeletal muscle differentiation and growth. Interestingly, IGF2 P0 becomes 
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inactive in postnatal skeletal muscle and is specifically expressed in postnatal liver. Our 
results provide evidence for developmental shift in tissue-specific expression of an IGF2 
promoter. Developmental changes in tissue-specific expression of a gene were previously 
reported (Yoon et al., 1987; Schmidt-Ullrich et al., 1996).  
Transcription of IGF2 from distinct promoters is thought to be engaged in regulation of 
gene expression at multiple layers, including transcription and post-transcription. Different 
isoforms of IGF2 protein are derived from different promoters in human and mouse (see 
chapter 3). However, the functional significance of these isoforms remains unexplored. It is 
evident that IGF2 expression is also controlled at the translational level so that IGF2 
promoter-specific transcripts display different translational efficiency (Nielsen et al., 1990; 
De Moor et al., 1994; Moor et al., 1994; Teerink et al., 1994; Nielsen and Christiansen, 1995; 
Pedersen et al., 2002; Polesskaya et al., 2007; Dai et al., 2011). It is interesting to note that 
translational efficiency of IGF2 promoter-specific transcripts is developmentally controlled 
(Newell et al., 1994; Teerink et al., 1994; Nielsen et al., 1995; Nielsen et al., 1999). 
Differential regulation of mRNA stability by site-specific endonucleolytic cleavage provides 
another layer of tissue- and developmental stage-specific posttranscriptional regulation of 
IGF2 promoter-specific expression (Meinsma et al., 1991; Meinsma et al., 1992; Nielsen and 
Christiansen, 1992; Christiansen et al., 1994; Scheper et al., 1995; Scheper et al., 1996a; 
Scheper et al., 1996b; Van Dijk et al., 1998; van Dijk et al., 2000; van Dijk et al., 2001). 
Transcriptional regulation of IGF2 promoters occurs at the genetic level via differential 
interaction with tissue and developmental stage-specific transcription factors (Vandijk et al., 
1991; van Dijk et al., 1992; Holthuizen et al., 1993; Rietveld et al., 1997; Rodenburg et al., 
1997; Rietveld et al., 1999) and enhancer elements (Yoo-Warren et al., 1988; Leighton et al., 
1995; Ishihara et al., 2000; Kaffer et al., 2001; Eun et al., 2013) and at the epigenetic level via 
genomic imprinting. 
Changes in imprinting status resulting from epigenetic modifications are plausible 
mechanisms involved in tissue and developmental stage-specific expression of imprinted 
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genes (Latham, 1995; Jaenisch and Bird, 2003). Changes in imprinting of H19 in human 
placenta during development has been associated with DNA methylation levels in the 
imprinting control region upstream of H19 (Buckberry et al., 2012). Furthermore, in human 
placenta, higher rates of loss of imprinting have been observed during the first trimester of 
pregnancy compared with term (Jinno et al., 1995; Yu et al., 2009; Pozharny et al., 2010). It 
is interesting to note that IGF2 imprinting in liver of human, bovine (B. taurus) and ovine 
(Ovis aries) is developmentally regulated and shifts from monoallelic paternal expression 
during prenatal development to non-imprinted biallelic expression after birth (Vu and 
Hoffman, 1994; Ekstrom et al., 1995; McLaren and Montgomery, 1999; Goodall and 
Schmutz, 2007). Further evidence for developmental regulation of imprinting came from 
developmental stage-specific relaxation of imprinting of Kvlqt1 in mouse interspecific model 
of Mus musculus domesticus/Mus musculus castaneus (Jiang et al., 1998). Further 
investigation of the quantitative differences between expression of parental alleles are 
required to determine the extent to which tissue and developmental stage-specific changes in 
gene expression are caused by alterations in imprinting status. 
 
6.2 Genetic effects on transcript abundance of imprinted genes: 
Implications for mammalian heterosis 
In this thesis, we analysed fetal genetic and heterotic effects on expression of imprinted 
genes which are known to be involved in prenatal development and their associations with 
fetal body and tissue weight and heterosis in a bovine intraspecies model at midgestation. 
Significant genetic effects and heterosis was observed on fetal placental weight, which was 
highest in Bos indicus (Brahman) × Bos taurus (Angus) group (sire listed first). Evidence for 
parent-of-origin and fetal genetic influence on placental growth came from the interspecific 
crosses in the mouse (Peromyscus polionotus/Peromyscus maniculatus and Mus 
musculus/Mus spretus/Mus macedonicus) (Rogers and Dawson, 1970; Zechner et al., 1996; 
Zechner et al., 1997; Zechner et al., 2002) and equids (Equus asinus/Equus caballus) (Allen, 
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1975; Allen et al., 1993), which showed altered placental growth in hybrids and a striking 
difference between reciprocals in placental weight and size. 
Accumulating evidence demonstrates that placental adaptive responses to intrauterine 
environment, including changes in placental size and capacity for nutrient transport, occur 
through epigenetic changes in regulatory regions of imprinted domains and subsequently 
altered expression of imprinted genes which influences prenatal development with long term 
consequences for postnatal growth, suggesting a key role for placenta in fetal programming 
(Godfrey, 2002; Fowden et al., 2006a; Fowden et al., 2006b; Myatt, 2006; Jansson and 
Powell, 2007; Fowden et al., 2008; Coan et al., 2011; Fowden et al., 2011; Vaughan et al., 
2011; Burton and Fowden, 2012). 
Considering a positive correlation between placental and birth weight (Thomson et al., 
1969; Echternkamp, 1993; Jiang et al., 2009; Mericq et al., 2009), the heterosis observed in 
placenta at midgestation is likely to program birth and early postnatal weight. This is 
consistent with the heterosis reported for birth weight that was higher in the BA hybrid 
(Brown et al., 1993). The heterotic effect observed in placental weight was not yet manifested 
in fetal weight, which could be explained by reduced placental efficiency in the BA group. It 
is evident that adaptive changes in placental efficiency take place in response to alterations in 
placental size to regulate fetal nutrient acquisition (Frank et al., 2002; Angiolini et al., 2006; 
Coan et al., 2008a; Coan et al., 2008b; Fowden et al., 2009). H19-deficient mice with 
placental and fetal overgrowth displayed decreased expression of transporter genes and 
placental efficiency, whereas reduced placental growth in mice by downregulation of the Igf2 
P0 promoter resulted in increased transport capacity and placental efficiency (Angiolini et al., 
2011). 
The finding that highest placental weight is countered by lowest placental efficiency in 
the BA group could be evolutionarily explained by the parent-offspring conflict theory 
(Trivers, 1974; Haig, 1992) where changes in placental efficiency take place probably by the 
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effects of maternally expressed genes like IGF2R (Moore and Haig, 1991) to protect the 
mother from detrimental effects of fetal overgrowth. 
Our results suggested that IGF2R and AIRN could be involved in phenotypic variation of 
placental weight in hybrids, and heterosis in placental phenotype is likely to be caused by an 
expression pattern of polar overdominance imprinting (Wolf et al., 2008). Results from this 
study provide evidence for genetic effects on transcript abundances of imprinted genes which 
impact on placental weight and efficiency with possible consequences for fetal programming. 
Placental overgrowth observed in mouse interspecific crosses (Peromyscus 
polionotus/Peromyscus maniculatus and Mus musculus/Mus spretus) was shown to be 
associated with changes in transcript abundances of imprinted genes, including Igf2, and 
relaxation of imprinting (Vrana et al., 1998; Vrana et al., 2000; Zechner et al., 2002). The 
molecular (epi)genetic mechanisms underlying the specific expression pattern of 
IGF2R/AIRN in cotyledon remain to be understood. One possibility for the phenotypic polar 
overdominance expression pattern of IGF2R and AIRN is relaxation of imprinting in the B. 
indicus (sire) × B. taurus (dam) reciprocal. This speculation is supported by the observation in 
mouse that IGF2R imprinting is disrupted and IGF2R is biallelically expressed in placenta of 
one of the reciprocals in the interspecific Peromyscus polionotus/Peromyscus maniculatus 
hybrids (Vrana et al., 1998). Further evidence in support of our hypothesis comes from 
genetic background-dependent relaxation of imprinting of Kvlqt1 in the mouse interspecific 
model of Mus musculus domesticus/Mus musculus castaneus (Jiang et al., 1998). Biallelic 
expression of IGF2R (Buckberry et al., 2012), polymorphic imprinting of IGF2R (Xu et al., 
1993; Monk et al., 2006a) and loss of imprinting for a panel of imprinted genes (Monk et al., 
2006a; Diplas et al., 2009; Pozharny et al., 2010) have been shown in human placenta.  
Relative muscle weight displayed significant heterosis. The phenotypic pattern for 
relative muscle mass differed from that for placental weight. Relative muscle mass was not 
different between reciprocal fetuses and showed a phenotypic expression pattern of 
dominance (Wolf et al., 2008), whereas the reciprocal fetuses varied considerably in placental 
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weight. Therefore, the molecular mechanisms causing heterosis in skeletal muscle may be 
different from those in placenta. Notwithstanding the negative heterotic effect on H19 
expression, skeletal muscle weight was not significantly correlated with H19 expression in 
hybrids. Therefore, it is unclear whether our studied molecular systems can explain heterosis 
in muscle mass.  
Our results suggest that imprinted genes in the IGF system could be implicated in 
prenatal programming of heterosis in brain. Our molecular data suggest a change in brain 
gene expression in favour of a heterotic pattern which could manifest in phenotype at later 
stages of development. The observation of overexpression of AIRN in one of the reciprocals 
and correlation of AIRN expression with relative brain weight in hybrids implies that AIRN 
could have a role in programming hybrid brain phenotypes. It has been postulated that genetic 
programs predominantly direct early stages of brain development (Rubenstein and Rakic, 
1999). To our knowledge, heterosis in bovine pre and postnatal brain weight has not been 
explored. Several studies in mouse have investigated heterosis in brain weight. Heterosis in 
mouse body and brain weight has been shown at Days-42 and 100 after birth (Henderson, 
1973; Seyfried and Daniel, 1977; Bulman-Fleming et al., 1991), while no heterosis 
(overdominance effect) was seen at Day-70 of mouse postnatal life (Hahn and Haber, 1978). 
To our knowledge, this is the first study indicating that imprinted genes could be 
involved in prenatal programming of heterosis. Our results suggest that heterosis is 
programmed at the (epi)genetic level via changes in transcript abundance of imprinted genes 
in hybrids. In contrast to the heterosis previously reported for birth weight in a cross between 
B. taurus and B. indicus (Brown et al., 1993), no heterosis was observed for fetal body weight 
at midgestation. As midgestation is the beginning of the exponential phase of bovine fetal 
growth (Evans and Sack, 1973; Eley et al., 1978; Prior and Laster, 1979), it is reasonable to 
deduce that heterotic effects programmed at the molecular level in early stages of 
development, are manifested in phenotype in the exponential phase of prenatal growth or after 
birth. The study of heterosis at different developmental stages in the rat revealed that heterotic 
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responses become more pronounced during the rapid growth phase of postnatal development 
and with increasing age (Naso et al., 1975). 
 
6.3 Imprinted genes as molecular drivers of parent-of-origin 
effects on fetal growth-related phenotypes 
Fetal body weight and absolute weights of fetal tissues, except brain, were higher in 
fetuses with maternal B. taurus genetics compared with those with B. indicus maternal 
genetics. Although absolute brain weight did not change significantly across genetic groups 
relative brain weight was higher in fetuses with maternal B. indicus genetics compared with 
those with maternal B. taurus genetics. A maternal effect on adult brain weight has previously 
been reported in the mouse (Mus musculus) (Henderson, 1973; Hahn and Haber, 1978; 
Wahlsten, 1983). While absolute weights of fetal tissues, except brain, were correlated with 
H19 expression, relative brain weight did not show significant relationship with H19 
expression. This suggests that (epi)genetic systems which drive the differential parent-of-
origin effect on relative brain weight, are different from those affecting fetal weight and 
weights of other studied fetal tissues.  
Maternal effects on fetal phenotypes may be caused by parent-of-origin effects of 
imprinted genes (Amen et al., 2007a) or epistatic interaction of miRNAs and their target sites 
(Clop et al., 2006). Moreover, mitochondrial DNA variations (Schutz et al., 1994; Mannen et 
al., 1998; Mannen et al., 2003; Hiendleder et al., 2004) or X chromosome effects (Amen et 
al., 2007a; Amen et al., 2007b) may contribute to Bt × Bi maternal (epi)genetic effects on 
phenotypes. It has been shown that at the phenotypic level, parent-of-origin effects resulting 
from maternal effects can be confounded by genomic imprinting (Hager et al., 2008). 
The parent-of-origin effects on fetal phenotypic traits studied here are consistent with a 
phenotypic pattern of genomic imprinting for maternally expressed genes (Wolf et al., 2008). 
Therefore, we hypothesised a role for imprinted genes in causing parent-of-origin effects on 
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phenotypes and studied expression of the genes which are known to be paternally (H19 and 
IGF2R) and maternally (IGF2 and AIRN) imprinted in bovine prenatal development. 
We did not find a phenotypic pattern of genomic imprinting associated with transcript 
abundances for paternally expressed genes (Wolf et al., 2008). This may be explained by lack 
of fetal genetic effects on transcript abundance of the paternally expressed IGF2 gene in most 
fetal tissues. Also, in most fetal tissues, IGF2 expression was not correlated with fetal 
phenotypes. In agreement with the parental genetic conflict hypothesis (Moore and Haig, 
1991), the paternally expressed IGF2, which is a growth enhancer, did not contribute to 
prenatal phenotypic variations, which is to be expected to protect the mother from detrimental 
effects caused by fetal overgrowth, and IGF2 effects on phenotype are likely to be manifested 
postnatally. A genome wide scan of the mouse genome for imprinted QTL revealed that 
effects of most iQTLs are manifested in the traits expressed at later stages of postnatal life 
(Wolf et al., 2008). Several studies in porcine have revealed that IGF2 is a candidate QTL 
with a major effect on postnatal muscle mass and other growth related phenotypes (Jeon et 
al., 1999; Nezer et al., 1999). 
Surprisingly, the results of the current study indicated that differences in fetal body and 
tissue growth between B. taurus and B. indicus could be attributed to differential expression 
of the maternally expressed gene, H19. In addition, the parent-of-origin phenotypic patterns 
were consistent with the expression pattern of the maternally expressed H19 gene for all the 
studied tissues, except brain. With respect to the negative relationship of H19 expression with 
fetal body weight and weights of fetal tissues, including skeletal muscle, liver, lung, heart, 
kidney and placenta, our results suggest that maternal effects on fetal phenotypes are likely to 
be mediated by H19. H19 might exert its effect through fine-tuning of an imprinted gene 
network (Gabory et al., 2009) and regulation of growth-suppressing miRNA (Keniry et al., 
2012). Expression of H19 in skeletal muscle was significantly influenced by the interaction 
between paternal and maternal genomes. Interestingly, final maternal weight of B. taurus and 
B. indicus, which represents maternal environmental conditions, was differentially correlated 
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with H19 expression in fetal skeletal muscle. H19 expression in fetal skeletal muscle was 
positively correlated with B. indicus final maternal weight and negatively correlated with B. 
taurus final maternal weight. The evolutionary explanation for these observations may be that 
B. indicus has evolved to survive in poor environmental conditions with restricted food supply 
and therefore signals to enhance activity of fetal growth suppressing genes to protect the 
mother from detrimental effects of fetal overgrowth and consequently increased fetal nutrient 
demand. These observations suggest an important role of H19 in developmental programming 
of fetal growth.  
 
6.4 B. taurus / B. indicus polymorphisms in the imprinting control 
region (ICR) of H19: Plausible mechanisms for differential 
expression of H19 
Analysis of H19 expression revealed that H19 transcript abundance in B. indicus was 
between 1.5 to 2.2-fold higher than in B. taurus in all examined tissues, except brain. We 
sought to find plausible molecular mechanisms underlying genetic effects on differential B. 
taurus / B. indicus H19 expression. The observations that (epi)genetic mutations in the 
IGF2/H19 ICR have been implicated in aberrant imprinting and developmental abnormalities 
(Hark et al., 2000; Pant et al., 2003; Schoenherr et al., 2003; Pant et al., 2004; Sparago et al., 
2004; Szabó et al., 2004; Li et al., 2005) led us to hypothesise that genetic polymorphisms in 
the regulatory sequences of H19 imprinted domain could account for the varying transcript 
abundances between subspecies. We performed a B. taurus / B. indicus sequence similarity 
search in the H19 ICR and found major polymorphisms within the conserved consensus 
sequence of the first CTCF binding site (the most upstream to H19 promoter) where two CpG 
sites are disrupted in B. indicus. This CTCF binding site resides within an evolutionarily 
conserved region and reveals sequence homology with human CTCF binding site 6 
(Hansmann et al., 2011). In human, only CTCF binding site 6 is differentially methylated on 
the paternal allele and its methylation status is linked to H19 expression (Takai et al., 2001). 
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This suggests an important functional role for the bovine CTCF binding site 1. Different 
theories could be postulated to explain how polymorphisms in the CTCF binding site are 
linked to the altered H19 expression. One hypothesis is that polymorphisms in the CpG sites 
may cause reduced methylation of the CTCF binding site on the paternal chromosome 
without changing their CTCF binding properties that result in biallelic expression of H19 in 
B. indicus but does not change allelic expression of IGF2. In support of this hypothesis, there 
are two lines of experimental evidence. In mouse (Mus musculus castaneus), the paternal ICR 
was substituted by two copies of chicken beta globin insulator (ChβGI)2 which had two 
CTCF binding sites and was of similar size to ICR with sufficient number of CpG 
dinucleotides (Szabó et al., 2002; Lee et al., 2010). The (ChβGI)2 on the paternal 
chromosome was prevented from de novo methylation in the male germ cells and acted as an 
insulator through binding the CTCF. This led to reduced IGF2 expression, overactivation of 
paternal H19 allele and reduced fetal growth by 44-61% of normal fetal size. This model does 
not explain the stable expression of IGF2 in all genetic groups, which was observed in our 
results. Hypomethylation of the H19 differentially methylated region has been shown to be 
correlated with biallelic H19 expression in cloned bovine (B. taurus/B. indicus), but was not 
associated with IGF2 allelic expression (Zhang et al., 2004; Curchoe et al., 2009; Suzuki et 
al., 2011). An alternative theory is that polymorphisms in the consensus sequences change 
binding ability of the CTCF-binding site resulting in epigenetic modification in the imprinted 
domain and subsequently altered H19 expression. This is supported by several lines of 
evidence that suggest CTCF is the major epigenetic organiser of the maternal H19 imprinted 
domain (Han et al., 2008; Li et al., 2008; Singh et al., 2010a; Singh et al., 2010b; Singh et al., 
2011). It is also possible that mutation in one of the CTCF binding sites interacts with other 
CTCF binding sites and change their methylation status (Pant et al., 2004). Another 
possibility is that the polymorphism may occur in the binding site for another regulatory 
protein that overlaps CTCF binding motifs and subsequently changes epigenetic status of 
chromatin in the ICR and leads to activation of the paternal H19. It has been shown that 
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mutations in the Zfp57-Trim28-Setdb1 repressor complex binding site, which overlaps CTCF 
binding motifs, without affecting CTCF binding sites result in CTCF binding and induced 
insulation on the paternal ICR due to reduced ICR methylation (Engel et al., 2004; Matsuzaki 
et al., 2010; Quenneville et al., 2011; Singh et al., 2012). Further studies are needed to 
elucidate B. taurus- and B. indicus-specific differential methylation of parental alleles in the 
H19 ICR and promoter and its association with H19 overall expression and imprinting.  
Together, these findings led us to speculate that higher expression of H19 in B. indicus 
tissues could be attributable to partial or complete relaxation of imprinting resulting from 
epigenetic changes in the ICR. In this scenario, changes in DNA methylation patterns are the 
consequence of gene regulation rather than being its cause. Recently, it has been suggested 
that sequence polymorphisms in regulatory regions of genes alter their methylation status and 
consequently lead to changes in binding characteristics (Schübeler, 2012). The interplay 
between genetics and epigenetics has been shown to affect spatial expression pattern of H19 
(Lin et al., 1999). 
 
6.5 General conclusions 
Our results demonstrate that fetal genetics significantly influences tissue-specific 
transcript abundance of imprinted genes and induces specific expression patterns that cause 
heterotic effects on gene expression. This suggests that imprinted genes could be implicated 
in prenatal programming of postnatal heterosis in phenotypes. Our findings suggest that the 
imprinting pattern of polar overdominance, as described previously (Wolf et al., 2008), could 
explain the phenotypic patterns associated with heterosis. We identified a key role of H19 as a 
driver of differential parent-of-origin phenotypic patterns in prenatal development, suggesting 
that imprinted gene networks and epistatic miRNA interference could be the molecular basis 
for observed parent-of-origin effects on fetal growth related traits. We posited that the 
sequence variation in the functional regulatory intergenic CTCF binding site may be 
responsible for the differential subspecies-specific expression pattern of H19 by causing 
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altered epigenetic status in the imprinted domain. Taken together, our findings significantly 
enhance understanding of the interplay between genetics and epigenetics and its contribution 
to variations in prenatal growth-related phenotypes with possible consequences for postnatal 
performance and heterosis. These results have significance in animal breeding and can help 
realise the unexplained sources of variations in muscle traits attributed to non-Mendelian 
(epi)genetic effects and interactions, which lead to improved efficiency of selection programs. 
 
6.6 Future works 
 Tissue-specific DNA methylation studies of regulatory elements of IGF2/H19 (i.e. 
CTCF binding sites located within H19 ICR) and IGF2R/AIRN (i.e. DMR1 and DMR2) in the 
genetic groups and developmental stages. Altered DNA methylation patterns of DMR2 in 
bovine embryos produced by somatic cell nuclear transfer (SCNT) were correlated with 
altered IGF2R expression (Long and Cai, 2007). In another study, DNA methylation of 
DMR2 and allelic expression of IGF2R did not alter in bovine fetuses derived from in vitro 
fertilisation (IVF) (Bebbere et al., 2013). In addition, the intergenic ICR containing putative 
CTCF binding sites with differential DNA methylation patterns have been characterised 
upstream of bovine (B. taurus/B. indicus) H19 (Curchoe et al., 2009; Hansmann et al., 2011; 
Robbins et al., 2012). 
 Identification of subspecies-specific genetic polymorphisms in regulatory sequences of 
IGF2/H19 and IGF2R/AIRN. 
 Study of the link between genetic polymorphisms and DNA methylation differences in 
regulatory sequences of IGF2/H19 and IGF2R/AIRN. 
 Detailed studies of IGF2/H19 and IGF2R/AIRN tissue-specific imprinting in the 
genetic groups and developmental stages. 
 Study of correlation between differences in tissue-specific imprinting status and 
overall expression of IGF2/H19 and IGF2R/AIRN. 
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 Study of correlation between differences in tissue-specific DNA methylation and 
overall expression of IGF2/H19 and IGF2R/AIRN. 
 Study of correlation between differences in tissue-specific DNA methylation and 
imprinting status of IGF2/H19 and IGF2R/AIRN. 
This will link changes in epigenetric modification and mechanisms with differences in 
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Appendix 1 Protocol of RNA extraction using AllPrep™ DNA/RNA Micro (Qiagen GmbH, 
Inc., Hilden, Germany). 
1. Add 350 μl Buffer RLT Plus to the tissue (maximum 10 mg). 
2. Perform homogenisation using ceramic beads, as optimised. 
3. Centrifuge the lysate for 3 min at full speed. Carefully remove the supernatant by 
pipetting, and transfer it to an AllPrep DNA spin column placed in a 2 ml collection 
tube (supplied). Close the lid gently, and centrifuge for 30 s at ≥8000 x g (≥10,000 
rpm). 
4. Place the AllPrep DNA spin column in a new 2 ml collection tube (supplied), and 
store at room temperature (15–25ºC) or at 4ºC for later Genomic DNA purification. 
5. Add 1 volume (usually 350 μl) of 70% ethanol to the flow-through from step 4, and 
mix well by pipetting. 
6. Transfer the sample, including any precipitate that may have formed, to an RNeasy 
MinElute spin column placed in a 2 ml collection tube (supplied). Close the lid gently, 
and centrifuge for 15 s at ≥8000 x g (≥10,000 rpm). Discard the flowthrough. 
7. Add 700 μl Buffer RW1 to the RNeasy MinElute spin column. Close the lid gently, 
and centrifuge for 15 s at ≥8000 x g (≥10,000 rpm) to wash the spin column 
membrane. Discard the flow-through. 
8. Add 500 μl Buffer RPE to the RNeasy MinElute spin column. Close the lid gently, 
and centrifuge for 15 s at ≥8000 x g (≥10,000 rpm) to wash the spin column 
membrane. Discard the flow-through. 
9. Add 500 μl of 80% ethanol to the RNeasy MinElute spin column. Close the lid gently, 
and centrifuge for 2 min at ≥8000 x g (≥10,000rpm) to wash the spin column 
membrane. Discard the collection tube with the flow-through. 
10. Place the RNeasy MinElute spin column in a new 2 ml collection tube (supplied). 
Open the lid of the spin column, and centrifuge at full speed for 5 min. Discard the 
collection tube with the flow-through. 
11. Place the RNeasy MinElute spin column in a new 1.5 ml collection tube (supplied). 
Add 14 μl RNase-free water directly to the centre of the spin column membrane. Close 



















Exon/intron Accession No. 
IGF2R (F) GATGGTAATGAGCAGGCTTACC 60 123 IGF2R (Exon 47) NM_174352.2 
IGF2R (R) ATCTCCTCCATCAGCCACTC 60 123 IGF2R (Exon 48) NM_174352.2 
AIRN (F) AATCTCTTGCGGAGTGTTCAT 57 136 IGF2R (intron 2) DQ835615.1 
AIRN (R) CTCTGTTGTATCGTGTCTTTCG 57 136 IGF2R (intron 2) DQ835615.1 
IGF2 (F) CTTCGCCTCGTGCTGCTATG 60 134 IGF2 (Exon 8) NM_174087.3 
IGF2 (R) GTCGGTTTATGCGGCTGGAT 60 134 IGF2 (Exon 9) NM_174087.3 
H19 (F) TCAAGATGACAAGAGATGGTGCTA 60 171 H19 (Exons 3_4) NR_003958.2 
H19 (R) GGTGTGGGTCGTCCGTTC 60 171 H19 (Exon 5) NR_003958.2 
IGF2 P0 (F) CACGCTCTAAAAATGCCCTTCA 60 103 IGF2 (intron 1) EU518675 1 
IGF2 P0 (R) TGCTCTGGCTGTGGTGCTCA 60 103 IGF2 (Exon 2) EU518675 1 
IGF2 P1e2 (F) CCTCAGCCTCATCCCCTCCTTTGC 60 217 IGF2 (Exon 2) EU518675 1 
IGF2 P1e2 (R) CTGTGCTCTATTTGCTGTGTTGTCT 60 217 IGF2 (Exon 2) EU518675 1 
IGF2 P1e3 (F) GGTCAGCCCTTTGCCCAG 62 179 IGF2 (Exon 3) NM_174087.3 
IGF2 P1e3 (R) CACCAGCACCGACTTTCCT 62 179 IGF2 (Exon 8) NM_174087.3 
IGF2 P2e4 (F) TCCAGCCTCGCGACATCA 61 66 IGF2 (Exons 4-8) DQ298749.1 
IGF2 P2e4 (R) CAAGAAGGCAAGAAGCACCA 61 66 IGF2 (Exon 8) DQ298749.1 
IGF2 P2e5 (F) TACGCAAGTCCAACGCATAGA 60 160 IGF2 (Exon 5) DQ298745.1 
IGF2 P2e5 (R) CAAGAAGGCAAGAAGCACCA 60 160 IGF2 (Exon 8) DQ298745.1 
IGF2 P3 (F) AGACAGCCCGTCCTCCCTA 60 246 IGF2 (Exon 6) BC116039 1 
IGF2 P3 (R) CACCAGCACCGACTTTCCT 60 246 IGF2 (Exon 8) BC116039 1 
IGF2 P4 (F) CAGCGAGCCTCCTGTCCA 60 64 IGF2 (Exon 7) AY957981.1 
IGF2 P4 (R) CACCAGCACCGACTTTCCT 60 64 IGF2 (Exon 8) AY957981.1 
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VPS4A (F) GAAGACAGAAGGCTACTCGGGTG 60 106 NM_001046615.1 
VPS4A (R) ACAGACCTTTTTGAAGTGTGTTGCT 60 106 NM_001046615.1 
GAK (F) CACGACCATCTCACACTACCCA 60 128 NM_001046084.2 
GAK (R) AGTTTGAGTACAAGTCCACAATTTCC 60 128 NM_001046084.2 
TBP (F) GCAACAGTTCAGTAGTTATGAGCCAG 60 164 NM_001075742.1 
TBP (R) GAATAGGGTAGATGTTCTCAAAGGCT 60 164 NM_001075742.1 
H3F3A (F) ACTGCTACAAAAGCCGCTC 60 231 XM_003586223.1 
H3F3A (R) ACTTGCCTCCTGCAAAGCAC 60 231 XM_003586223.1 
UBB (F) AGATCCAGGATAAGGAAGGCAT 62 198 NM_174133.2 
UBB (R) GCTCCACCTCCAGGGTGAT 62 198 NM_174133.2 
ACTB (F) CTCTTCCAGCCTTCCTTCCT 62 245 NM_173979.3 
ACTB (R) CCAATCCACACGGAGTACTTG 62 245 NM_173979.3 
RPS9 (F) TAGGCGCAGACGGGCAAACA 60 136 NM_001101152.2 
RPS9 (R) CCCATACTCGCCGATCAGCTTCA 60 136 NM_001101152.2 
GAPDH (F) GGGTCATCATCTCTGCACCT 62 173 NM_001034034.2 
GAPDH (R) CATAAGTCCCTCCACGATGC 62 173 NM_001034034.2 
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Appendix 4 Amplification efficiency and coefficient of determination for quantitative real 
time PCR runs for target transcripts in the studied fetal (Day-153) tissues. 







IGF2R Muscle 0.88 0.992 
IGF2R Heart 0.97 0.993 
IGF2R Liver 0.99 0.993 
IGF2R Brain 0.99 0.990 
IGF2R Cotyledon 0.92 0.992 
IGF2R Lung 0.92 0.996 
IGF2R Kidney 0.95 0.993 
IGF2 Muscle 0.96 0.999 
IGF2 Heart 0.96 0.995 
IGF2 Liver 0.96 0.997 
IGF2 Brain 0.90 0.991 
IGF2 Cotyledon 0.97 0.996 
IGF2 Lung 0.98 0.993 
IGF2 Kidney 0.88 0.99 
H19 Muscle 0.95 0.997 
H19 Heart 0.96 0.994 
H19 Liver 0.97 0.996 
H19 Brain 0.96 0.991 
H19 Cotyledon 0.95 0.996 
H19 Lung 0.99 0.993 
H19 Kidney 1.00 0.994 
AIRN Muscle 0.88 0.992 
AIRN Heart 0.87 0.993 
AIRN Liver 0.96 0.995 
AIRN Brain 1.00 0.990 
AIRN Cotyledon 0.96 0.993 
AIRN Lung 0.98 0.992 
AIRN Kidney 0.96 0.992 
IGF2 P0 Muscle 0.80 0.988 
IGF2 P1e2 Muscle 0.94 0.987 
IGF2 P1e3 Muscle 0.88 0.992 
IGF2 P2e5 Muscle 1.00 0.994 
IGF2 P2e5 Heart 0.95 0.99 
IGF2 P2e5 Liver 0.98 0.993 
IGF2 P2e5 Cotyledon 0.98 0.993 
IGF2 P2e5 Lung 0.95 0.995 
IGF2 P2e5 Kidney 0.94 0.989 
IGF2 P2e4 Muscle 0.90 0.990 
IGF2 P2e4 Liver 1.00 0.996 
IGF2 P3 Muscle 1.09 0.990 
IGF2 P3 Heart 1.06 0.992 
IGF2 P3 Liver 1.03 0.995 
IGF2 P3 Cotyledon 1.00 0.997 
IGF2 P3 Lung 1.03 0.994 
IGF2 P3 Kidney 1.08 0.996 
IGF2 P4 Muscle 0.97 0.993 
IGF2 P4 Heart 0.96 0.995 
IGF2 P4 Liver 0.98 0.994 
IGF2 P4 Cotyledon 0.91 0.993 
IGF2 P4 Lung 0.96 0.991 
IGF2 P4 Kidney 0.94 0.991 
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Appendix 5 Amplification efficiency and coefficient of determination for quantitative real 
time PCR runs for housekeeping genes in the studied fetal (Day-153) tissues. 







ACTB Muscle 0.83 0.995 
RPS9 Muscle 0.87 0.998 
UBB Muscle 0.95 0.983 
H3F3A Muscle 0.82 0.997 
TBP Muscle 1.00 0.981 
VPS4A Muscle 0.88 0.993 
GAK Muscle 0.72 0.989 
ACTB Heart 0.88 0.997 
RPS9 Heart 0.93 0.998 
UBB Heart 0.89 0.995 
H3F3A Heart 0.89 0.995 
TBP Heart 1.10 0.989 
VPS4A Heart 0.91 0.99 
GAK Heart 0.78 0.993 
ACTB Liver 0.89 0.997 
RPS9 Liver 0.90 0.998 
UBB Liver 0.87 0.994 
H3F3A Liver 0.94 0.995 
TBP Liver 0.92 0.99 
VPS4A Liver 0.93 0.995 
GAK Liver 0.72 0.991 
ACTB Brain 0.89 0.998 
RPS9 Brain 0.94 0.998 
UBB Brain 0.95 0.989 
H3F3A Brain 0.92 0.984 
TBP Brain 1.04 0.981 
VPS4A Brain 0.91 0.991 
GAK Brain 0.78 0.985 
ACTB Cotyledon 0.85 0.994 
RPS9 Cotyledon 0.97 0.996 
UBB Cotyledon 0.93 0.994 
GAPDH Cotyledon 0.98 0.998 
TBP Cotyledon 0.95 0.988 
VPS4A Cotyledon 0.94 0.996 
GAK Cotyledon 0.78 0.990 
ACTB Lung 0.85 0.993 
RPS9 Lung 0.88 0.996 
UBB Lung 0.85 0.992 
H3F3A Lung 0.90 0.995 
TBP Lung 0.88 0.990 
VPS4A Lung 0.94 0.995 
GAK Lung 0.77 0.992 
ACTB Kidney 0.90 0.994 
RPS9 Kidney 0.91 0.994 
UBB Kidney 0.85 0.992 
H3F3A Kidney 0.86 0.995 
TBP Kidney 0.97 0.986 
VPS4A Kidney 0.90 0.993 




Appendix 6 Amplification efficiency and coefficient of determination for quantitative real 
time PCR runs for analysis of expression of target transcripts in the tissues of three 
developmental stages. 
Target transcript Amplification efficiency Coefficient of determination (R
2
) 
IGF2R 0.89 0.990 
IGF2 0.96 0.998 
H19 1.00 0.997 
AIRN 0.94 0.991 
IGF2 P0 0.78 0.986 
IGF2 P1e2 0.96 0.988 
IGF2 P1e3 0.94 0.989 
IGF2 P2e5 0.98 0.992 
IGF2 P2e4 1.11 0.986 
IGF2 P3 1.16 0.987 
IGF2 P4 0.88 0.992 
 
Appendix 7 Summary of distribution of maternal and paternal genomes and sex of fetuses. 
















Figure S4 Fetal carcass weights for the four different combinations of maternal and paternal genomes and fetal 
sex at midgeststion. 
Least square means with standard errors of means and P-values for significant differences (t-test) between means 
are indicated. Data were analyzed with a general linear model in SPSS 17.00 that included the factors fetal 
genetic group i, i = Bt × Bt, Bt × Bi, Bi × Bt, Bi × Bi (paternal genetics given first) and fetal sex j, j = male, 
female. The interaction between fetal genetic group and fetal sex was included in the model but removed as it 
was not significant (P>0.05). 
 
 
Figure S5 Quadratic effects of final maternal weight nested within maternal genomes on absolute weight of fetal 
M. quadriceps femoris at midgestation. 





Figure S6 Daily weight gain and final weight for Bos taurus taurus and Bos taurus indicus dams. 
(A) Post-conception maternal daily gain: Final maternal weight – weight at conception divided by days of 
gestation. (B) Final maternal weight: Weight before slaughter on Day-153 of gestation. P-values for significantly 
different means (t-test) are indicated. Bt: Bos taurus taurus, Angus. Bi: Bos taurus indicus, Brahman. 
